
<html lang="en"     class="pb-page"  data-request-id="1392e52f-68aa-4d94-83ec-0c113932d0df"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm1016208;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-8;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Pharmacological Characterization of Fluorescent Peptides for Imaging Human V1b Vasopressin or Oxytocin Receptors" /></meta><meta name="dc.Creator" content="Maithé  Corbani" /></meta><meta name="dc.Creator" content="Miguel  Trueba" /></meta><meta name="dc.Creator" content="Stoytcho  Stoev" /></meta><meta name="dc.Creator" content="Brigitte  Murat" /></meta><meta name="dc.Creator" content="Julie  Mion" /></meta><meta name="dc.Creator" content="Véra  Boulay" /></meta><meta name="dc.Creator" content="Gilles  Guillon" /></meta><meta name="dc.Creator" content="Maurice  Manning" /></meta><meta name="dc.Description" content="Among the four known vasopressin and oxytocin receptors, the specific localization of the V1b isoform is poorly described because of the lack of selective pharmacological tools. In an attempt to ad..." /></meta><meta name="Description" content="Among the four known vasopressin and oxytocin receptors, the specific localization of the V1b isoform is poorly described because of the lack of selective pharmacological tools. In an attempt to ad..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 23, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm1016208" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm1016208" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm1016208" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm1016208" /></link>
        
    
    

<title>Design, Synthesis, and Pharmacological Characterization of Fluorescent Peptides for Imaging Human V1b Vasopressin or Oxytocin Receptors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm1016208" /></meta><meta property="og:title" content="Design, Synthesis, and Pharmacological Characterization of Fluorescent Peptides for Imaging Human V1b Vasopressin or Oxytocin Receptors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0003.jpeg" /></meta><meta property="og:description" content="Among the four known vasopressin and oxytocin receptors, the specific localization of the V1b isoform is poorly described because of the lack of selective pharmacological tools. In an attempt to address this need, we decided to design, synthesize, and characterize fluorescent selective V1b analogues. Starting with the selective V1b agonist [deamino-Cys1,Leu4,Lys8]vasopressin (d[Leu4,Lys8]VP) synthesized earlier, we added blue, green, or red fluorophores to the lysine residue at position 8 either directly or by the use of linkers of different lengths. Among the nine analogues synthesized, two exhibited very promising properties. These are d[Leu4,Lys(Alexa 647)8]VP (3) and d[Leu4,Lys(11-aminoundecanoyl-Alexa 647)8]VP (9). They remained full V1b agonists with nanomolar affinity and specifically decorated the plasma membrane of CHO cells stably transfected with the human V1b receptor. These new selective fluorescent peptides will allow the cellular localization of V1b or OT receptor isoforms in native tissues." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm1016208"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm1016208">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm1016208&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm1016208&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm1016208&amp;href=/doi/10.1021/jm1016208" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 2864-2877</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm101609j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm1016297" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Pharmacological Characterization of Fluorescent Peptides for Imaging Human V1b Vasopressin or Oxytocin Receptors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maith%C3%A9++Corbani">Maithé Corbani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miguel++Trueba">Miguel Trueba</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stoytcho++Stoev">Stoytcho Stoev</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brigitte++Murat">Brigitte Murat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Mion">Julie Mion</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=V%C3%A9ra++Boulay">Véra Boulay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gilles++Guillon">Gilles Guillon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maurice++Manning">Maurice Manning</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Institute of Functional Genomics, CNRS UMR5203- INSERM U661, University of Montpellier I and II, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France</span></div><div class="aff-info" id="aff2"><span class="aff-text">Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, Basque Country University, Leioa, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-text">Department of Biochemistry and Cancer Biology, University of Toledo College of Medicine, Toledo, Ohio, United States</span></div><div class="corresp-info">Phone: (419) 383-4131. Fax: (419) 383-6228. E-mail: <a href="/cdn-cgi/l/email-protection#14797561667d77713a79757a7a7d7a735461607b7871707b3a717061"><span class="__cf_email__" data-cfemail="b8d5d9cdcad1dbdd96d5d9d6d6d1d6dff8cdccd7d4dddcd796dddccd">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm1016208&amp;href=/doi/10.1021%2Fjm1016208" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 2864–2877</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 23, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 December 2010</li><li><span class="item_label"><b>Published</b> online</span>23 March 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 April 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm1016208" title="DOI URL">https://doi.org/10.1021/jm1016208</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2864%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaith%25C3%25A9%2BCorbani%252C%2BMiguel%2BTrueba%252C%2BStoytcho%2BStoev%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D8%26contentID%3Djm1016208%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BPharmacological%2BCharacterization%2Bof%2BFluorescent%2BPeptides%2Bfor%2BImaging%2BHuman%2BV1b%2BVasopressin%2Bor%2BOxytocin%2BReceptors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2877%26publicationDate%3DApril%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm1016208"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1128</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm1016208" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Pharmacological Characterization of Fluorescent Peptides for Imaging Human V1b Vasopressin or Oxytocin Receptors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maithé&quot;,&quot;last_name&quot;:&quot;Corbani&quot;},{&quot;first_name&quot;:&quot;Miguel&quot;,&quot;last_name&quot;:&quot;Trueba&quot;},{&quot;first_name&quot;:&quot;Stoytcho&quot;,&quot;last_name&quot;:&quot;Stoev&quot;},{&quot;first_name&quot;:&quot;Brigitte&quot;,&quot;last_name&quot;:&quot;Murat&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Mion&quot;},{&quot;first_name&quot;:&quot;Véra&quot;,&quot;last_name&quot;:&quot;Boulay&quot;},{&quot;first_name&quot;:&quot;Gilles&quot;,&quot;last_name&quot;:&quot;Guillon&quot;},{&quot;first_name&quot;:&quot;Maurice&quot;,&quot;last_name&quot;:&quot;Manning&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;2864-2877&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm1016208&quot;},&quot;abstract&quot;:&quot;Among the four known vasopressin and oxytocin receptors, the specific localization of the V1b isoform is poorly described because of the lack of selective pharmacological tools. In an attempt to address this need, we decided to design, synthesize, and characterize fluorescent selective V1b analogues. Starting with the selective V1b agonist [deamino-Cys1,Leu4,Lys8]vasopressin (d[Leu4,Lys8]VP) synthesized earlier, we added blue, green, or red fluorophores to the lysine residue at position 8 either directly or by the use of linkers of different lengths. Among the nine analogues synthesized, two exhibited very promising properties. These are d[Leu4,Lys(Alexa 647)8]VP (3) and d[Leu4,Lys(11-aminoundecanoyl-Alexa 647)8]VP (9). They remained full V1b agonists with nanomolar affinity and specifically decorated the plasma membrane of CHO cells stably transfected with the human V1b receptor. These new selective fluorescent peptides will allow the cellular localization of V1b or OT receptor isoforms in native tissues.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1016208&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1016208" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1016208&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1016208" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1016208&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1016208" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm1016208&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1016208&amp;href=/doi/10.1021/jm1016208" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm1016208" /></input><a href="/doi/pdf/10.1021/jm1016208" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm1016208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm1016208%26sid%3Dliteratum%253Aachs%26pmid%3D21428295%26genre%3Darticle%26aulast%3DCorbani%26date%3D2011%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BPharmacological%2BCharacterization%2Bof%2BFluorescent%2BPeptides%2Bfor%2BImaging%2BHuman%2BV1b%2BVasopressin%2Bor%2BOxytocin%2BReceptors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D8%26spage%3D2864%26epage%3D2877%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jmcmar.2011.54.issue-8/production/jmcmar.2011.54.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Among the four known vasopressin and oxytocin receptors, the specific localization of the V1b isoform is poorly described because of the lack of selective pharmacological tools. In an attempt to address this need, we decided to design, synthesize, and characterize fluorescent selective V1b analogues. Starting with the selective V1b agonist [deamino-Cys<sup>1</sup>,Leu<sup>4</sup>,Lys<sup>8</sup>]vasopressin (d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP) synthesized earlier, we added blue, green, or red fluorophores to the lysine residue at position 8 either directly or by the use of linkers of different lengths. Among the nine analogues synthesized, two exhibited very promising properties. These are d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (<b>3</b>) and d[Leu<sup>4</sup>,Lys(11-aminoundecanoyl-Alexa 647)<sup>8</sup>]VP (<b>9</b>). They remained full V1b agonists with nanomolar affinity and specifically decorated the plasma membrane of CHO cells stably transfected with the human V1b receptor. These new selective fluorescent peptides will allow the cellular localization of V1b or OT receptor isoforms in native tissues.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="nomen"><span><h4></h4></span><span><p class="first last">Symbols and abbreviations are in accordance with the recommendations of the IUPAC-IUB Commission on Biochemical Nomenclature ( <cite>Eur. J. Biochem.</cite> <span class="NLM_year">1989</span>, <em>180</em>, A9−A11) and IUPHAR ( <cite>Trends Pharmacol. Sci.</cite> <span class="NLM_year">2001</span>). All amino acids are in the <span class="smallcaps smallerCapital">l</span>-configuration unless otherwise noted.</p></span></div></div><div class="extra-info-sec articleNote"><h4><span>∥</span> Author Contributions</h4><p class="last">Both authors collaborated equally on this work.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Vasopressin (VP) and the VP receptor family including V1a, V1b, V2, and the related oxytocin (OT) receptor are involved in many different physiological functions. Among them, the V1b receptor is well-known for the activation of adrenocorticotropin hormone (ACTH) secretion in the pituitary, thus strongly participating, with corticotrophin releasing hormone (CRF), in the activation of the pituitary/corticotrope axis in stress and anxiety.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Vasopressin also regulates adrenal function by mediating catecholamines secretion<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and induces pancreatic insulin secretion via V1b receptors.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Besides this neuroendocrine effect, V1b receptors have been suspected to be localized centrally and to participate in cognitive and behavioral functions involved in rewarding, cognition, and sociality (see ref <a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">4</a> for review).</div><div class="NLM_p">Although several publications describe the vasopressin V1a, V2, and OT receptor distribution by using autoradiography<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> or immunodetection<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> techniques, the lack of selective radiolabeled VP analogues or of receptor antibodies has hindered progress in the detection of V1b receptor distribution in native tissues. Results obtained by molecular approaches such as polymerase chain reaction after reverse transcription (RT-PCR)<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> or messenger ribonucleic acid (mRNA) detection by in situ hybridization,<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> although more accurate, did not provide clear information regarding the brain regions detected by immunostaining. This was partially due to the fact that the probes shared common sequences with V1a and OT receptors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Fluorescent tools have been synthesized for other receptors of the VP/OT family.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> However, although good fluorescent V1a and OT ligands have been produced, to date, no good fluorescent specific ligand is available to selectively detect central and peripheral V1b receptors. Here we describe the synthesis of nine new fluorescent analogues for the human V1b receptor (hV1b-R). Two of them are promising new tools for the detection of V1b or OT receptors in native tissue. In our previous work,<a onclick="showRef(event, 'ref17 ref18 ref3 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref3 ref19">(17, 18, 3, 19)</a> by replacing the glutamine<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> of the natural arginine vasopressin (AVP) with a cyclohexylalanine or a leucine, by replacing the arginine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> with a lysine, and by removing the NH<sub>2</sub> of the cysteine<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> to increase stability toward aminopeptidases, we produced analogues showing an increased selectivity for the rat V1b receptor (rV1b-R). Namely, the [deamino-Cys<sup>1</sup>,4-leucine,8-lysine]vasopressin (d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP) analogue, previously synthesized in the du Vigneaud laboratory,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> was found to be selective for the rV1b-R<a onclick="showRef(event, 'ref3 ref19'); return false;" href="javascript:void(0);" class="ref ref3 ref19">(3, 19)</a> and, to a lesser extent, for the hV1b-R. It conserved a nanomolar affinity for these receptor isoforms.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> By studying the structure/activity of the ligand/V1b receptor complex, we have also been able to propose a model of the ligand−receptor interaction.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This model predicts that the first six amino acids would be located into a “binding pocket” inside the membrane, whereas the residues at positions 7, 8, and 9 would be outside. Thus, the Lys<sup>8</sup> residue provides an epsilon NH<sub>2</sub> group which could be used for further additions. Accordingly, we have taken advantage of the stability and good selectivity of d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP<a onclick="showRef(event, 'ref3 ref18'); return false;" href="javascript:void(0);" class="ref ref3 ref18">(3, 18)</a> to introduce fluorophores on the side chain of the Lys<sup>8</sup> residue to create fluorescent tools that would conserve the pharmacology of d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP, resist degradation, and selectively decorate with an excellent resolution the plasma membrane of CHO cells expressing V1b and/or OT receptors.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Rationale for Fluorescent Selective V1b Synthesis</h3><div class="NLM_p">We used d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (peptide <b>A</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tblIII" href="#tblIII">3</a>) as the parent molecule for designing fluorescent V1b analogues, since we had previously shown that this peptide is a V1b selective agonist for both rat and human VP/OT receptors.<a onclick="showRef(event, 'ref3 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref3 ref18 ref19">(3, 18, 19)</a> First, we carried out the addition of a hydroxyl (OH) group at the N terminal position of d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP to give [1-<span class="smallcaps smallerCapital">l</span>-(−)-2-hydroxy-3-thiopropanoic acid,4-leucine,8-lysine]vasopressin ([HO<sup>1</sup>][Leu<sup>4</sup>,Lys<sup>8</sup>]VP) (peptide <b>B</b> in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>). We had shown previously that this modification was helpful in the design of fluorescent agonists for the hOT-R.<a onclick="showRef(event, 'ref16 ref22'); return false;" href="javascript:void(0);" class="ref ref16 ref22">(16, 22)</a> We observed that the OH modification at position 1 did not affect the ligand’s affinity but strongly increased its selectivity for the hV1b-R (see Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>). We thus also synthesized a short series of OH-modified fluorescent compounds. We selected different fluorophores to attach to the d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (peptide <b>A</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). First, we chose the anthraniloyl (Atn) group, a small fluorescent molecule with MW = 97 Da and a quantum yield (<i>R</i>) of 0.358, used for the design of analogue <b>1</b> and highly sensitive to microenvironmental changes.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We have also selected the Alexa fluorophores (Molecular Probes) for their brightness and their resistance to photobleaching.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We have used Alexa Fluor 488 (Alexa 488) (MW = 643; quantum yield <i>R</i> = 0.60; molar extinction coefficient ε = 71 000) and Alexa Fluor 647 (Alexa 647) (MW ≈ 1250; <i>R</i> not determined, ε = 239 000), the latter being one of the brightest fluorescent molecules reported so far.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Moreover, Alexa fluorophores are charged molecules, soluble in water, and not prone to create molecular stacking as the tetramethylrhodamine is (which they are derived from). The aliphatic ω-aminocarboxylic acids, 3-aminopropionic acid (β-Ala), 7-aminohexanoic acid (Aha), and 11-aminoundecanoic acid (Aud) were selected as linkers of various sizes to optimize the interaction of the fluorescent ligand to the V1b receptor. Their spacer arms consist of 4, 8, and 12 atoms, respectively, and will be referred to as 4A, 8A, and 12A further in the text. The structures of the fluorescent peptides and of their parent analogues, designed according to the above rationale, are given in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. General structure of fluorescent peptides (<b>1</b>−<b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>−<b>11</b>, <b>13</b>) and parent peptides (<b>A</b>, <b>4</b>, <b>6</b>, <b>8</b>, <b>B</b>, <b>12</b>). X represents the modification on Cys<sup>1</sup> by either H atom or OH group, and Y represents the types of linker and fluorophore attached at position Lys<sup>8</sup> of the parent peptides d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) and HO<sup>1</sup>[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>B</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Physicochemical Properties of Fluorescent Peptides <b>1</b>−<b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>−<b>11</b>, <b>13</b>, Parent Peptides <b>A</b> and <b>B</b>, and Intermediates <b>4</b>, <b>6</b>, <b>8</b>, <b>12</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">TLC, <i>R<sub>f</sub></i> <a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center" char=".">yield,<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> %</th><th class="colsep0 rowsep0" align="center" char=".">a</th><th class="colsep0 rowsep0" align="center" char=".">b</th><th class="colsep0 rowsep0" align="center" char=".">c</th><th class="colsep0 rowsep0" align="center" char=".">d</th><th class="colsep0 rowsep0" align="center" char=".">HPLC<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a><i>t</i><sub>R</sub>, min</th><th class="colsep0 rowsep0" align="center">formula</th><th class="colsep0 rowsep0" align="center" char=".">MW (calcd)</th><th class="colsep0 rowsep0" align="center" char=".">MW (MS) (found)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">60.6</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">12.4</td><td class="colsep0 rowsep0" align="left">C<sub>47</sub>H<sub>67</sub>O<sub>11</sub>N<sub>11</sub>S<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1026.3</td><td class="colsep0 rowsep0" align="char" char=".">1026.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]VP<sup>e</sup></td><td class="colsep0 rowsep0" align="char" char=".">24.3</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">0.55</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="char" char=".">13.6</td><td class="colsep0 rowsep0" align="left">C<sub>54</sub>H<sub>72</sub>O<sub>12</sub>N<sub>12</sub>S<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1145.4</td><td class="colsep0 rowsep0" align="char" char=".">1145.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Alexa 488)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">74.4</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="left">C<sub>68</sub>H<sub>77</sub>O<sub>21</sub>N<sub>13</sub>S<sub>4</sub></td><td class="colsep0 rowsep0" align="char" char=".">1540.7</td><td class="colsep0 rowsep0" align="char" char=".">1540.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">43.1</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">10.1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(β-Ala)<sup>8</sup>]VP<sup>e</sup></td><td class="colsep0 rowsep0" align="char" char=".">67.9</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">15.0</td><td class="colsep0 rowsep0" align="left">C<sub>50</sub>H<sub>72</sub>O<sub>12</sub>N<sub>12</sub>S<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1097.3</td><td class="colsep0 rowsep0" align="char" char=".">1097.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(β-Ala-Alexa 647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">64.4</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">10.1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aha)<sup>8</sup>]VP<sup>e</sup></td><td class="colsep0 rowsep0" align="char" char=".">36.5</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">13.1</td><td class="colsep0 rowsep0" align="left">C<sub>54</sub>H<sub>80</sub>O<sub>12</sub>N<sub>12</sub>S<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1153.5</td><td class="colsep0 rowsep0" align="char" char=".">1153.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aha-Alexa 647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">35.0</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">10.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP<sup>e</sup></td><td class="colsep0 rowsep0" align="char" char=".">41.9</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">14.4</td><td class="colsep0 rowsep0" align="left">C<sub>58</sub>H<sub>88</sub>O<sub>12</sub>N<sub>12</sub>S<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1209.5</td><td class="colsep0 rowsep0" align="char" char=".">1209.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">55.9</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">11.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>B</b></td><td class="colsep0 rowsep0" align="left">[HO<sup>1</sup>][Leu<sup>4</sup>,Lys<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">54.2</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">11.1</td><td class="colsep0 rowsep0" align="left">C<sub>47</sub>H<sub>67</sub>O<sub>12</sub>N<sub>11</sub>S<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1042.3</td><td class="colsep0 rowsep0" align="char" char=".">1042.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">[HO<sup>1</sup>][Leu<sup>4</sup>,Lys(Alexa 488)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">39.8</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">11.3</td><td class="colsep0 rowsep0" align="left">C<sub>68</sub>H<sub>77</sub>O<sub>22</sub>N<sub>13</sub>S<sub>4</sub></td><td class="colsep0 rowsep0" align="char" char=".">1556.7</td><td class="colsep0 rowsep0" align="char" char=".">1556.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">[HO<sup>1</sup>][Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">49.6</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">11.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">[HO<sup>1</sup>][Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP<sup>e</sup></td><td class="colsep0 rowsep0" align="char" char=".">54.4</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">12.7</td><td class="colsep0 rowsep0" align="left">C<sub>58</sub>H<sub>88</sub>O<sub>13</sub>N<sub>12</sub>S<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1225.6</td><td class="colsep0 rowsep0" align="char" char=".">1226.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">[HO<sup>1</sup>][Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="char" char=".">55.1</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">11.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Yields are based on the amount of peptide used in the reaction and are uncorrected for acetic acid, TFA, and water content. Yields of peptides <b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>, <b>11</b>, and <b>13</b> are approximated and based on the MW (∼1250) of Alexa 647 given by Invitrogen/Molecular Probes (pending patent).</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Solvent systems and conditions are given in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">All peptides were at least 95% pure. For elution, a linear gradient 90:10 to 30:70 (0.05% aqueous TFA/0.05% TFA in CH<sub>3</sub>CN) over 30 min with flow rate 1.0 mL/min was applied.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (A) was resynthesized as previously described.<a onclick="showRef(event, 'ref3 ref19'); return false;" href="javascript:void(0);" class="ref ref3 ref19">(3, 19)</a> For original synthesis see ref <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a>. Abbreviations of position 8 substituents and linkers are as follows: Atn (anthraniloyl), β-Ala (β-alanine), Aha (7-aminoheptanoic acid), and Aud (11-aminoundecanoyl).</p></div></div></div><div class="NLM_table-wrap" id="tblII"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Properties of Fluorescent Vasopressin Analogues for Human Vasopressin and Oxytocin Receptors<a class="ref internalNav" href="#tblII-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">affinity <i>K</i><sub>i</sub> for [<sup>3</sup>H]AVP (nM)</th><th class="rowsep1 colsep0" colspan="3" align="center">hV<sub>1b</sub>-R selectivity index (SI)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">analogue</th><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center">hV<sub>1a</sub>-R</th><th class="colsep0 rowsep0" align="center">hV<sub>1b</sub>-R</th><th class="colsep0 rowsep0" align="center">hV<sub>2</sub>-R</th><th class="colsep0 rowsep0" align="center">hOT-R</th><th class="colsep0 rowsep0" align="center">V<sub>1a</sub>/V<sub>1b</sub></th><th class="colsep0 rowsep0" align="center">V<sub>2</sub>/V<sub>1b</sub></th><th class="colsep0 rowsep0" align="center">OT/V<sub>1b</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AVP</td><td class="colsep0 rowsep0" align="left">AVP<a class="ref internalNav" href="#tIIfn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.68 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.5</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP<a class="ref internalNav" href="#tIIfn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">69 ± 16</td><td class="colsep0 rowsep0" align="left">0.52 ± 0.07</td><td class="colsep0 rowsep0" align="left">6714 ± 806</td><td class="colsep0 rowsep0" align="left">29 ± 6</td><td class="colsep0 rowsep0" align="left">133</td><td class="colsep0 rowsep0" align="left">12912</td><td class="colsep0 rowsep0" align="left">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">246 ± 53</td><td class="colsep0 rowsep0" align="left">0.65 ± 0.22</td><td class="colsep0 rowsep0" align="left">4918 ± 1447</td><td class="colsep0 rowsep0" align="left">21 ± 5</td><td class="colsep0 rowsep0" align="left">378</td><td class="colsep0 rowsep0" align="left">7566</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Alexa488)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">258 ± 36</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="left">30 ± 9</td><td class="colsep0 rowsep0" align="left">215</td><td class="colsep0 rowsep0" align="left">>83333</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Alexa647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">12,033 ± 1903</td><td class="colsep0 rowsep0" align="left">165 ± 16</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="left">36 ± 7.5</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">>606</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(β-Ala)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">215 ± 50</td><td class="colsep0 rowsep0" align="left">1,3 ± 0,5</td><td class="colsep0 rowsep0" align="left">5200 ± 190</td><td class="colsep0 rowsep0" align="left">12.6 ± 2.1</td><td class="colsep0 rowsep0" align="left">165</td><td class="colsep0 rowsep0" align="left">4000</td><td class="colsep0 rowsep0" align="left">9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(β-Ala-Alexa647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">8011 ± 2035</td><td class="colsep0 rowsep0" align="left">65 ± 11</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="left">62 ± 9</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">>1538</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aha) <sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">266 ± 28</td><td class="colsep0 rowsep0" align="left">0.61 ± 0.05</td><td class="colsep0 rowsep0" align="left">22010 ± 3310</td><td class="colsep0 rowsep0" align="left">22 ± 7</td><td class="colsep0 rowsep0" align="left">436</td><td class="colsep0 rowsep0" align="left">36082</td><td class="colsep0 rowsep0" align="left">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>, Lys(Aha−Alexa647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">2158 ± 369</td><td class="colsep0 rowsep0" align="left">74 ± 6</td><td class="colsep0 rowsep0" align="left">70705 ± 17325</td><td class="colsep0 rowsep0" align="left">121 ± 16</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">955</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">384 ± 93</td><td class="colsep0 rowsep0" align="left">3.7 ± 1.5</td><td class="colsep0 rowsep0" align="left">31100 ± 7900</td><td class="colsep0 rowsep0" align="left">210 ± 67</td><td class="colsep0 rowsep0" align="left">104</td><td class="colsep0 rowsep0" align="left">8405</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aud-Alexa647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">1930 ± 326</td><td class="colsep0 rowsep0" align="left">13.0 ± 3.9</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="left">86 ± 27</td><td class="colsep0 rowsep0" align="left">148</td><td class="colsep0 rowsep0" align="left">>7692</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>B</b></td><td class="colsep0 rowsep0" align="left">HO[Leu<sup>4</sup>, Lys<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">879 ± 123</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.5</td><td class="colsep0 rowsep0" align="left">1558 ± 137</td><td class="colsep0 rowsep0" align="left">179 ± 20</td><td class="colsep0 rowsep0" align="left">517</td><td class="colsep0 rowsep0" align="left">934</td><td class="colsep0 rowsep0" align="left">105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">HO[Leu<sup>4</sup>,Lys(Alexa488)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">55300 ± 11250</td><td class="colsep0 rowsep0" align="left">149 ± 26</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="left">963 ± 197</td><td class="colsep0 rowsep0" align="left">371</td><td class="colsep0 rowsep0" align="left">>336</td><td class="colsep0 rowsep0" align="left">671</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">HO[Leu<sup>4</sup>,Lys(Alexa647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">29300 ± 5700</td><td class="colsep0 rowsep0" align="left">1799 ± 255</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="left">324 ± 29</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">>56</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">HO[Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">2790 ± 381</td><td class="colsep0 rowsep0" align="left">8.4 ± 2.7</td><td class="colsep0 rowsep0" align="left">45000 ± 13400</td><td class="colsep0 rowsep0" align="left">3742 ± 713</td><td class="colsep0 rowsep0" align="left">332</td><td class="colsep0 rowsep0" align="left">5357</td><td class="colsep0 rowsep0" align="left">445</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">HO[Leu<sup>4</sup>,Lys(Aud-Alexa647)<sup>8</sup>]VP</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="left">668 ± 89</td><td class="colsep0 rowsep0" align="left">>100000</td><td class="colsep0 rowsep0" align="left">3415 ± 965</td><td class="colsep0 rowsep0" align="left">>150</td><td class="colsep0 rowsep0" align="left">>150</td><td class="colsep0 rowsep0" align="left">5.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tblII-fn1"><div class="footnote" id="tblII-fn1"><sup>a</sup><p class="last">Binding assays were performed on plasma membranes derived from CHO cells stably expressing the different VP/OT receptors as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. <i>K</i><sub>i</sub> values are the mean ± SEM of at least three independent experiments, each performed in triplicate. For each analogue, the hV<sub>1b</sub>-R SI was calculated as follows: SI = (<i>K</i><sub>i</sub> analogue for hV<sub><i>x</i></sub>-R)/(<i>K</i><sub>i</sub> analogue for hV<sub>1b</sub>-R), where hV<sub><i>x</i></sub>-R is hV<sub>1a</sub>-R, hV<sub>2</sub>-R, or hOT-R. Abbreviations of the linkers are as follows: β-Ala (β-alanine, 4A), Aha (7-aminoheptanoic acid, 8A), and Aud (11-aminoundecanoyl, 12A). Atn is for anthraniloyl.</p></div><div class="footnote" id="tIIfn1"><sup>b</sup><p class="last">Data from reference.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></p></div></div></div><div class="NLM_table-wrap" id="tblIII"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Functional Properties of Some Fluorescent Analogues on Phospholipase C Activity in CHO Cells Stably Expressing Human V1b or OT Receptors<a class="ref internalNav" href="#tblIII-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">CHO hV1b-R</th><th class="rowsep1 colsep0" colspan="2" align="center">CHO hOT-R</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">analogue</th><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AVP<a class="ref internalNav" href="#tIIIfn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">8.3 ± 2.2</td><td class="colsep0 rowsep0" align="left">27.5 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OT</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">24.5 ± 2.6</td><td class="colsep0 rowsep0" align="left">31 ± 1</td><td class="colsep0 rowsep0" align="left">10.8 ± 1.3</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys<sup>8</sup>]-VP<a class="ref internalNav" href="#tIIIfn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.5 ± 0.4</td><td class="colsep0 rowsep0" align="left">99 ± 6</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]-VP</td><td class="colsep0 rowsep0" align="left">2.48 ± 2.1</td><td class="colsep0 rowsep0" align="left">108 ± 8.5</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Alexa 488)<sup>8</sup>]-VP</td><td class="colsep0 rowsep0" align="left">6.93 ± 4</td><td class="colsep0 rowsep0" align="left">93.1 ± 4.6</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]-VP</td><td class="colsep0 rowsep0" align="left">401 ± 14</td><td class="colsep0 rowsep0" align="left">112 ± 9</td><td class="colsep0 rowsep0" align="left">70.6 ± 19</td><td class="colsep0 rowsep0" align="left">73.4 ± 5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aha-Alexa 647)<sup>8</sup>]-VP</td><td class="colsep0 rowsep0" align="left">267 ± 44</td><td class="colsep0 rowsep0" align="left">106.7 ± 4.3</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]-VP</td><td class="colsep0 rowsep0" align="left">11.4 ± 2.6</td><td class="colsep0 rowsep0" align="left">102 ± 2</td><td class="colsep0 rowsep0" align="left">172 ± 22</td><td class="colsep0 rowsep0" align="left">69.7 ± 3.05</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tblIII-fn1"><div class="footnote" id="tblIII-fn1"><sup>a</sup><p class="last">Phospholipase C stimulation was performed on CHO cells stably expressing hV1b-R or hOT-R. For each analogue, EC<sub>50</sub> values and <i>E</i><sub>max</sub> were calculated as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Results are the mean ± SEM of at least three independent experiments, each performed in triplicate.</p></div><div class="footnote" id="tIIIfn1"><sup>b</sup><p class="last">Data from ref <a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">3</a>.</p></div></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Binding Pharmacological Properties of Fluorescent Analogues</h3><div class="NLM_p">We first characterized the binding properties of each analogue and compared their affinities to those of AVP or of the corresponding parent peptide <b>A</b> or peptide <b>B</b> taken as references (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>). Attaching the Atn fluorophore directly to the d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) to give d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]VP (analogue <b>1</b>) did not affect the affinity for the hV1b-R (0.65 vs 0.52 nM) and poorly changed the selectivity versus the hV1a, hV2, and hOT receptors. Thus, since there was no major decrease in affinity or selectivity, we did not perform further modifications of analogue <b>1</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding pharmacological profiles of d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) and d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP analogue <b>9</b> for human vasopressin and oxytocin receptors stably expressed in CHO cells lines. The binding properties of analogues <b>3</b> and <b>9</b> were determined by competition experiments on plasma membranes prepared from CHO cells stably expressing hV1a-R, hV2-R, hV1b-R, or hOT-R. Plasma membranes expressing the different VP/OT receptor isoforms were incubated for 1 h at 30 °C with ∼1 nM <sup>3</sup>[H]AVP in the presence or absence (control, C) of increasing concentrations of unlabeled analogue <b>3</b> or <b>9</b>. Nonspecific and total binding were determined respectively with and without 1 μM of either AVP or OT, depending on the nature of the receptor studied. Specific binding calculated as the difference between total and nonspecific binding is expressed as percent of the corresponding control specific binding and is the mean ± SEM of at least three independent experiments each performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For analogue <b>2</b>, d[Leu<sup>4</sup>,Lys(Alexa 488)<sup>8</sup>]VP, with Alexa 488 replacing Atn, the affinity for the hV1b receptor was still very good, with a <i>K</i><sub>i</sub> of 1.2 nM compared to 0.52 nM for the parent analogue <b>A</b>. Its selectivities toward the hV1a-R and hV2-R were excellent (Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>). For analogue <b>3</b>, d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP, the affinity for the hV1b-R dropped dramatically to 165 nM (Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), probably because of the relative size of the fluorescent moiety. The Alexa 647 fluorophore is indeed about twice as big as Alexa 488, thus conferring a MW of ∼2200 to analogue <b>3</b> vs 1500 for analogue <b>2</b>. In spite of its loss of affinity, analogue <b>3</b> retained good selectivity for the hV1b versus the hV1a and hV2 receptors. Moreover, both fluorescent V1b analogues <b>2</b> and <b>3</b> exhibited a good affinity for the hOT-R: 30 nM for analogue <b>2</b> (Alexa 488) and 36 nM for analogue <b>3</b> (Alexa 647). Introducing an OH group at position 1 of analogue <b>A</b> to give <b>B</b> ([HO][Leu<sup>4</sup>,Lys<sup>8</sup>]VP) reduced the affinity of this analogue for the hOT-R (<i>K</i><sub>i</sub> of 179 nM for analogue <b>B</b> vs 29 nM for analogue <b>A</b>). Thus, we synthesized analogues of <b>B</b> coupled to Alexa 488 (analogue <b>10</b>) and to Alexa 647 (analogue <b>11</b>). Introducing an Alexa 488 or Alexa 647 to <b>B</b> led to decreases of the affinities for the hOT-R of the resultant fluorescent peptides <b>10</b> and <b>11</b>. For the Alexa 488 analogue <b>10</b>, the <i>K</i><sub>i</sub> for hOT-R was 963 nM compared with 30 nM for analogue <b>2</b>. The Alexa 647 derivative (analogue <b>11</b>) exhibited a <i>K</i><sub>i</sub> for hOT-R of 324 nM compared with 36 nM for analogue <b>3</b>. However, the affinities of peptides <b>10</b> and <b>11</b> for hV1b-R also dropped dramatically (from 1.2 to 149 nM for the Alexa 488 analogues (<b>2</b> and <b>10</b>) and from 165 to 1799 nM for the Alexa 647 analogues (<b>3</b> and <b>11</b>).</div><div class="NLM_p">In order to improve the affinity of the Alexa 647 analogues for the hV1b-R, we introduced linkers of different lengths. We first verified that attaching linkers to the reference analogue d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) maintained the affinity of the nonfluorescent analogues for the hV1b-R within the nanomolar range (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>). Adding a 4A-spacer (3-aminopropionyl) βAla to d[Leu<sup>4</sup>,Lys(Alexa647)<sup>8</sup>]VP analogue <b>3</b> to give d[Leu<sup>4</sup>,Lys(β-Ala-Alexa 647)<sup>8</sup>]VP (analogue <b>5</b>) improved its affinity (65 nM for analogue <b>5</b> compared with 165 nM for analogue <b>3</b>) but did not improve its selectivity for hV1b versus hOT receptors (selectivity index of 1 for analogue <b>5</b> vs 0.2 for analogue <b>3</b>). Increasing the length of the spacer to eight atoms with a 7-aminohexanoyl (Aha) linker to give d[Leu<sup>4</sup>,Lys(Aha-Alexa 647)<sup>8</sup>]VP (analogue <b>7</b>) modestly improved the affinity and selectivity of analogue <b>7</b>. Further increasing the length of the spacer to 12 atoms with an 11-aminoundecanoyl (Aud) linker to give d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (analogue <b>9</b>) significantly improved the affinity and selectivity of analogue <b>9</b>. The <i>K</i><sub>i</sub> was 13 nM for analogue <b>9</b> compared to 165 nM for analogue <b>3</b>. This improvement might result from the fact that the high MW fluorescent moiety is now more distant from the core peptide (<b>A</b>) and does not hamper the ligand−receptor interaction as much (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The selectivity was also much better (SI of 6.6 compared to 0.2, Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In order to try to gain more V1b-R selectivity vs OT-R, an OH-version of analogue <b>9</b> (HO[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP, analogue <b>13</b>) was also synthesized. The affinity severely dropped (from 13 to 668 nM) without any improvement in its selectivity. We thus decided to forego using HO[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (peptide <b>B</b>) for any further designs of fluorescent V1b ligands.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Influence of the size of the linker between Alexa 647 and peptide <b>A</b> on its V1b affinity and selectivity for human vasopressin and oxytocin receptors. (A) The V1b affinity of parent analogues <b>A</b>, <b>4</b>, <b>6</b>, and <b>8</b> and that of their corresponding peptides with Alexa 647 attached to linkers of different lengths (analogues <b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>) are plotted as the numbers of atoms in the spacer bound to Lys<sup>8</sup>. Values are from Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>. (B) The hV1b-R selectivity index of analogues described above is plotted as the number of atoms of the spacer bound to Lys<sup>8</sup>. Values are from Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a> with V1b selectivity index calculated as log[<i>K</i><sub>i</sub>(hVx-R)/<i>K</i><sub>i</sub>(hV1b-R)], where Vx is hV2-R, hV1a-R, or hOT-R.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Functional Properties of Fluorescent Peptides: Capacity To Stimulate Phospholipase C</h3><div class="NLM_p">As both the hV1b and hOT receptors are directly coupled to phospholipase C (PLC),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> we measured the ability of each fluorescent analogue to activate PLC in stably transfected CHO cells. First we looked at the capacity of the most promising analogues to stimulate PLC in a CHO hV1b-R cell line. As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and summarized in Table <a class="ref showTableEvent internalNav" data-ID="tblIII" href="#tblIII">3</a>, with the exception of OT, which behaved as a partial agonist of the hV1b-R (31% of maximal VP-stimulated PLC activation), all analogues tested were full agonists with analogue <b>3</b> having a higher EC<sub>50</sub>. The Atn analogue (<b>1</b>) and the Alexa 488 analogue (<b>2</b>) showed EC<sub>50</sub> in the same range as analogue <b>A</b> and AVP (Table <a class="ref showTableEvent internalNav" data-ID="tblIII" href="#tblIII">3</a>). The Alexa 647 analogues <b>3</b>, <b>7</b>, and <b>9</b>, although full agonists, showed EC<sub>50</sub> values of 401 nM for analogue <b>3</b> (Alexa 647 directly attached to analogue <b>A</b>) and 267 nM for analogue <b>7</b> (having the 8A, Aha linker). Only the 12A Aud-peptide (analogue <b>9</b>) displayed a good EC<sub>50</sub> of 11.4 nM for hV1b-R coupling. Second, as the Alexa 647 compounds displayed some affinity for the hOT-R too, we also compared their capacities to activate PLC in a CHO hOT-R cell line. We observed that, compared to OT, the natural ligand AVP was a partial agonist (27.5% of maximal OT-stimulated PLC activation). Analogues <b>3</b> and <b>9</b> also displayed partial agonism, with ∼70% of PLC activation compared to the one induced by the natural agonist OT. In general, the respective EC<sub>50</sub> of all analogues for either the hV1b-R or the hOT-R remained well correlated with their binding properties (compare Tables <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a> and <a class="ref showTableEvent internalNav" data-ID="tblIII" href="#tblIII">3</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Functional properties of d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) and d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (analogue <b>9</b>) on phospholipase C activity in CHO cells stably expressing the human V1b and OT receptors. Left: CHO cells stably expressing the hV<sub>1b</sub>-R were incubated with or without (control) increasing amounts of fluorescent or parent peptides. Total inositol phosphate (InsP) that accumulated was measured as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and expressed as % of maximal AVP stimulation (1 μM). Data are the mean ± SEM of three independent experiments, each performed in triplicate. Right: Similar experiments were performed with CHO cells stably expressing the hOT-R. Total inositol phosphate that accumulated was measured as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and expressed as the % of maximal OT stimulation (1 μM). Data are the mean ± SEM of three independent experiments, each performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Labeling Properties of Fluorescent Peptides Evaluated by Spectrofluorimetry and Cell Imaging</h3><div class="NLM_p">The Atn analogue <b>1</b>, d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]VP, was designed to provide a fluorescent V1b selective ligand with blue emission that could be a possible partner of an Alexa 488 analogue to record experimental fluorescence resonance energy transfer (FRET) between V1b homodimers. Since UV confocal microscopes are not easily available, the Atn analogue <b>1</b> cannot be tested by imaging but by spectrofluorimetry of cell suspensions in cuvettes. Living CHO cells, stably expressing hV1b receptors, were exposed to analogue <b>1</b> for 1 h at 12 °C, washed, and evaluated for the fluorescence emitted at the wavelength (λ) of 412 nm by spectrofluorimetry. Complete excitation and emission spectra were established previously, and the value of 412 nm was found to be the λ<sub>max</sub> of experimental emission for analogue <b>1</b> whereas the λ<sub>max</sub> of excitation was confirmed to be 343 nm (data not shown). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> (A), analogue <b>1</b> can display a saturable fluorescent binding in Dulbecco’s modified Eagles medium/bovine serum albumin/4-2-hydroxylethyl-l-piperazineethanesulfonic acid (DMEM/BSA/HEPES) buffer with a fluorescence (EC<sub>50</sub>) of 1.7 nM, a value very close to the one obtained by binding experiments performed on membrane preparations derived from CHO cells stably expressing hV1b-R (0.65 nM). This binding (analogue <b>1</b> used at the saturating concentration of 10 nM) can be completely suppressed with an excess of the nonfluorescent analogue <b>A</b> (1 μM) demonstrating its specificity (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Fluorescent properties of d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]VP (analogue <b>1</b>), d[Leu<sup>4</sup>,Lys(Alexa 488)<sup>8</sup>]VP (analogue <b>2</b>), and d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) on CHO cells stably expressing the human V1b receptor. (A) Histogram (top): Cells in suspension were incubated for 1 h at 12 °C with 10 nM analogue <b>1</b> in the absence (dark bar) or in the presence (hatched bar) of 1 μM d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (analogue <b>A</b>) and compared to control cells incubated without fluorescent ligand (white bar). Cells were washed three times with cold PBS and measured for fluorescent emission at 412 nm in cuvettes of spectrofluorimetry. Saturation curve (bottom): Aliquots of cells were incubated with increasing concentrations of analogue <b>1</b> for 1 h at 12 °C, washed three times, and counted for fluorescence emission at 412 nm. The endogenous fluorescence at 412 nm of control cells, not exposed to fluorescent ligand, was deduced for each concentration. (B) CHO hV1b-R cells grown on coverslips were incubated in the presence of analogue <b>2</b> (50 nM) or of analogue <b>3</b> (250 nM) for 1 h at 12 °C in the absence or in the presence of 1 μM d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (analogue <b>A</b>). Confocal imaging was performed with Zeiss LSM510 Meta microscope using a 63× (NA 1.4) objective with an argon laser excitation at 488 nm and a BP 505−530 nm emission filter for analogue <b>2</b> (green) and with a helium/neon laser excitation at 633 nm with a LP650 for emission for analogue <b>3</b> (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Fluorescent derivatives of the V1b agonist d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (A) were designed to provide tools for imaging the V1b-R on cells in culture. To verify this point, confocal imaging was conducted on living CHO stable cell lines, expressing either one of the four human receptors, i.e., V1a-R, V1b-R, V2-R, or OT-R. Only CHO cells expressing the hV1b-R and the hOT-R could be labeled. The CHO hV1a-R and the CHO hV2-R remained unlabeled, even at the concentration of 500 nM of either Alexa 488 or Alexa 647 analogues (data not shown). In CHO hV1b-R, the binding appeared to be patchy and mainly localized at the plasma membrane (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B and Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> right panels). This “patchy” effect was not due to internalization, since the experiments were conducted at 12 °C, a temperature below the chain-melting transition temperature of the membrane lipids (16 °C). This aspect was also observed after one night of incubation at 4 °C, a condition where internalization cannot take place either (data not shown). Moreover, the distribution of the fluorescent labeling with either Alexa 488 or Alexa 647 compounds was found to be similar and was completely suppressed in the presence of 1 μM analogue <b>A</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Displacement of d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) and of d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (analogue <b>9</b>) binding with nonfluorescent ligands on CHO hV1b-R and hOT-R stable cell lines. CHO cells on coverslips were incubated in the presence of analogue <b>3</b> (250 nM) or of analogue <b>9</b> (150 nM) for 1 h at 12 °C in the absence or in the presence of 100 nM selective V1b agonist d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (analogue <b>A</b>) or of 1 μM non-peptide AVP V2 antagonist <b>15</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or of 500 nM V1a/OT peptide antagonist Manning compound.<a onclick="showRef(event, 'cit27a'); return false;" href="javascript:void(0);" class="ref cit27a">(27a)</a> Confocal imaging was performed with Zeiss LSM510 Meta microscope using a 63× (NA 1.4) with laser excitation at 633 nm and LP650 for emission. The bar represents 10 μm (zoom 4×). Images are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> further shows the ability of the fluorescent analogues <b>3</b> and <b>9</b> to selectively label hV1b or hOT receptors at the plasma membrane of stably transfected CHO cells. Plasma membrane labeling observed on CHO hV1b-R cells incubated with 250 nM of analogue <b>3</b> (a mixed OT/V1b agonist; see Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>) is totally suppressed by co-incubation with 100 nM analogue <b>A</b> but only very partially when similar experiments were performed on CHO hOT-R cells (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, top rows). The complete displacement of analogue <b>3</b> from CHO hOT-R was obtained only with 500 nM or more of <b>A</b>, in agreement with its respective affinities for hV1b-R (0.52 nM) compared to hOT-R (29 nM).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> As expected, [1-β-mercapto-β,β-cyclopentamethylenepropionyl,2-0-methyl tyrosine,8-arginine]vasopressin (Manning compound) (500 nM), a mixed OT/V1a antagonist,<a onclick="showRef(event, 'ref26 cit27a cit27b'); return false;" href="javascript:void(0);" class="ref ref26 cit27a cit27b">(26, 27a, 27b)</a> totally displaced analogue <b>3</b> from CHO hOT-R cells but not from CHO hV1b-R cells. Similarly, total displacement of analogue <b>3</b> from CHO hOT-R cells was also obtained with a specific non-peptide OT antagonist, 4-chloro-3-[(3<i>R</i>)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1<i>H</i>-indol-3-yl]-<i>N</i>-ethyl-<i>N</i>-(3-pyridylmethyl)benzamide, hydrochloride (<b>14</b>) (SR126768A)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (100 nM), and this displacement was not seen on CHO hV1b-R cells (not shown). Analogue <b>3</b> labeling was not displaced by the selective non-peptide AVP V2 antagonist (1-[4-<i>N</i>-<i>tert</i>-butylcarbamoyl)-2-methoxybenzenesulfonyl]-5-ethoxy-3-spiro-[4-(2-morpholinoethoxy)cyclohexane]indol-2-one, phosphate monohydrate (<b>15</b>) (SR121463)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (1 μM), neither from CHO hV1b-R nor from CHO hOT-R cells.</div><div class="NLM_p">The labeling of hV1b-R CHO cells with 150 nM analogue <b>9</b> (a selective V1b agonist; see Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>) was intense and completely displaced by 100 nM <b>A</b> but neither by 500 nM Manning compound nor by 1 μM <b>15</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, bottom row left). When similar experiments were performed on CHO hOT-R cells, the labeling was very low and both <b>A</b> (V1b selective) and Manning compound (OT/V1a peptide antagonist) totally displaced analogue <b>9</b> labeling (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, bottom row right). However, this labeling was not displaced by the non-peptide AVP V2 antagonist <b>15</b> (1 μM) neither from CHO hV1b-R nor from CHO hOT-R cells as previously shown for analogue <b>3</b>.</div><div class="NLM_p">In order to fully characterize the imaging properties of the two analogues <b>3</b> and <b>9</b>, we have established saturation curves of each analogue in the conditions of living cells (DMEM/BSA/HEPES) on CHO cells expressing either V1b-R or OT-R. The membrane fluorescence was quantified with a laser scanning microscope (LSM) browser after confocal imaging using helium/neon laser 633 nm for detecting Alexa 647 analogues (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Analogue <b>9</b>, which displays a better affinity for the hV1b-R as compared to analogue <b>3</b> (as measured by competition studies on membrane preparations with <sup>3</sup>[H]-AVP, see Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>), also showed a better capacity to bind membrane V1b-R sites on living cells at low concentration (affinity of the fluorescent ligand of 14.23 ± 2.19 nM for analogue <b>9</b> compared to 172.3 ± 19 nM for analogue <b>3</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a> left panel). On CHO hOT-R cells, the affinities of the two analogues were quite similar, with a slight preference for analogue <b>3</b> (109 ± 9.7 nM) compared to analogue <b>9</b> (162 ± 17 nM) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, right panel), reflecting the results obtained in the displacement studies performed with <sup>3</sup>[H]AVP (Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Fluorescent binding properties of d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) and d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (analogue <b>9</b>) on CHO cells stably expressing the human V1b and OT receptors. CHO hV1b-R cells on coverslips were incubated in the presence of increasing concentrations of analogue <b>3</b> or of analogue <b>9</b> for 1 h at 12 °C, washed 3 times with PBS, and fixed with 4% PFA. Confocal imaging was performed with a Zeiss LSM510 Meta microscope using a 63× objective with a helium/neon laser excitation at 633 nm with a LP650 for emission. Membrane fluorescence was evaluated on 30−40 cells for each concentration of analogue by LSM Browser and ImageJ using the 1−250 fluorescent unit dynamics. After deduction of the values of control unlabeled lines 5−7 cells, saturation curves were constructed with the mean of three distinct experiments and expressed as % of the maximal labeling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Receptors of the vasopressin and OT family are important in the regulation of the stress processes (review in ref <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>). Centrally, the V1b receptors have been involved in stress and especially in learning and memory processes. Important data have been obtained by the use of knock-out (KO) animals, but after a period of cloning and pharmacological characterization in the past decade, it became necessary to elucidate the distribution of these receptors to better understand their central functions in vivo.</div><div class="NLM_p">To do so, tracers are necessary and the radiolabeled natural hormones were the first candidates to detect receptors in situ. However, because of the close affinity between AVP and OT for the OT receptors,<a onclick="showRef(event, 'ref26 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref31">(26, 31)</a> it is very difficult to discriminate between their receptor sites. Other studies were conducted using receptor antibodies, but since no good antibody against the V1b-R is available, the information about V1b receptor localization remains uncertain. Moreover, data obtained by in situ hybridization experiments were not always reliable, because of the partial similarities between the VP and OT receptor probes,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> and reflect mRNA levels encoding the receptor and not the expression of the receptor itself.</div><div class="NLM_p">Agonists and antagonists for different classes of receptors have been produced, but still, all were not completely selective, especially toward the V1b-R.<a onclick="showRef(event, 'cit27b'); return false;" href="javascript:void(0);" class="ref cit27b">(27b)</a> A selective V1b agonist was produced by replacement in AVP of the glutamine residue in position 4 by a leucine<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and made highly resistant to degradation by deamination at the Cys<sup>1</sup> position. The subsequent replacement of Arg<sup>8</sup> by a Lys<sup>8</sup>, leading to the V1b agonist <b>A</b>,<a onclick="showRef(event, 'ref3 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref3 ref19 ref20">(3, 19, 20)</a> did not modify its V1b selectivity. This allowed the covalent addition of a fluorophore to the free ε NH<sub>2</sub> group of the Lys residue at position 8 in <b>A</b>, thus making possible the synthesis of new fluorescent V1b agonists.</div><div class="NLM_p">Taking advantage of the progress in confocal microscopy and in the production of new fluorophores, we elected to design and synthesize the fluorescent V1b analogues reported here. We selected three different colors for complementary purposes. The Atn, successfully attached to the μ opioid receptor agonist DALDA (H-Dmt-<span class="smallcaps smallerCapital">d</span>-Arg-Phe-Lys-NH<sub>2</sub> with Dmt = 2′,6′-dimethyltyrosine),<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> is a good reporter of environment<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> displaying a relatively small size. Thus, we confirm here that the Atn fluorophore does not prevent d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]VP <b>(1)</b> from binding to the V1b-R with a similar affinity as the parent peptide <b>A</b> (0.65 vs 0.52 nM). It may be a good compound to probe ligand binding interactions with V1b receptors and to confirm the data about the vasopressin V1b binding pocket we have obtained by modeling.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> It may also be a good donor to a green acceptor in FRET experiments for identification of V1b-R homodimers in vivo. Thus, although other receptors of the vasopressin/oxytocin family are known to be expressed as homodimers (OT-R/OT-R)<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> or heterodimers (V1a-R/V2-R),<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> nothing is known about V1b-R monomers or dimers. Only heterodimers of V1b-R with corticotrophin-releasing hormone receptor type 1 (CRHR1) have been described.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> We have also chosen the “Alexa family” of fluorophores (Molecular Probes) that develop very good brightness and good resistance to degradation and to photobleaching, compared to Cyanines <b>3</b> and <b>5</b>, for example,<a onclick="showRef(event, 'ref24 ref39'); return false;" href="javascript:void(0);" class="ref ref24 ref39">(24, 39)</a> and that are relatively easy to attach to peptides. The Alexa 488 was selected because it is excited in the 488 nm range, a wavelength very common on any fluorescent microscope, including the electrophysiological settings, where it can be an excellent tool to reveal cells to be recorded (data not shown). It was also a good acceptor for energy transfer with Atn (good overlapping of the emission of Atn/excitation of Alexa 488 spectra) so that we could conduct studies on V1b-R homodimers in natural tissues later. Alexa 647 was also selected because it provides an extremely bright signal (ε = 239 000) compared to other Alexa fluorophores including Alexa 488 (ε = 165 000), a quality that will be essential for detecting low levels of receptors in tissue slices. As Alexa 647 excitation is in the far red, cell autofluorescence is also very low.</div><div class="NLM_p">The pharmacological properties (binding, coupling to PLC) were determined for the 13 analogues and compared with the parent peptide d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (analogue <b>A</b>) and to the two natural peptides AVP and OT (Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>). First it appears that all analogues conserved a very good selectivity for V1b-R vs V1a-R and V2-R. Directly attaching the fluorophore reduced slightly the selectivity, from 56-fold in d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (analogue <b>A</b>) to 32-fold (analogue <b>1</b>, Atn) and to 25-fold in analogue <b>2</b> (Alexa 488). The selectivity was totally inverted for analogue <b>3</b> (Alexa 647), becoming 5 times better for the OT-R compared to the V1b-R. As a possible explanation, it has been previously proposed that in the OT molecule, compared to AVP, the neutral Leu<sup>8</sup> is an important amino acid to keep OT-R selectivity, while this position has to be positively charged to interact with vasopressin receptors.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> As the Lys<sup>8</sup> of d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) (that has replaced the Arg<sup>8</sup> naturally present in AVP) is now neutralized by attaching a bulky residue on the free ε NH<sub>2</sub>, it may explain the modification of V1b-R toward OT-R selectivity. It is also possible that the bulky fluorescent molecule (especially big in the case of Alexa 647) prevents the 1−6 sequence of the peptide <b>A</b> to fit into the binding pocket situated at the top of TM5 and TM7 as described in our V1b-R model.<a onclick="showRef(event, 'ref21 ref42'); return false;" href="javascript:void(0);" class="ref ref21 ref42">(21, 42)</a> To overcome this problem, we added linkers of different sizes, 4A (βAla), 8A (Aha), and 12A (Aud). These linkers, comprising carbon chains of different lengths, all have a C-terminal NH<sub>2</sub> group to which a fluorophore could be covalently attached. We observed that, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A, the longer the linker, the more the affinity of the Alexa 647 analogue for the V1b-R becomes closer to that of the parent peptide <b>A</b>. This affinity reaches 13 nM for analogue <b>9</b>, compared to 0.52 nM for <b>A</b> and compared to 3.7 nM observed for analogue <b>8</b>, which corresponds to an analogue of <b>A</b> simply connected to the Aud linker with no fluorophore. The selectivity toward the hV1b-R also increased. Thus ,analogue <b>3</b> (Alexa 647 without a linker) is more selective for the hOT-R compared to the hV1b-R (36 nM vs 165 nM). With the Aud linker (analogue <b>9</b>), it became more selective for the hV1b-R (13 nM) compared to the hOT-R (86 nM). Thus, we totally inverted the compound selectivity (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). The selectivity for the hV1a-R and the hV2-R was not strongly modified, and both analogues <b>3</b> and <b>9</b> remained low-affinity agonists for these two receptor isoforms (over 2000-fold).</div><div class="NLM_p">We also noticed that replacing one of the hydrogens on the α carbon at position 1 by a hydroxyl group in peptide <b>A</b> to give peptide <b>B</b> enhanced the hV1bR/hOTR selectivity. Thus, for analogue <b>B</b>, the affinity for the hV1b-R was conserved (1.7 nM vs 0.52 nM), whereas the hV1bR/hOTR selectivity was doubled (V1b-R SI of 105 instead of 56). We thus synthesized OH-substituted versions of the analogues coupled to Alexa 488 or Alexa 647 (peptides <b>10</b>−<b>13</b>). Unfortunately, although the affinity for the hOT-R remained weak, the affinity for the hV1b-R also dropped (to 149 nM for the Alexa 488 analogue (<b>10</b>) and to 1799 nM for the Alexa 647 analogue (<b>11</b>). Adding a 12A linker (analogue <b>13</b>) did not improve the affinities, neither for the hOT-R (3415 nM) nor for the hV1b-R (668 nM). So we did not pursue this track any further.</div><div class="NLM_p">To fully characterize the analogues, functional coupling was evaluated for the most promising compounds (Table <a class="ref showTableEvent internalNav" data-ID="tblIII" href="#tblIII">3</a>). The activation of PLC was measured for the parent peptide <b>A</b> and the fluorophore-coupled analogues Atn (analogue <b>1</b>), Alexa 488 (analogue <b>2</b>), and Alexa 647 (analogue <b>3</b>) and with linkers (analogues <b>7</b> and <b>9</b>). The activity was compared to that of the corresponding native peptides AVP and OT in two different stable cell lines: one expressing hV1b-R, the other hOT-R. First, it appears that the EC<sub>50</sub> values were in the same range compared to the <i>K</i><sub>i</sub> values. All analogues (original <b>A</b>, Atn-, Alexa 488-, or Alexa 647-coupled analogues) were full agonists at the hV1b-R compared to the natural peptide AVP (Table <a class="ref showTableEvent internalNav" data-ID="tblIII" href="#tblIII">3</a>). Only OT displayed partial agonism. The two Alexa 647 analogues <b>3</b> and <b>9</b> were also tested on CHO hOT-R, and both displayed partial agonism, with ∼70% of activity compared to 100% observed with OT. AVP was also a partial agonist at hOT-R with an <i>E</i><sub>max</sub> of only 27.5%. It is well-known that the OT-R can couple to G<sub>q</sub> (PLC) and also to G<sub>i</sub>,<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> which is not the case for the V1b-R. These data confirm that OT can be a partial agonist for AVP receptors and, on the contrary, AVP can be a partial agonist for the OT-R. Since it is known that there is a functional antagonism between AVP and OT, the first (AVP) being released during the stress and the second (OT) being present in nursing and calming behaviors, each acting at its own receptors, the partial agonism shown here could play a role in this functional antagonism by competing for the opposite site and preventing the “opposite effect” hormone from interacting with its own receptor, thus reinforcing the physiological effects.</div><div class="NLM_p">The membrane hV1b receptors are labeled as patches. This patchy effect could reveal domains of the membrane where the receptors are concentrated. However, it does not seem to be due to the fact that the ligand is an agonist, since it also happened with other peptides from the vasopressin family including the V1a antagonist Rhm<sup>8</sup>-PVA (4OH-Ph(CH<sub>2</sub>)<sub>2</sub>CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys-(5-carboxytetramethylrhodamyl)-NH<sub>2</sub>) on rat hepatocytes cells,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> V1a/OT derivatives attached to Rhm (tetramethylrhodamyl)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and with other ligands such as Alexa 488-opioid dermorphin and deltorphin<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> on CHO cells. However, this aspect was similar to the one observed on living cells before paraformaldehyde (PFA) fixation (not shown) and we preferred this technique to the one using antibodies, where fixation and Triton permeation are necessary for receptor detection and may give distortions. Thus, we depict here functional receptors capable of PLC activation and of internalization (not shown).</div><div class="NLM_p">In this study, in contrast to studies performed only on membranes, we have validated the capacity of the fluorescent ligands <b>3</b> and <b>9</b> to label directly specific living cells and we have verified that the pharmacological and functional data fit well with the imaging data. Often, many new compounds lack full characterization on all VP and OT receptor isoforms, and because they display only a partial specificity (V1b SI < 50), they could induce nonspecific labeling of several OT/AVP receptors.<a onclick="showRef(event, 'cit27b'); return false;" href="javascript:void(0);" class="ref cit27b">(27b)</a> From our data, analogues <b>3</b> and <b>9</b> seem really promising for detecting human V1b or OT receptors. d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP analogue <b>9</b> seems more selective for the hV1b-R but also presents some affinity for hOT-R. Utilized at 150 nM and in the presence of 100 nM OT-R selective OT antagonist <b>14</b> (or of the Manning compound), it provides a very selective labeling of the hV1b-R. d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) presents a mixed affinity for hV1b and hOT receptors and can also be used in the presence of 100 nM of the non-peptide OT antagonist <b>14</b> or of the Manning compound to selectively label V1b sites. It can also be used to label OT sites in the presence of the selective non-peptide AVP V1b antagonist (2<i>S</i>,4<i>R</i>)-1-[5-chloro-1-[2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1<i>H</i>-indol-3yl]-4-hydroxy-<i>N</i>,<i>N</i>-dimethyl-2-pyrrolidine carboxamine (<b>16</b>) (SR149415).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Thus, the labeling of analogue <b>3</b> on CHO hOT-R cells was only completely suppressed with high concentrations of analogue <b>A</b>, more than 500 nM or with the non-peptide V1b antagonist <b>16</b> at a concentration higher than 500 nM (not shown) at which it can also compete with hOT-R as described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p last">To conclude, by inserting different fluorophores at position 8 in d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>), we generated two new promising fluorescent analogues d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (<b>3</b>) and d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (<b>9</b>) capable of selectively labeling hV1b-R or hOT-R expressed on CHO cells. We completely characterized their conditions of utilization. In natural conditions on nonfixed tissue, these fluorescent peptides <b>3</b> and <b>9</b>, having the Alexa 647 fluorophore attached to the lysine residue at position 8, will allow the detection of very low levels of V1b or OT binding sites on native tissues in the CNS, with almost no background, and will permit, for the first time, the cartography of the V1b receptor within the brain.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Materials</h3><div class="NLM_p">All reagents used were analytical grade. Most standard chemicals were purchased from Sigma (St. Louis, MO) or Merck (Darmstadt, Germany) unless otherwise indicated. AVP and OT were from Bachem (Bubendorf, Switzerland) and [<sup>3</sup>H]AVP (44 Ci/mmol) and myo-[2-<sup>3</sup>H]inositol (20 Ci/mmol) from PerkinElmer (Courtabœuf, France). Fetal calf serum and polyornithine came from Sigma (Saint-Quentin Fallavier, France). Dulbecco’s modified Eagle medium (DMEM) and penicillin−streptomycin were purchased from Invitrogen (Cergy Pontoise, France). Inositol-free DMEM came from ICN Biochemicals (Orsay, France). Dowex AG1-X8 formate form 200−400 mesh was purchased from Bio-Rad (Munich, Germany). All peptides and fluorescent derivatives listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Manning compound<a onclick="showRef(event, 'cit27a'); return false;" href="javascript:void(0);" class="ref cit27a">(27a)</a> were synthesized in the laboratory of Dr. M. Manning (College of Medicine, University of Toledo, OH, U.S.) as described below. The non-peptide OT antagonist <b>14</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> the non-peptide AVP V2 antagonist <b>15</b>,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and the non-peptide AVP V1b antagonist <b>16</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> were from Sanofi-Synthelabo (Toulouse, France).</div><div class="NLM_p last"><span class="smallcaps smallerCapital">l</span>-(−)-2-Hydroxy-3-methoxybenzylthiopropanoic acid (HO-Mpr(Mob) was synthesized as previously described for HO-Mpr(Bzl).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The Mpr(Meb) and Boc-11-aminoundecanoic acid were from Chem-Impex International (Wood Dale, IL). The <i>N</i><sup>α</sup>-Boc protected amino acids were purchased from Bachem (Torrance, CA) and Chem-Impex International (Wood Dale, IL). The Boc-Gly-resin was from Calbiochem-Novabiochem Corp. (San Diego, CA). The Alexa Fluor 488 carboxylic acid, 2,3,5,6-tetrafluorophenyl ester (Alexa Fluor 488 5-TFP) (5-isomer), and Alexa Fluor 647 carboxylic acid succinimidyl ester were from Invitrogen/Molecular Probes, Inc. (Eugene, OR). The <i>N</i>-carboxyanthranilic anhydride (isatoic anhydride) and Boc-β-alanine (Boc-3-aminopropionic acid) were from Sigma-Aldrich, Inc. (St. Louis, MO). The Boc-7-aminoheptanoic acid (BOC-Aha) was from Bachem (Torrance, CA). Peptide d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<b>A</b>) was resynthesized as previously described.<a onclick="showRef(event, 'ref3 ref19'); return false;" href="javascript:void(0);" class="ref ref3 ref19">(3, 19)</a> Peptide [HO<sup>1</sup>]Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>B</b>) was synthesized specifically for this study by the Merrifield solid-phase method<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> with modifications previously described<a onclick="showRef(event, 'ref48 ref49 ref3 ref19'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref3 ref19">(48, 49, 3, 19)</a> as shown in <a class="ref internalNav" href="#sec4_2" aria-label="Solid-Phase Synthesis Procedures">Solid-Phase Synthesis Procedures</a> below. TLC was run on precoated silica gel plates (60F-254, 3 Merck) with the following solvent systems: (a) 1-butanol/AcOH/H<sub>2</sub>O (upper phase) (4:1:5); (b) 1-butanol/AcOH/H<sub>2</sub>O (4:1:2); (c) 1-butanol/AcOH/H<sub>2</sub>O/pyridine (15:3:3:10); (d) 1-butanol/AcOH/H<sub>2</sub>O (2:1:1). Loads of 10−15 μg each were applied, and chromatograms were developed at a minimal length of 10 cm. For detection, a combination of monitoring on a UV lamp (model UVGL-58, UVP Inc., San Gabriel, CA) and the chlorine gas procedure for the KI-starch reagent<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> was used. Analytical HPLC was performed on a Hitachi D-7000 HPLC system under the following conditions: 90:10 to 30:70 0.05% aqueous TFA/0.05% TFA in MeCN, linear gradient over 30 min at 1.0 mL/min (λ = 254 or 214 nm) on a Vydac 218TP54 C18 column (Grace Vydac, Hesperia, CA). For semipreparative HPLC the same apparatus and gradient were used over 30 min at 5.0 mL/min (λ = 214 nm) on a Vydac 218TP510 C18 column. All peptides were at least 95% pure. Mass spectra (MS) were done by the Tuft’s Core Facility, Department of Physiology (Boston, MA) on a MALDI-TOF Voyager mass spectrometer (Perspective Biosystems/Applied Biosystems) using dihydrobenzoic acid as the matrix.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Solid-Phase Synthesis Procedures</h3><div class="NLM_p">The schematic structures of d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) and parent molecules including all fluorescent analogues are illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. Their syntheses will be described below.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> HO-Mpr(Mob)-Tyr(Bzl)-Phe-Leu-Asn-Cys(Mob)-Pro-Lys(2CIZ)-Gly-NH<sub>2</sub> (Protected Precursor for Peptide <b>B</b> (PrB))</h4><div class="NLM_p last">Boc-Gly-resin (0.7 g, 0.5 mmol) was subjected to eight cycles of deprotection, neutralization, and coupling with Boc-Lys(2CIZ), Boc-Pro, Boc-Cys(Mob), Boc-Asn-ONp, Boc-Leu, Boc-Phe, Boc-Tyr(Bzl), and HO-Mpr(Mob), respectively. A 1 M HCl/AcOH mixture was used in all the deprotection steps.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Neutralizations were carried out with 10% Et<sub>3</sub>N/CH<sub>2</sub>Cl<sub>2</sub>. All coupling reactions (except when Boc-Asn was involved) were performed by the DCC/HOBt procedure<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> in CH<sub>2</sub>Cl<sub>2</sub>/DMF (9:1, v/v). Boc-asparagine was coupled as its nitrophenyl ester<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> in DMF. The resulting protected peptidyl resin was cleaved by ammonolysis in methanol.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The protected peptide was extracted with hot DMF (30 mL), and the product was precipitated by the addition of hot water (∼300 mL). After cooling, the product was collected, dried in vacuo over P<sub>2</sub>O<sub>5</sub>, and reprecipitated from DMF (30 mL) and ether (∼200 mL). Collection and drying in vacuo over P<sub>2</sub>O<sub>5</sub> gave the required protected nonapeptide amide (PrB) 0.53 g 68.5% yield.** Mp 112−114 °C. TLC, <i>R<sub>f</sub></i> (solvent system): 0.73 (a); 0.78 (b); 0.70 (c); 0.77 (d).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> [HO<sup>1</sup>][Leu<sup>4</sup>,Lys<sup>8</sup>]VP (Free Peptide <b>B</b>)</h4><div class="NLM_p last">The Na/liquid NH<sub>3</sub> procedure<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> with the modifications previously described<a onclick="showRef(event, 'ref5 ref48 ref49 ref54'); return false;" href="javascript:void(0);" class="ref ref5 ref48 ref49 ref54">(5, 48, 49, 54)</a> was used for the deprotection of the protected precursor PrB. A solution of PrB in sodium-dried ammonia (∼400 mL) was treated at the boiling point and with stirring with sodium from a stick of metal contained in a small-bore glass tube until a light-blue color persisted in the solution for about 30 s. NH<sub>4</sub>Cl was added to discharge the color. Reoxidation of the resulting deblocked disulfydryl peptide (<b>B</b>) was performed with potassium ferricyanide (K<sub>3</sub>[Fe(CN)<sub>6</sub>]) using the modified reverse procedure<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> as follows. The peptide residue was dissolved in 25 mL of 50% AcOH, and the solution was diluted with 50 mL of H<sub>2</sub>O. The peptide solution was added dropwise with stirring over a period of 15−30 min to a 600 mL aqueous solution that contained 20 mL of a 0.01 M solution of K<sub>3</sub>[Fe(CN)<sub>6</sub>]. Meanwhile, the pH was adjusted to approximately 7.0 with concentrated ammonium hydroxide. Following oxidation, the free peptide (<b>B</b>) was isolated and purified as follows. After acidification with AcOH to pH 4.5 and stirring for 20 min with an anion exchange resin (Bio-Rad, AG 3 × 4, Cl<sup>−</sup> form, 5 g damp weight), the suspension was slowly filtered and washed with 0.2 M AcOH (3 × 30 mL). The combined filtrate and washings were lyophilized. The resulting powder was desalted on a Sephadex G-15 column (110 cm × 2.7 cm), eluting with aqueous AcOH (50%), with a flow rate of 5 mL/h.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The eluate was fractionated and monitored for absorbance at 254 nm. The fractions making up the major peak were checked by TLC, pooled, and lyophilized. The residue was further subjected to gel filtration on Sephadex LH-20 using a 100 cm × 1.5 cm column, eluting with aqueous AcOH (2 M) with a flow rate of 4 mL/min. The peptide was eluted in a single peak (absorbance at 254 nm). After lyophilization of the pertinent fractions, the collected peptide was subjected to a final semipreparative HPLC purification to give 54.9 mg (54.2%) of desired [HO<sup>1</sup>]Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>B</b>). TLC, <i>R<sub>f</sub></i> (solvent system): 0.26 (a); 0.22 (b); 0.18 (c); 0.38 (d). HPLC, <i>t</i><sub>R</sub>: 11.1 min. MW (calculated): 1042.3. MW (found by MS): 1042.6.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Fluorescent Analogue Synthesis</h4><div id="sec4_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> Peptide Labeling with Anthraniloyl (Atn) Fluorophore (Peptide <b>1</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>)</h5><div class="NLM_p last">We adapted the synthesis of Boc-Dap(Atn)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and Boc-Lys(Atn)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> for the preparation of d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]VP (peptide <b>1</b>) as follows: To a stirred solution of 12.5 mg (12.2 μM) of d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) and 1.3 mg (12.2 μM) of dry Na<sub>2</sub>CO<sub>3</sub> in water/acetonitrile (1:1 v/v, 150 μL), isatoic anhydride, 2.38 mg (14.6 μM) in 100 μL of acetonitrile, was added. The mixture was stirred overnight at room temperature at pH ∼8 and with TLC monitoring. The mixture was acidified to pH 2 with 5% aqueous KHSO<sub>4</sub> and was subjected to a two-step purification procedure, first on a Sephadex G-15 column with 25% acetic acid as eluent and finally by semipreparative HPLC to give the desired peptide <b>1.</b></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure for Peptide Labeling with Alexa 488 and Alexa 647 Fluorophores</h4><div id="sec4_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Fluorescent Peptides with Alexa Fluorophore Directly Attached at Position 8 of Parent Peptide d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) and [HO<sup>1</sup>][Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>B</b>) (Peptides <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>))</h5><div class="NLM_p last">The preparation of the fluorescent peptides <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b> was performed as described by Albizu and co-workers<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> with some modifications as follows: 1.2 μM (in excess) parent peptide d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) or [HO<sup>1</sup>][Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>B</b>) was dissolved in 100 μL of anhydrous DMF and mixed with 5 μL of DIPEA. The solution was added to 1 mg of the appropriate fluorophore. For fluorescent peptides <b>2</b> and <b>3</b> the parent peptide was d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>). For fluorescent peptides <b>10</b> and <b>11</b> the parent peptide was [HO<sup>1</sup>][Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>B</b>). The fluorophores were as follows: for peptides <b>2</b> and <b>10</b> Alexa 488 tetrafluorophenyl ester (5-carboxy pure isomer) was used. For peptides <b>3</b> and <b>11</b>, Alexa 647 succinimidyl ester was utilized. The reaction mixture was whirled using a vortex for 1 h at room temperature in the dark with pH, TLC, and HPLC monitoring. After the reaction was over, the mixture was acidified (6 μL of TFA) and evaporated in vacuo. The fluorescent peptide was isolated by semipreparative HPLC and lyophilized. Yields of <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b> are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Fluorescent Peptides with the Alexa 647 Fluorophore Attached at Position 8 of Parent Peptide d[Leu<sup>4</sup>, Lys<sup>8</sup>]VP (<b>A</b>) by Means of Spacer (Peptides <b>5</b>, <b>7</b>, <b>9</b>, and <b>13</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>))</h5><div class="NLM_p last">All peptides <b>5</b>, <b>7</b>, <b>9</b>, and <b>13</b> were prepared by a general two-step procedure as follows. First, the spacer-containing peptides d[Leu<sup>4</sup>,Lys(β-Ala)<sup>8</sup>]VP (<b>4</b>), d[Leu<sup>4</sup>,Lys(Aha)<sup>8</sup>]VP (<b>6</b>), d[Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP (<b>8</b>), and [HO<sup>1</sup>][Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP (<b>12</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were synthesized as described below. Next, the Alexa 647 fluorophore was attached to peptides <b>4</b>, <b>6</b>, <b>8</b>, and <b>12</b> as described above to give the desired peptides <b>5</b>, <b>7</b>, <b>9</b>, and <b>13</b>.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Preparation of d[Leu<sup>4</sup>,Lys(Aha)<sup>8</sup>VP (<b>6</b>)</h5><div class="NLM_p last">7.35 mg (30 μM) of Boc-7 aminoheptanoic acid (Boc-Aha), 7.35 mg (30 μM) of DCC, and 4.1 mg (30 μM) of HOBt were dissolved in ∼200 μL of dry DMF, and the mixture was stirred for 30 min. Next, 23.6 mg (23 μM) of d[Leu<sup>4</sup>Lys<sup>8</sup>]VP (<b>A</b>) as a solution in ∼150 μL of dry DMF and neutralized in advance with DIPEA was added, and the reaction mixture was incubated overnight at room temperature with continuous stirring and pH ∼8.5 monitoring. The desired pH was maintained using DIPEA. After the reaction was over (TLC and HPLC monitoring), the reaction mixture was separated on a Sephadex G-15 column using 25% AcOH as an eluent. The fraction containing the peptide was collected and lyophilized. The Boc-protecting group of the peptide was removed by treatment with 50% TFA in CH<sub>2</sub>Cl<sub>2</sub> for 30 min at room temperature. The reaction mixture was evaporated by a flow of N<sub>2</sub>, and the resulting residue was subjected to a final purification by semipreparative HPLC to give the spacer-containing peptide d[Leu<sup>4</sup>,Lys(Aha)<sup>8</sup>]VP (<b>6</b>) with a yield of 9.7 mg (36.5%) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Spacer-containing peptides d[Leu<sup>4</sup>,Lys(β-Ala)<sup>8</sup>]VP (<b>4</b>) and d[Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP (<b>8</b>) were prepared in the same manner as peptide (<b>6</b>), using the parent peptide d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) and Boc-β-Ala and Boc-Aud, respectively. Peptide [HO<sup>1</sup>]Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP (<b>12</b>) was prepared by the same approach, utilizing Boc-Aud and the parent peptide [HO<sup>1</sup>][Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>B</b>). Yields of <b>4</b>, <b>8</b>, and <b>12</b> are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Synthesis of d[Leu<sup>4</sup>,Lys(Aha-Alexa 647)<sup>8</sup>VP (<b>7</b>)</h5><div class="NLM_p">1.38 mg (1.2 μM) (in excess) of peptide d[Leu<sup>4</sup>,Lys(Aha)<sup>8</sup>]VP (<b>6</b>) was dissolved in 100 μL of anhydrous DMF, mixed with 5 μL of DIPEA. The solution was added to 1 mg of Alexa 647 succinimidyl ester, and the reaction mixture was whirled using vortex for 1 h at room temperature in the dark at pH ∼8 with TLC and HPLC monitoring. After the reaction was over, the mixture was acidified (6 μL TFA) and evaporated in vacuo. The fluorescent peptide d[Leu<sup>4</sup>,Lys(Aha-Alexa 647)<sup>8</sup>]VP (<b>7</b>) was isolated by semipreparative HPLC and lyophilized. Yield 1 mg (∼35.0%) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">Peptides d[Leu<sup>4</sup>,Lys(β-Ala)<sup>8</sup>]VP (<b>4</b>), d[Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP (<b>8</b>), and [HO<sup>1</sup>][Leu<sup>4</sup>,Lys(Aud)<sup>8</sup>]VP (<b>12</b>) were labeled utilizing Alexa 647 succinimidyl ester as described above for peptide <b>7</b> to give peptides d[Leu<sup>4</sup>,Lys(β-Ala-Alexa 647)<sup>8</sup>]VP (<b>5</b>), d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (<b>9</b>), and [HO<sup>1</sup>][Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (<b>13</b>). Yields of <b>5</b>, <b>9</b>, and <b>13</b> are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_p last">The structures of peptides <b>1</b>, <b>2</b>, <b>4</b>, <b>6</b>, <b>8</b>, <b>10</b>, and <b>12</b> were confirmed by MALDI-TOF mass spectrometry (MS). The structures of the Alexa 647 containing peptides <b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>, <b>11</b>, and <b>13</b> were not confirmed by mass spectrometry, since the structure of the Alexa 647 fluorophore has not been revealed by Invitrogen/Molecular Probes because of a pending patent application. The analytical and some other physicochemical data of the fluorescent peptides <b>1</b>−<b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>−<b>11</b>, <b>13</b> and of the intermediates <b>4</b>, <b>6</b>, <b>8</b>, <b>12</b> are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div></div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Membrane Preparation</h3><div class="NLM_p last">Four different Chinese hamster ovary (CHO) cell lines stably expressing the human V1a, V1b, V2, or OT receptors were washed twice in phosphate buffered saline (PBS) without CaCl<sub>2</sub> and MgCl<sub>2</sub>, harvested in lysis buffer (15 mM Tris-HCl, pH 7.4; 2 mM MgCl<sub>2</sub>; 0.3 mM ethylene diaminetetraacetic acid (EDTA), Polytron homogenized, and centrifuged at 44000<i>g</i> for 20 min at 4 °C as previously described.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Pellets were washed in 50 mM Tris-HCl (pH 7.4), 3 mM MgCl<sub>2</sub> and centrifuged at 44000<i>g</i> for 20 min at 4 °C. Membranes were resuspended in a small volume of the same buffer. Protein concentration was determined by the method of Bradford (Bio-Rad protein assay kit) using bovine serum albumin (BSA) as a standard, and membranes were stored in liquid nitrogen.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Binding Assays</h3><div class="NLM_p last">Membrane incubations with [<sup>3</sup>H]AVP were performed as previously described.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Briefly, 10−20 μg of membrane proteins were incubated for 60 min at 30 °C in a medium containing 50 mM Tris-HCl (pH 7.4), 3 mM MgCl<sub>2</sub>, 1 mg/mL BSA, 0.01 mg/mL leupeptine, and 1 nM <sup>3</sup>[H]AVP in the presence (nonspecific binding) or in the absence (total binding) of 1 μM unlabeled AVP in a final volume of 200 μL. For <i>K</i><sub>i</sub> determinations, increasing amounts of the unlabeled analogue to be tested were added to the incubation medium to a fixed concentration of tritiated ligand. The membrane-associated radioactivity was collected by filtration through GF/C filters and counted. Specific binding was calculated as the difference between total and nonspecific binding values and expressed as percent of the specific binding determined without unlabeled analogue.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Phospholipase C Assay</h3><div class="NLM_p last">Inositol phosphate (InsP) accumulation was determined as described previously.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> CHO cells were seeded at 100 000 cells per well in 24-well plates and grown for 24 h in their regular culture medium, then incubated for another 24 h period in serum- and inositol-free medium supplemented with 2 μCi/ml myo-[2-<sup>3</sup>H]inositol. Cells were then washed twice with HBS, incubated for 15 min in HBS supplemented with 20 mM LiCl, and further stimulated for 15 min at 37 °C in the same buffer with increasing concentrations of vasopressin analogues. The reaction was stopped by perchloric acid (5% vol/vol). Total InsPs was extracted, purified on Dowex AG1-X8 anion exchange chromatography column, and counted.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cell Labeling and Imaging</h3><div class="NLM_p">CHO cells, seeded on 12 mm glass coverslips precoated with polyornithine, were incubated in DMEM, BSA 0.2 mg/mL, HEPES 25 mM, pH 7.4, for 1 h at 12 °C with fluorescent analogues in the absence or in the presence of nonfluorescent VP analogues. In the latter case, a 30 min preincubation of the cells in the same medium containing only these ligands was performed. After three washes with cold PBS, the cells were finally fixed in 4% PFA at 4 °C overnight and mounted with mowiol. The fluorescent cells were imaged using a confocal microscope Zeiss LSM510 Meta equipped with an Axiovert200 M microscope. The objective 63× (NA 1.4) for oil immersion was used. For detection of Alexa 488-labeled cells, the excitation was performed with an argon laser at λ = 488 nm. The green emission was collected using a BP 505−530 nm emission filter. For detection of Alexa 647, helium/neon laser 633 nm was used. The emission was collected with a LP650 nm filter. Images were captured in multitracking mode to avoid channel cross-talk, and the settings were established on unlabeled cells used as negative control. For fluorescence quantification, the Zeiss LSM Browser was used as previously described<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> with 30−40 cells evaluated for each fluorescent binding condition.</div><div class="NLM_p last">Alternatively, the binding of the Atn-labeled peptide (analogue <b>1</b>) was evaluated by cuvette spectrofluorimetry. Cells were detached with PBS, 10 mM EDTA and incubated with the fluorescent analogue in DMEM, 0.2 mg/mL BSA, 25 mM HEPES, pH 7.4, at 12 °C as previously described. After three cold washes with PBS and gentle centrifugation (900<i>g</i>, 4 min), the cells were resuspended in PBS and placed in a cuvette at 4 °C. The fluorescence was measured using λ = 343 nm excitation and λ = 412 nm emission in a Photon Technology International 810 spectrometer equipped with a UV lamp. These values were chosen after full excitation and emission curves had been established with soluble Atn-analogue <b>1</b>. The specific detection was calculated by deducing the fluorescence emission measured in CHO hV1b-R cells incubated with an excess of nonfluorescent ligand.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Data Analysis</h3><div class="NLM_p last">All data were were analyzed using Prism (GraphPad Software, Inc., San Diego, CA). For the radioligand binding data, the inhibitory dissociation constant (<i>K</i><sub>i</sub>) for unlabeled vasopressin analogues was calculated from binding competition experiments according to the Cheng and Prusoff equation: <i>K</i><sub>i</sub> = IC<sub>50</sub>(1 + [L]/<i>K</i><sub>d</sub>), where IC<sub>50</sub> is the concentration of unlabeled analogue leading to half-maximal inhibition of specific binding, [L] the concentration of the radioligand present in the assay, and <i>K</i><sub>d</sub> its affinity for the receptor studied. The respective <i>K</i><sub>d</sub> values of <sup>3</sup>[H]AVP for hV1a-R (1.1 nM), hV1b-R (0.68 nM), hV2-R (1.2 nM), and hOT-R (1.7 nM) had been previously determined by Pena et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and are listed in Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a> (line 1). For the PLC assay, results are expressed as the mean ± SEM of the number of distinct experiments indicated (<i>n</i>). Statistical analysis of the data was performed using the one-way analysis of variance test.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maurice Manning</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Cancer Biology, University of Toledo College of Medicine, Toledo, Ohio, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bcd1ddc9ced5dfd992d1ddd2d2d5d2dbfcc9c8d3d0d9d8d392d9d8c9"><span class="__cf_email__" data-cfemail="234e4256514a40460d4e424d4d4a4d446356574c4f46474c0d464756">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maithé Corbani</span> - <span class="hlFld-Affiliation affiliation">Institute of Functional Genomics, CNRS UMR5203- INSERM U661, University of Montpellier I and II, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miguel Trueba</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, Basque Country University, Leioa, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stoytcho Stoev</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry and Cancer Biology, University of Toledo College of Medicine, Toledo, Ohio, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brigitte Murat</span> - <span class="hlFld-Affiliation affiliation">Institute of Functional Genomics, CNRS UMR5203- INSERM U661, University of Montpellier I and II, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Mion</span> - <span class="hlFld-Affiliation affiliation">Institute of Functional Genomics, CNRS UMR5203- INSERM U661, University of Montpellier I and II, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Véra Boulay</span> - <span class="hlFld-Affiliation affiliation">Institute of Functional Genomics, CNRS UMR5203- INSERM U661, University of Montpellier I and II, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gilles Guillon</span> - <span class="hlFld-Affiliation affiliation">Institute of Functional Genomics, CNRS UMR5203- INSERM U661, University of Montpellier I and II, 141 Rue de la Cardonille, 34094 Montpellier Cedex 05, France</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm1016208" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Agence Nationale pour la Recherche (ANR) for Grant ANR09 MNPS031-01. We thank Rao Makineni, Robert Tyner, and Frederick Paulsen for their generous research support (to M.M.), and we acknowledge NIH Grant GM-25280 (to M.M.). M.T. acknowledges financial support from Grant BFU2007-63022/BFI from the Ministerio de Educacion y Ciencia (Madrid, Spain), Grant IT-309-07, fellowship from the Departamento de Educacion, Universidades e Investigacion de Gobierno Vasco (Vitoria-Gasteiz, Spain), and the Invited Professor fellowship from the University Montpellier II (France). We thank the Montpellier RIO Imaging Facility, especially Julien Cau and Nicole Lautredou. We acknowledge Nathalie Galeotti for the quality control of the fluorescent peptides throughout this study. We are grateful to Claudine Serradeil-leGal (Sanofi Synthélabo, Toulouse, France) for her generous gift of selective non-peptide vasopressin and oxytocin antagonists. We also thank Anna Chlebowski for her expert assistance in the preparation of this manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> Abbreviations Used</h2><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">ACTH</td><td class="NLM_def"><p class="first last">adrenocorticotropin hormone</p></td></tr><tr><td class="NLM_term">β-Ala</td><td class="NLM_def"><p class="first last">3-aminopropionyl</p></td></tr><tr><td class="NLM_term">Alexa 488</td><td class="NLM_def"><p class="first last">Alexa Fluor 488 carboxylic acid, 2,3,5,6-tetrafluorophenyl ester (5-isomer), and the related acyl group</p></td></tr><tr><td class="NLM_term">Alexa 647</td><td class="NLM_def"><p class="first last">Alexa Fluor 647 carboxylic acid succinimidyl ester and the related acyl group (structure unknown, pending patent application)</p></td></tr><tr><td class="NLM_term">Aha</td><td class="NLM_def"><p class="first last">7-aminohexanoyl</p></td></tr><tr><td class="NLM_term">Atn</td><td class="NLM_def"><p class="first last">anthraniloyl</p></td></tr><tr><td class="NLM_term">Aud</td><td class="NLM_def"><p class="first last">11-aminoundecanoyl</p></td></tr><tr><td class="NLM_term">AVP</td><td class="NLM_def"><p class="first last">arginine vasopressin</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">Bzl</td><td class="NLM_def"><p class="first last">benzyl</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CHO hV1a-R, CHO hV1b-R, CHO hV2-R, and CHO hOT-R</td><td class="NLM_def"><p class="first last">CHO cells stably expressing human vasopressin V1a, V1b, V2, and oxytocin receptors, respectively</p></td></tr><tr><td class="NLM_term">CRH (or CRF)</td><td class="NLM_def"><p class="first last">corticotrophin releasing hormone</p></td></tr><tr><td class="NLM_term">CRHR1</td><td class="NLM_def"><p class="first last">corticotrophin-releasing hormone receptor type 1</p></td></tr><tr><td class="NLM_term">2CLZ</td><td class="NLM_def"><p class="first last">2-chlorobenzyloxycarbonyl</p></td></tr><tr><td class="NLM_term">DALDA</td><td class="NLM_def"><p class="first last">H-Dmt-<span class="smallcaps smallerCapital">d</span>-Arg-Phe-Lys-NH<sub>2</sub>, Dmt, 2′,6′-dimethyltyrosine</p></td></tr><tr><td class="NLM_term">Dap</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-2,3-diaminopropionic acid</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last">dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP</td><td class="NLM_def"><p class="first last">[deamino-Cys<sup>1</sup>,4-leucine,8-lysine]vasopressin</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">ε</td><td class="NLM_def"><p class="first last">molar extinction coefficient</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub> or <i>K</i><sub>act</sub></td><td class="NLM_def"><p class="first last">concentration of agonist leading to half-maximal activity</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximal efficiency</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">EGFP</td><td class="NLM_def"><p class="first last">enhanced green fluorescent protein</p></td></tr><tr><td class="NLM_term">ESMS</td><td class="NLM_def"><p class="first last">electron spray mass spectrometry</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">Gi</td><td class="NLM_def"><p class="first last">G-protein type i</p></td></tr><tr><td class="NLM_term">Go</td><td class="NLM_def"><p class="first last">G-protein type o</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HBS</td><td class="NLM_def"><p class="first last">HEPES buffer saline</p></td></tr><tr><td class="NLM_term">HO<sup>1</sup>[Leu<sup>4</sup>,Lys<sup>8</sup>]VP</td><td class="NLM_def"><p class="first last">[1-<span class="smallcaps smallerCapital">l</span>-(−)-2-hydroxy-3-thiopropanoic acid,4-leucine,8-lysine]vasopressin</p></td></tr><tr><td class="NLM_term">HO-Mpr</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-(−)-2-hydroxy-3-thiopropanoyl</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">InsPs</td><td class="NLM_def"><p class="first last">total inositol phosphates</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>d</sub></td><td class="NLM_def"><p class="first last">affinity at concentration of ligand leading to half-maximal specific binding deduced from saturation experiments</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">inhibitory dissociatation constant at concentration of peptide leading to half-maximal specific binding deduced from competition experiments</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knock-out animals</p></td></tr><tr><td class="NLM_term">λ</td><td class="NLM_def"><p class="first last">wavelength</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">LSM</td><td class="NLM_def"><p class="first last">laser scanning microscope</p></td></tr><tr><td class="NLM_term">mowiol</td><td class="NLM_def"><p class="first last">mounting medium for fluorescence microscopy</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger ribonucleic acid</p></td></tr><tr><td class="NLM_term">Manning compound</td><td class="NLM_def"><p class="first last">[1-β-mercapto-β,β-cyclopentamethylenepropionyl,2-<i>O</i>-methyltyrosine,8-arginine]vasopressin (VP V1a/OT antagonist)</p></td></tr><tr><td class="NLM_term">Mob</td><td class="NLM_def"><p class="first last"><i>p</i>-methoxybenzyl</p></td></tr><tr><td class="NLM_term">Mpr</td><td class="NLM_def"><p class="first last">3-mercaptopropionyl</p></td></tr><tr><td class="NLM_term">ONp</td><td class="NLM_def"><p class="first last"><i>p</i>-nitrophenyl ester</p></td></tr><tr><td class="NLM_term">OT</td><td class="NLM_def"><p class="first last">oxytocin</p></td></tr><tr><td class="NLM_term">OT-R</td><td class="NLM_def"><p class="first last">oxytocin receptor</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PFA</td><td class="NLM_def"><p class="first last">paraformaldehyde</p></td></tr><tr><td class="NLM_term">PLC</td><td class="NLM_def"><p class="first last">phospholipase C</p></td></tr><tr><td class="NLM_term">Rhm</td><td class="NLM_def"><p class="first last">tetramethylrhodamyl</p></td></tr><tr><td class="NLM_term">Rhm<sup>8</sup>-PVA</td><td class="NLM_def"><p class="first last">4-HO-Ph(CH<sub>2</sub>)<sub>2</sub>-CO-<span class="smallcaps smallerCapital">d</span>-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5-carboxytetramethylrhodamyl]-NH<sub>2</sub></p></td></tr><tr><td class="NLM_term"><span class="smallcaps smallerCapital">d</span>-Tyr(Me)</td><td class="NLM_def"><p class="first last"><i>O</i>-methyl-<span class="smallcaps smallerCapital">d</span>-tyrosine</p></td></tr><tr><td class="NLM_term">RT-PCR</td><td class="NLM_def"><p class="first last">polymerase chain reaction after reverse transcription</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">VP</td><td class="NLM_def"><p class="first last">vasopressin</p></td></tr><tr><td class="NLM_term">V1a-R, V1b-R, and V2-R</td><td class="NLM_def"><p class="first last">vasopressin receptor isoforms V1a (vascular), V1b (pituitary), and V2 (renal), respectively</p></td></tr></table></div></div><div class="NLM_fn" id="nomen"><p class="first last">Symbols and abbreviations are in accordance with the recommendations of the IUPAC-IUB Commission on Biochemical Nomenclature ( <cite>Eur. J. Biochem.</cite> <span class="NLM_year">1989</span>, <em>180</em>, A9−A11) and IUPHAR ( <cite>Trends Pharmacol. Sci.</cite> <span class="NLM_year">2001</span>). All amino acids are in the <span class="smallcaps smallerCapital">l</span>-configuration unless otherwise noted.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title">Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1986&pages=171-177&author=S.+Jardauthor=R.+C.+Gaillardauthor=G.+Guillonauthor=J.+Marieauthor=P.+Schoenenbergauthor=A.+F.+Mullerauthor=M.+Manningauthor=W.+H.+Sawyer&title=Vasopressin+antagonists+allow+demonstration+of+a+novel+type+of+vasopressin+receptor+in+the+rat+adenohypophysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJard%26aufirst%3DS.%26aulast%3DGaillard%26aufirst%3DR.%2BC.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DMarie%26aufirst%3DJ.%26aulast%3DSchoenenberg%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DA.%2BF.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3DVasopressin%2520antagonists%2520allow%2520demonstration%2520of%2520a%2520novel%2520type%2520of%2520vasopressin%2520receptor%2520in%2520the%2520rat%2520adenohypophysis%26jtitle%3DMol.%2520Pharmacol.%26date%3D1986%26volume%3D30%26spage%3D171%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazzini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chouinard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">Vasopressin, a potent autocrine/paracrine regulator of mammal adrenal functions</span> <span class="citation_source-journal">Endocr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.3109%2F07435809809032672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=9888562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1998&pages=703-710&author=G.+Guillonauthor=E.+Grazziniauthor=M.+Andrezauthor=C.+Bretonauthor=M.+Truebaauthor=C.+Serradeil-Le+Galauthor=C.+Boccaraauthor=S.+Derickauthor=L.+Chouinardauthor=N.+Gallo-Payet&title=Vasopressin%2C+a+potent+autocrine%2Fparacrine+regulator+of+mammal+adrenal+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Vasopressin: a potent autocrine/paracrine regulator of mammal adrenal functions</span></div><div class="casAuthors">Guillon, G.; Grazzini, E.; Andrez, M.; Breton, C.; Trueba, M.; Serradeil-Le Gal, C.; Boccara, G.; Derick, S.; Chouinard, L.; Gallo-Payet, N.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">703-710, 1Plate</span>CODEN:
                <span class="NLM_cas:coden">ENRSE8</span>;
        ISSN:<span class="NLM_cas:issn">0743-5800</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review with 16 refs.  The control of adrenal functions by locally secreted neuropeptides or neurotransmitters is of great physiol. importance.  Vasopressin (VP) is one of these autocrine/paracrine regulators.  The authors demonstrated by RT-PCR and perifusion expts. that rat and human adrenal medulla expressed and released vasopressin under basal conditions and under stimulation by acetylcholine.  Intra-adrenal concns. of VP may be sufficient to activate adrenal VP receptors.  In the cortex, only the V1a receptor subtype has been detected.  It triggered both steroid secretion and cortical growth.  In the medulla, both V1a and V1b receptor subtypes were expressed.  V1b receptors were mainly present on chromaffin cells and stimulated catecholamine secretion.  The role of the V1a receptor remains unclear.  Pathophysiol. studies also revealed that human pheochromocytoma did not overexpress vasopressin receptors but might oversecrete vasopressin causing high plasma VP concns. and elevated blood pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr82uSVpdXfB7Vg90H21EOLACvtfcHk0ljLqoNaTz2kqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVShsA%253D%253D&md5=7ec4840dca1ef993c0577d8c6c99de18</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3109%2F07435809809032672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F07435809809032672%26sid%3Dliteratum%253Aachs%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DGrazzini%26aufirst%3DE.%26aulast%3DAndrez%26aufirst%3DM.%26aulast%3DBreton%26aufirst%3DC.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DBoccara%26aufirst%3DC.%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DChouinard%26aufirst%3DL.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DVasopressin%252C%2520a%2520potent%2520autocrine%252Fparacrine%2520regulator%2520of%2520mammal%2520adrenal%2520functions%26jtitle%3DEndocr.%2520Res.%26date%3D1998%26volume%3D24%26spage%3D703%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wo, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Pharmacological and physiological characterization of d[Leu<sup>4</sup>,Lys<sup>8</sup>]vasopressin, the first V<sub>1b</sub> selective agonist for rat vasopressin/oxytocin receptors</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">4136</span><span class="NLM_x">–</span> <span class="NLM_lpage">4146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=4136-4146&author=A.+Penaauthor=B.+Muratauthor=M.+Truebaauthor=M.+A.+Venturaauthor=G.+Bertrandauthor=L.+L.+Chengauthor=S.+Stoevauthor=H.+H.+Szetoauthor=N.+C.+Woauthor=G.+Brossardauthor=C.+Serradeil-Le+Galauthor=M.+Manningauthor=G.+Guillon&title=Pharmacological+and+physiological+characterization+of+d%5BLeu4%2CLys8%5Dvasopressin%2C+the+first+V1b+selective+agonist+for+rat+vasopressin%2Foxytocin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPena%26aufirst%3DA.%26aulast%3DMurat%26aufirst%3DB.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DVentura%26aufirst%3DM.%2BA.%26aulast%3DBertrand%26aufirst%3DG.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DWo%26aufirst%3DN.%2BC.%26aulast%3DBrossard%26aufirst%3DG.%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DPharmacological%2520and%2520physiological%2520characterization%2520of%2520d%255BLeu4%252CLys8%255Dvasopressin%252C%2520the%2520first%2520V1b%2520selective%2520agonist%2520for%2520rat%2520vasopressin%252Foxytocin%2520receptors%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D4136%26epage%3D4146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Donaldson, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span> </span><span class="NLM_article-title">Oxytocin, vasopressin and the neurogenetics of sociality</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=900-904&author=Z.+R.+Donaldsonauthor=L.+J.+Young&title=Oxytocin%2C+vasopressin+and+the+neurogenetics+of+sociality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonaldson%26aufirst%3DZ.%2BR.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DOxytocin%252C%2520vasopressin%2520and%2520the%2520neurogenetics%2520of%2520sociality%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D900%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreifuss, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title"><sup>125</sup>I-Labelled d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]OVT: a selective oxytocin receptor ligand</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2F0014-2999%2888%2990778-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=2835249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVSnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1988&pages=197-207&author=J.+Elandsauthor=C.+Barberisauthor=S.+Jardauthor=E.+Tribolletauthor=J.-J.+Dreifussauthor=K.+Bankowskiauthor=M.+Manningauthor=W.+H.+Sawyer&title=125I-Labelled+d%28CH2%295%5BTyr%28Me%292%2CThr4%2CTyr-NH29%5DOVT%3A+a+selective+oxytocin+receptor+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Iodine-125-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT:  a selective oxytocin receptor ligand</span></div><div class="casAuthors">Elands, Jack; Barberis, Claude; Jard, Serge; Tribollet, Eliane; Dreifuss, Jean Jacques; Bankowski, Krzysztof; Manning, Maurice; Sawyer, Wilbur H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">An oxytocic antagonist, [1-(β-mercapto-β,β-cyclopentamethylenepropionic acid, 2-O-methyltyrosine, 4-threonine, 8-ornithine, 9-tyrosylamide]vasotocin (d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT) (I), was monoiodinated at the Ph moiety of the tyrosylamide residue at position 9.  125I-labeling was performed with 1,3,4,6-tetrachloro-3α,6α-diphenylglycoluril.  Iodination resulted in an increased affinity for rat uterine oxytocin receptors.  A considerably lower affinity for rat vascular V1- and renal V2-receptors was found, resulting in a highly specific oxytocin receptor ligand.  [125I]I bound selectively to 1 population of binding sites in rat uterus and ventral hippocampal membrane prepns.  Dissocn. consts. ranged 0.03-0.06 nM.  After 3 days of exposure, autoradiog. revealed binding in regions known to contain oxytocin receptors as well as labeling in some new regions, whereas no binding was found in the lateral septum, a structure contg. mainly [8-arginine]vasopressin receptors.  The high specific radioactivity of 125I-labeling allowed important redns. in membrane protein amt., gain in precision of binding anal., and considerably lower exposure times for autoradiog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpGjEbPeGWLVg90H21EOLACvtfcHk0lj-P7WTPNvxHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVSnsb0%253D&md5=c66ed9424a00ab6f5cd1a74764698d20</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990778-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990778-9%26sid%3Dliteratum%253Aachs%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DDreifuss%26aufirst%3DJ.-J.%26aulast%3DBankowski%26aufirst%3DK.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3D125I-Labelled%2520d%2528CH2%25295%255BTyr%2528Me%25292%252CThr4%252CTyr-NH29%255DOVT%253A%2520a%2520selective%2520oxytocin%2520receptor%2520ligand%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D147%26spage%3D197%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kelly, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzonka, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhonston, C. I.</span><span> </span><span class="NLM_article-title">[<sup>125</sup>I]-d(CH2)5,Sar7]AVP: a selective radioligand for V1 vasopressin receptors</span> <span class="citation_source-journal">J. Recept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=2521670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaL1MXhs1Kgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1989&pages=27-41&author=J.+M.+Kellyauthor=J.+M.+Abrahamsauthor=P.+A.+Philipsauthor=F.+A.+Mendelsohnauthor=Z.+Grzonkaauthor=C.+I.+Jhonston&title=%5B125I%5D-d%28CH2%295%2CSar7%5DAVP%3A+a+selective+radioligand+for+V1+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">[125I]-[d(CH2)5,Sar7]AVP:  a selective radioligand for V1 vasopressin receptors</span></div><div class="casAuthors">Kelly, J. M.; Abrahams, J. M.; Phillips, P. A.; Mendelsohn, F. A. O.; Grzonka, Z.; Johnston, C. I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptor Research</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-41</span>CODEN:
                <span class="NLM_cas:coden">JRERDM</span>;
        ISSN:<span class="NLM_cas:issn">0197-5110</span>.
    </div><div class="casAbstract">The AVP V1 receptor antagonist [1-(β-mercapto-β,β-cyclopentamethylenepropionic acid), 7-sarcosine,8-arginine]vasopressin ([d(CH2)5,Sar7]AVP) was radioiodinated and its receptor-binding properties were detd. in rat liver and kidney plasma membranes.  The binding was of high affinity to single classes of receptors (liver: Kd = 3.0 nM and Bmax = 530 fmol/mg protein, kidney: Kd = 0.5 nM and Bmax = 11 fmol/mg protein).  Competition of [125I]-[d(CH2)5,Sar7]AVP binding by unlabeled AVP analogs gave the following order of potency in both tissues, consistent with that expected for binding to a V1 receptor: [d(CH2)5,Tyr(Me)2]AVP > AVP > [d(CH2)5,D-Ile2,Ile4] AVP > DDAVP.  No degrdn. of [125I]-[d(CH2)5,Sar7]AVP during incubation or storage was detected by HPLC anal.  [125I]-[d(CH2)5,Sar7]AVP and in vitro autoradiog. were used to localize brain AVP receptors.  These studies suggest that [125I]-[d(CH2)5,Sar7]AVP is a suitable selective radioligand for labeling V1 receptors and will provide a valuable tool for the study of the localization and regulation of AVP V1 receptors in tissues and in receptor isolation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhm8CAkFrnB7Vg90H21EOLACvtfcHk0lj-P7WTPNvxHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhs1Kgtbg%253D&md5=be4bbc5ab2407f4628166692c679f03f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DAbrahams%26aufirst%3DJ.%2BM.%26aulast%3DPhilips%26aufirst%3DP.%2BA.%26aulast%3DMendelsohn%26aufirst%3DF.%2BA.%26aulast%3DGrzonka%26aufirst%3DZ.%26aulast%3DJhonston%26aufirst%3DC.%2BI.%26atitle%3D%255B125I%255D-d%2528CH2%25295%252CSar7%255DAVP%253A%2520a%2520selective%2520radioligand%2520for%2520V1%2520vasopressin%2520receptors%26jtitle%3DJ.%2520Recept.%2520Res.%26date%3D1989%26volume%3D9%26spage%3D27%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goumaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggenbass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreifuss, J. J.</span><span> </span><span class="NLM_article-title">Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain</span> <span class="citation_source-journal">J. Recept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=1653339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK3MXksVahu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=333-346&author=E.+Tribolletauthor=M.+Goumazauthor=M.+Raggenbassauthor=J.+J.+Dreifuss&title=Appearance+and+transient+expression+of+vasopressin+and+oxytocin+receptors+in+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain</span></div><div class="casAuthors">Tribollet, E.; Goumaz, M.; Raggenbass, M.; Dreifuss, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptor Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">333-46</span>CODEN:
                <span class="NLM_cas:coden">JRERDM</span>;
        ISSN:<span class="NLM_cas:issn">0197-5110</span>.
    </div><div class="casAbstract">Binding sites for arginine vasopressin (AVP) and for oxytocin (OT) were studied by in vitro autoradiog. in sections from the brain of rat fetuses, neonates and infants; their distribution was compared to that of the brain of adults.  Specific binding sites were first detected in the vagal complex for OT and in the reticular formation for AVP at embryonic day 14 (E14) and E16 resp.  In the perinatal period, other areas become labeled.  Approx. 1 wk after birth, a stable pattern of distribution is established for AVP-binding sites, and a different stable pattern obtained for OT-binding sites.  For both types of sites and in many areas, the d. of labeling increases during the next 2 wk to reach adult levels, whereas labeling decreases concomitantly in other areas of the brain.  The distribution of AVP-binding sites is of the adult pattern by the time of weaning.  In contrast, the adult pattern of distribution of OT-binding sites is only established after puberty, when new OT receptors appear in some regions of the hypothalamus and basal forebrain.  Transient binding sites for AVP and OT, i.e., sites located in areas which were labeled in neonates but not in weanlings, were shown to have the same ligand affinity as the binding sites present in the adult.  Electrophysiol. studies suggest that at least some of these transient binding sites represent authentic receptors and may be involved in neuronal signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonZkZEhMAm4rVg90H21EOLACvtfcHk0lj-P7WTPNvxHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVahu7Y%253D&md5=89c6e2b94be1556d976c7aed1cb7c9fc</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DGoumaz%26aufirst%3DM.%26aulast%3DRaggenbass%26aufirst%3DM.%26aulast%3DDreifuss%26aufirst%3DJ.%2BJ.%26atitle%3DAppearance%2520and%2520transient%2520expression%2520of%2520vasopressin%2520and%2520oxytocin%2520receptors%2520in%2520the%2520rat%2520brain%26jtitle%3DJ.%2520Recept.%2520Res.%26date%3D1991%26volume%3D11%26spage%3D333%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hernando, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoots, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lolait, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbach, J. P. H.</span><span> </span><span class="NLM_article-title">Immunohistochemical localisation of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">1659</span><span class="NLM_x">–</span> <span class="NLM_lpage">1668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2001&pages=1659-1668&author=F.+Hernandoauthor=O.+Schootsauthor=S.+J.+Lolaitauthor=J.+P.+H.+Burbach&title=Immunohistochemical+localisation+of+the+vasopressin+V1b+receptor+in+the+rat+brain+and+pituitary+gland%3A+anatomical+support+for+its+involvement+in+the+central+effects+of+vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHernando%26aufirst%3DF.%26aulast%3DSchoots%26aufirst%3DO.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBurbach%26aufirst%3DJ.%2BP.%2BH.%26atitle%3DImmunohistochemical%2520localisation%2520of%2520the%2520vasopressin%2520V1b%2520receptor%2520in%2520the%2520rat%2520brain%2520and%2520pituitary%2520gland%253A%2520anatomical%2520support%2520for%2520its%2520involvement%2520in%2520the%2520central%2520effects%2520of%2520vasopressin%26jtitle%3DEndocrinology%26date%3D2001%26volume%3D142%26spage%3D1659%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lolait, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Caroll, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahan, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Button, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. R.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browstein, M. J.</span><span> </span><span class="NLM_article-title">Extrapituitary expression of the rat V1b vasopressin receptor gene</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">6783</span><span class="NLM_x">–</span> <span class="NLM_lpage">6787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=6783-6787&author=S.+J.+Lolaitauthor=A.+M.+O%E2%80%99Carollauthor=L.+C.+Mahanauthor=C.+C.+Felderauthor=D.+C.+Buttonauthor=W.+R.+Youngauthor=E.+Mezeyauthor=M.+J.+Browstein&title=Extrapituitary+expression+of+the+rat+V1b+vasopressin+receptor+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Caroll%26aufirst%3DA.%2BM.%26aulast%3DMahan%26aufirst%3DL.%2BC.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DButton%26aufirst%3DD.%2BC.%26aulast%3DYoung%26aufirst%3DW.%2BR.%26aulast%3DMezey%26aufirst%3DE.%26aulast%3DBrowstein%26aufirst%3DM.%2BJ.%26atitle%3DExtrapituitary%2520expression%2520of%2520the%2520rat%2520V1b%2520vasopressin%2520receptor%2520gene%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D6783%26epage%3D6787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, H.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues</span> <span class="citation_source-journal">Biochem. Biophy. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1006%2Fbbrc.1995.2033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1995&pages=751-757&author=M.+Saitoauthor=T.+Sugimotoauthor=A.+Taharaauthor=H.+Kawashima&title=Molecular+cloning+and+characterization+of+rat+V1b+vasopressin+receptor%3A+evidence+for+its+expression+in+extra-pituitary+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1995.2033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1995.2033%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DTahara%26aufirst%3DA.%26aulast%3DKawashima%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520rat%2520V1b%2520vasopressin%2520receptor%253A%2520evidence%2520for%2520its%2520expression%2520in%2520extra-pituitary%2520tissues%26jtitle%3DBiochem.%2520Biophy.%2520Res.%2520Commun.%26date%3D1995%26volume%3D26%26spage%3D751%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hurbin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissin-Agasse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orcel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabié, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desarménien, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moos, F. C.</span><span> </span><span class="NLM_article-title">The V1a and V1b, but not V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">4701</span><span class="NLM_x">–</span> <span class="NLM_lpage">4707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=4701-4707&author=A.+Hurbinauthor=L.+Boissin-Agasseauthor=H.+Orcelauthor=A.+Rabi%C3%A9author=N.+Jouxauthor=M.+G.+Desarm%C3%A9nienauthor=P.+Richardauthor=F.+C.+Moos&title=The+V1a+and+V1b%2C+but+not+V2%2C+vasopressin+receptor+genes+are+expressed+in+the+supraoptic+nucleus+of+the+rat+hypothalamus%2C+and+the+transcripts+are+essentially+colocalized+in+the+vasopressinergic+magnocellular+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurbin%26aufirst%3DA.%26aulast%3DBoissin-Agasse%26aufirst%3DL.%26aulast%3DOrcel%26aufirst%3DH.%26aulast%3DRabi%25C3%25A9%26aufirst%3DA.%26aulast%3DJoux%26aufirst%3DN.%26aulast%3DDesarm%25C3%25A9nien%26aufirst%3DM.%2BG.%26aulast%3DRichard%26aufirst%3DP.%26aulast%3DMoos%26aufirst%3DF.%2BC.%26atitle%3DThe%2520V1a%2520and%2520V1b%252C%2520but%2520not%2520V2%252C%2520vasopressin%2520receptor%2520genes%2520are%2520expressed%2520in%2520the%2520supraoptic%2520nucleus%2520of%2520the%2520rat%2520hypothalamus%252C%2520and%2520the%2520transcripts%2520are%2520essentially%2520colocalized%2520in%2520the%2520vasopressinergic%2520magnocellular%2520neurons%26jtitle%3DEndocrinology%26date%3D1998%26volume%3D139%26spage%3D4701%26epage%3D4707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hurbin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favrot, M. C.</span><span> </span><span class="NLM_article-title">The vasopressin receptors colocalize with vasopressin in the magnocellular neurons of the rat supraoptic nucleus and are modulated by water balance</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2002&pages=456-466&author=A.+Hurbinauthor=L.+Dubrezauthor=J.+L.+Collauthor=M.+C.+Favrot&title=The+vasopressin+receptors+colocalize+with+vasopressin+in+the+magnocellular+neurons+of+the+rat+supraoptic+nucleus+and+are+modulated+by+water+balance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurbin%26aufirst%3DA.%26aulast%3DDubrez%26aufirst%3DL.%26aulast%3DColl%26aufirst%3DJ.%2BL.%26aulast%3DFavrot%26aufirst%3DM.%2BC.%26atitle%3DThe%2520vasopressin%2520receptors%2520colocalize%2520with%2520vasopressin%2520in%2520the%2520magnocellular%2520neurons%2520of%2520the%2520rat%2520supraoptic%2520nucleus%2520and%2520are%2520modulated%2520by%2520water%2520balance%26jtitle%3DEndocrinology%26date%3D2002%26volume%3D143%26spage%3D456%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Young, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersinger, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkovits, M.</span><span> </span><span class="NLM_article-title">The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2006&pages=1031-1039&author=W.+S.+Youngauthor=J.+Liauthor=S.+R.+Wersingerauthor=M.+Palkovits&title=The+vasopressin+1b+receptor+is+prominent+in+the+hippocampal+area+CA2+where+it+is+unaffected+by+restraint+stress+or+adrenalectomy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DW.%2BS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWersinger%26aufirst%3DS.%2BR.%26aulast%3DPalkovits%26aufirst%3DM.%26atitle%3DThe%2520vasopressin%25201b%2520receptor%2520is%2520prominent%2520in%2520the%2520hippocampal%2520area%2520CA2%2520where%2520it%2520is%2520unaffected%2520by%2520restraint%2520stress%2520or%2520adrenalectomy%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D143%26spage%3D1031%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neugebauer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escher, E.</span><span> </span><span class="NLM_article-title">Fluorescent peptide hormones: development of high affinity vasopressin analogues</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=7-11&author=G.+Guillonauthor=D.+Barbeauauthor=W.+Neugebauerauthor=S.+Guayauthor=L+Bilodeauauthor=M.-N.+Balestreauthor=N.+Gallo-Payetauthor=E.+Escher&title=Fluorescent+peptide+hormones%3A+development+of+high+affinity+vasopressin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DBarbeau%26aufirst%3DD.%26aulast%3DNeugebauer%26aufirst%3DW.%26aulast%3DGuay%26aufirst%3DS.%26aulast%3DBilodeau%26aufirst%3DL%26aulast%3DBalestre%26aufirst%3DM.-N.%26aulast%3DGallo-Payet%26aufirst%3DN.%26aulast%3DEscher%26aufirst%3DE.%26atitle%3DFluorescent%2520peptide%2520hormones%253A%2520development%2520of%2520high%2520affinity%2520vasopressin%2520analogues%26jtitle%3DPeptides%26date%3D1992%26volume%3D13%26spage%3D7%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelly, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tordjmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufour, M.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forchioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claret, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Distribution of signaling molecules involved in vasopressin-induced Ca<sup>2+</sup> mobilization in rat hepatocytes</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1177%2F002215549904700503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=10219053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlKgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1999&pages=601-616&author=D.+Tranauthor=N.+Stellyauthor=T.+Tordjmannauthor=T.+Durrouxauthor=M.-N.+Dufourauthor=A.+Forchioniauthor=R.+Seyerauthor=M.+Claretauthor=G.+Guillon&title=Distribution+of+signaling+molecules+involved+in+vasopressin-induced+Ca2%2B+mobilization+in+rat+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of signaling molecules involved in vasopressin-induced Ca2+ mobilization in rat hepatocyte multiplets</span></div><div class="casAuthors">Tran, Dien; Stelly, Nicole; Tordjmann, Thierry; Durroux, Thierry; Dufour, Marie Noelle; Forchioni, Arlette; Seyer, Rene; Claret, Michel; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-616</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">In freshly isolated rat hepatocyte multiplets, Ca2+ signals in response to vasopressin are highly organized.  In this study we used specific probes to visualize, by fluorescence and confocal microscopy, the main signaling mols. involved in vasopressin-mediated Ca2+ responses.  V1a receptors were detected with a novel fluorescent antagonist, Rhm8-PVA.  The Gαq/Gα11, PLCβ3, PIP2, and InsP3 receptors were detected with specific antibodies.  V1a vasopressin receptors and PIP2 were assocd. with the basolateral membrane and were not detected in the bile canalicular domain.  Gαq/Gα11, PLCβ3, and InsP3 receptors were assocd. with the basolateral membrane and also with other intracellular structures.  We used double labeling, Western blotting, and drugs (cytochalasin D, colchicine) known to disorganize the cytoskeleton to demonstrate the partial co-localization of Gαq/Gα11 with F-actin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZnn4DSRqwHrVg90H21EOLACvtfcHk0ljXvJDyZndsbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlKgsrw%253D&md5=d63f61c9b70578d92f37501c00be4e23</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1177%2F002215549904700503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F002215549904700503%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DD.%26aulast%3DStelly%26aufirst%3DN.%26aulast%3DTordjmann%26aufirst%3DT.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DDufour%26aufirst%3DM.-N.%26aulast%3DForchioni%26aufirst%3DA.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DClaret%26aufirst%3DM.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DDistribution%2520of%2520signaling%2520molecules%2520involved%2520in%2520vasopressin-induced%2520Ca2%252B%2520mobilization%2520in%2520rat%2520hepatocytes%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1999%26volume%3D47%26spage%3D601%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Mouillac, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assys and receptors studies</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=996-1005&author=T.+Mouillacauthor=M.+Manningauthor=T.+Durroux&title=Fluorescent+agonists+and+antagonists+for+vasopressin%2Foxytocin+G+protein-coupled+receptors%3A+usefulness+in+ligand+screening+assys+and+receptors+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMouillac%26aufirst%3DT.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DFluorescent%2520agonists%2520and%2520antagonists%2520for%2520vasopressin%252Foxytocin%2520G%2520protein-coupled%2520receptors%253A%2520usefulness%2520in%2520ligand%2520screening%2520assys%2520and%2520receptors%2520studies%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D996%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voirol, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wo, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben Mimoun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span> </span><span class="NLM_article-title">[1-Deamino-4-cyclohexylalanine]arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">4655</span><span class="NLM_x">–</span> <span class="NLM_lpage">4664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2002&pages=4655-4664&author=S.+Derickauthor=L.+L.+Chengauthor=M.+J.+Voirolauthor=S.+Stoevauthor=M.+Giacominiauthor=N.+C.+Woauthor=H.+H.+Szetoauthor=M.+Ben+Mimounauthor=M.+Andresauthor=R.+C.+Gaillardauthor=G.+Guillonauthor=M.+Manning&title=%5B1-Deamino-4-cyclohexylalanine%5Darginine+vasopressin%3A+a+potent+and+specific+agonist+for+vasopressin+V1b+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DVoirol%26aufirst%3DM.%2BJ.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DGiacomini%26aufirst%3DM.%26aulast%3DWo%26aufirst%3DN.%2BC.%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DBen%2BMimoun%26aufirst%3DM.%26aulast%3DAndres%26aufirst%3DM.%26aulast%3DGaillard%26aufirst%3DR.%2BC.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DManning%26aufirst%3DM.%26atitle%3D%255B1-Deamino-4-cyclohexylalanine%255Darginine%2520vasopressin%253A%2520a%2520potent%2520and%2520specific%2520agonist%2520for%2520vasopressin%2520V1b%2520receptors%26jtitle%3DEndocrinology%26date%3D2002%26volume%3D143%26spage%3D4655%26epage%3D4664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben Mimoun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of deamino-[Cys<sup>1</sup>]arginine vasopressin at position 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2388</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030611c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2375-2388&author=L.+L.+Chengauthor=S.+Stoevauthor=M.+Manningauthor=S.+Derickauthor=A.+Penaauthor=M.+Ben+Mimounauthor=G.+Guillon&title=Design+of+potent+and+selective+agonists+for+the+human+vasopressin+V1b+receptor+based+on+modifications+of+deamino-%5BCys1%5Darginine+vasopressin+at+position+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm030611c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030611c%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DBen%2BMimoun%26aufirst%3DM.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DDesign%2520of%2520potent%2520and%2520selective%2520agonists%2520for%2520the%2520human%2520vasopressin%2520V1b%2520receptor%2520based%2520on%2520modifications%2520of%2520deamino-%255BCys1%255Darginine%2520vasopressin%2520at%2520position%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2375%26epage%3D2388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wo, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of the first selective agonists for the rat vasopressin V<sub>1b</sub> receptor: based on modifications of deamino-[Cys<sup>1</sup>]arginine vasopressin at positions 4 and 8</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060928n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=835-847&author=A.+Penaauthor=B.+Muratauthor=M.+Truebaauthor=M.+A.+Venturaauthor=N.+C.+Woauthor=H.+H.+Szetoauthor=L.+L.+Chengauthor=S.+Stoevauthor=G.+Guillonauthor=M.+Manning&title=Design+and+synthesis+of+the+first+selective+agonists+for+the+rat+vasopressin+V1b+receptor%3A+based+on+modifications+of+deamino-%5BCys1%5Darginine+vasopressin+at+positions+4+and+8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm060928n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060928n%26sid%3Dliteratum%253Aachs%26aulast%3DPena%26aufirst%3DA.%26aulast%3DMurat%26aufirst%3DB.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DVentura%26aufirst%3DM.%2BA.%26aulast%3DWo%26aufirst%3DN.%2BC.%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DManning%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520the%2520first%2520selective%2520agonists%2520for%2520the%2520rat%2520vasopressin%2520V1b%2520receptor%253A%2520based%2520on%2520modifications%2520of%2520deamino-%255BCys1%255Darginine%2520vasopressin%2520at%2520positions%25204%2520and%25208%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D835%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Dyckes, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du Vigneaud, V.</span><span> </span><span class="NLM_article-title">Synthesis and some of the pharmacological properties of [4-leucine]-8-lysine-vasopressin and [1-deamino, 4-leucine]-8-lysine vasopressin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00265a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1973&pages=843-847&author=D.+F.+Dyckesauthor=M.+F.+Fergerauthor=V.+Du+Vigneaud&title=Synthesis+and+some+of+the+pharmacological+properties+of+%5B4-leucine%5D-8-lysine-vasopressin+and+%5B1-deamino%2C+4-leucine%5D-8-lysine+vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm00265a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00265a022%26sid%3Dliteratum%253Aachs%26aulast%3DDyckes%26aufirst%3DD.%2BF.%26aulast%3DFerger%26aufirst%3DM.%2BF.%26aulast%3DDu%2BVigneaud%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520some%2520of%2520the%2520pharmacological%2520properties%2520of%2520%255B4-leucine%255D-8-lysine-vasopressin%2520and%2520%255B1-deamino%252C%25204-leucine%255D-8-lysine%2520vasopressin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1973%26volume%3D16%26spage%3D843%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Rodrigo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1210%2Fme.2006-0202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=17082326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=512-523&author=J.+Rodrigoauthor=A.+Penaauthor=B.+Muratauthor=M.+Truebaauthor=T.+Durrouxauthor=D.+Rognan&title=Mapping+the+binding+site+of+arginine+vasopressin+to+V1a+and+V1b+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors</span></div><div class="casAuthors">Rodrigo, Jordi; Pena, Ana; Murat, Brigitte; Trueba, Miguel; Durroux, Thierry; Guillon, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">512-523</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Starting from the 2.8-Å resoln. x-ray structure of bovine rhodopsin, three-dimensional mol. models of the complexes between arginine vasopressin and two receptor subtypes (V1a, V1b) have been built.  Amino acid sequence alignment and docking studies suggest that four key residues (1.35, 2.65, 4.61, and 5.35) fine tune the binding of vasopressin and related peptide agonists to both receptor subtypes.  To validate these predictions, a series of single or double mutants were engineered at V1a and V1b receptor subtypes and tested for their binding and functional properties.  Two neg. charged amino acids at positions 1.35 and 2.65 are key anchoring residues to the Arg8 residue of arginine vasopressin.  Moreover, two amino acids (V4.61 and P5.35) delineating a hydrophobic subsite at the human V1b receptor are responsible for the recognition of V1b selective peptide agonists.  Last, one of the latter positions (5.35) is hypothesized to explain the pharmacol. species differences between rat and human vasopressin receptors for a V1b peptide agonist.  Altogether these refined three-dimensional models of V1a and V1b human receptors should enable the identification of further new selective V1a and V1b agonists as pharmacol. but also therapeutic tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiSR2zAZAfYrVg90H21EOLACvtfcHk0lgZRWp6MNHkIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWisbg%253D&md5=3da9d009a1b55b8e9420dfba0b0b77f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1210%2Fme.2006-0202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2006-0202%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DMurat%26aufirst%3DB.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DMapping%2520the%2520binding%2520site%2520of%2520arginine%2520vasopressin%2520to%2520V1a%2520and%2520V1b%2520vasopressin%2520receptors%26jtitle%3DMol.%2520Endocrinol.%26date%3D2007%26volume%3D21%26spage%3D512%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Terillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V1a receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2588</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2579-2588&author=S.+Terillonauthor=L.+L.+Chengauthor=S.+Stoevauthor=B.+Mouillacauthor=C.+Barberisauthor=M.+Manningauthor=T.+Durroux&title=Synthesis+and+characterization+of+fluorescent+antagonists+and+agonists+for+human+oxytocin+and+vasopressin+V1a+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerillon%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520fluorescent%2520antagonists%2520and%2520agonists%2520for%2520human%2520oxytocin%2520and%2520vasopressin%2520V1a%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2579%26epage%3D2588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Taki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohsaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisido, M.</span><span> </span><span class="NLM_article-title">A non-natural amino acid for efficient incorporation into proteins as a sensitive fluorescent probe</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">507</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2001&pages=35-38&author=M.+Takiauthor=T.+Hohsakaauthor=H.+Murakamiauthor=K.+Tairaauthor=M.+Sisido&title=A+non-natural+amino+acid+for+efficient+incorporation+into+proteins+as+a+sensitive+fluorescent+probe"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaki%26aufirst%3DM.%26aulast%3DHohsaka%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DTaira%26aufirst%3DK.%26aulast%3DSisido%26aufirst%3DM.%26atitle%3DA%2520non-natural%2520amino%2520acid%2520for%2520efficient%2520incorporation%2520into%2520proteins%2520as%2520a%2520sensitive%2520fluorescent%2520probe%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D507%26spage%3D35%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Panchuk-Voloshina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugland, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop-Stewart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalgat, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huagland, R.</span><span> </span><span class="NLM_article-title">Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1177%2F002215549904700910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=10449539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK1MXmtValsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1999&pages=1179-1188&author=N.+Panchuk-Voloshinaauthor=R.+P.+Hauglandauthor=J.+Bishop-Stewartauthor=M.+K.+Bhalgatauthor=P.+J.+Millardauthor=F.+Maoauthor=W.-Y.+Leungauthor=R.+Huagland&title=Alexa+dyes%2C+a+series+of+new+fluorescent+dyes+that+yield+exceptionally+bright%2C+photostable+conjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates</span></div><div class="casAuthors">Panchuk-Voloshina, Nataliya; Haugland, Rosaria P.; Bishop-Stewart, Janell; Bhalgat, Mahesh K.; Millard, Paul J.; Mao, Fei; Leung, Wai-Yee; Haugland, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1179-1188</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Alexa 350, Alexa 430, Alexa 488, Alexa 532, Alexa 546, Alexa 568, and Alexa 594 dyes are a new series of fluorescent dyes with emission/excitation spectra similar to those of AMCA, Lucifer Yellow, fluorescein, rhodamine 6G, tetramethylrhodamine or Cy3, lissamine rhodamine B, and Texas Red, resp. (the nos. in the Alexa names indicate the approx. excitation wavelength max. in nm).  All Alexa dyes and their conjugates are more fluorescent and more photostable than their commonly used spectral analogs listed above.  In addn., Alexa dyes are insensitive to pH in the 4-10 range.  We evaluated Alexa dyes compared with conventional dyes in applications using various conjugates, including those of goat anti-mouse IgG (GAM), streptavidin, wheat germ agglutinin (WGA), and Con A (ConA).  Conjugates of Alexa 546 are at least twofold more fluorescent than Cy3 conjugates.  Proteins labeled with the Alexa 568 or Alexa 594 dyes are several-fold brighter than the same proteins labeled with lissamine rhodamine B or Texas Red dyes, resp.  Alexa dye derivs. of phalloidin stain F-actin with high specificity.  Hydrazide forms of the Alexa dyes are very bright, formaldehyde-fixable polar tracers.  Conjugates of the Alexa 430 (ex 430 nm/em 520 nm) and Alexa 532 (ex 530 nm/em 548 nm) fluorochromes are spectrally unique fluorescent probes, with relatively high quantum yields in their excitation and emission wavelength ranges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXJnPjLPC6lbVg90H21EOLACvtfcHk0ljsLD0uJHh6Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtValsLw%253D&md5=9dd2e5d27eed61cc38242ed476435ef4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1177%2F002215549904700910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F002215549904700910%26sid%3Dliteratum%253Aachs%26aulast%3DPanchuk-Voloshina%26aufirst%3DN.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26aulast%3DBishop-Stewart%26aufirst%3DJ.%26aulast%3DBhalgat%26aufirst%3DM.%2BK.%26aulast%3DMillard%26aufirst%3DP.%2BJ.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DLeung%26aufirst%3DW.-Y.%26aulast%3DHuagland%26aufirst%3DR.%26atitle%3DAlexa%2520dyes%252C%2520a%2520series%2520of%2520new%2520fluorescent%2520dyes%2520that%2520yield%2520exceptionally%2520bright%252C%2520photostable%2520conjugates%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1999%26volume%3D47%26spage%3D1179%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ballard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeva, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deSilva, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, N. R.</span><span> </span><span class="NLM_article-title">Comparison of Alexa Fluor and Cy dye for practical DNA microarray use</span> <span class="citation_source-journal">Mol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1007%2Fs12033-007-0006-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=17873405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1WktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=175-183&author=J.+L.+Ballardauthor=V.+K.+Peevaauthor=C.+J.+deSilvaauthor=J.+L.+Lynchauthor=N.+R.+Swanson&title=Comparison+of+Alexa+Fluor+and+Cy+dye+for+practical+DNA+microarray+use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Alexa Fluor and CyDye for practical DNA microarray use</span></div><div class="casAuthors">Ballard, Joanne L.; Peeva, Violet K.; de Silva, Christopher J. S.; Lynch, Jessica L.; Swanson, Nigel R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-183</span>CODEN:
                <span class="NLM_cas:coden">MLBOEO</span>;
        ISSN:<span class="NLM_cas:issn">1073-6085</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Microarrays are a powerful tool for comparison and understanding of gene expression levels in healthy and diseased states.  The method relies upon the assumption that signals from microarray features are a reflection of relative gene expression levels of the cell types under investigation.  It has previously been reported that the classical fluorescent dyes used for microarray technol., Cy3 and Cy5, are not ideal due to the decreased stability and fluorescence intensity of the Cy5 dye relative to the Cy3, such that dye bias is an accepted phenomena necessitating dye swap exptl. protocols and anal. of differential dye affects.  The incentive to find new fluorophores is based on alleviating the problem of dye bias through synonymous performance between counterpart dyes.  Alexa Fluor 555 and Alexa Fluor 647 are increasingly promoted as replacements for CyDye in microarray expts.  Performance relates to the mol. and steric similarities, which will vary for each new pair of dyes as well as the spectral integrity for the specific application required.  Comparative anal. of the performance of these two competitive dye pairs in practical microarray applications is warranted towards this end.  The findings of the study showed that both dye pairs were comparable but that conventional CyDye resulted in significantly higher signal intensities and signal minus background levels with no significant difference in background values.  This translated to greater levels of differential gene expression with CyDye than with the Alexa Fluor counterparts.  However, CyDye fluorophores and in particular Cy5, were less photostable over time and following repeated scans in microarray expts.  These results suggest that precautions against potential dye affects will continue to be necessary and that no one dye pair negates this need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQAm8fW1hXXbVg90H21EOLACvtfcHk0ljsLD0uJHh6Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1WktL0%253D&md5=93213e5b08d3b03cbd34b395b2229ba8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs12033-007-0006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12033-007-0006-4%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DJ.%2BL.%26aulast%3DPeeva%26aufirst%3DV.%2BK.%26aulast%3DdeSilva%26aufirst%3DC.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BL.%26aulast%3DSwanson%26aufirst%3DN.%2BR.%26atitle%3DComparison%2520of%2520Alexa%2520Fluor%2520and%2520Cy%2520dye%2520for%2520practical%2520DNA%2520microarray%2520use%26jtitle%3DMol.%2520Biotechnol.%26date%3D2007%26volume%3D36%26spage%3D175%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of AVP an OT receptors and therapeutic potential</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1358%2Fdnp.1999.12.5.863621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK1MXltVCkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=279-298&author=C.+Barberisauthor=D.+Morinauthor=T.+Durrouxauthor=B.+Mouillacauthor=G.+Guillonauthor=R.+Seyerauthor=M.+Hibertauthor=E.+Tribolletauthor=M.+Manning&title=Molecular+pharmacology+of+AVP+an+OT+receptors+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of AVP and OT receptors and therapeutic potential</span></div><div class="casAuthors">Barberis, C.; Morin, D.; Durroux, T.; Mouillac, B.; Guillon, G.; Seyer, R.; Hibert, M.; Tribollet, E.; Manning, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">279-292</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review with 142 refs.  Classically, vasopressin (AVP) and oxytocin (OT) receptors were defined on the basis of the second messenger system coupled to the receptors and the affinity of a series of AVP and OT analogs with enhanced selectivity for a certain receptor type.  These classification criteria have led to the distinction of vasopressin V1a, V1b and V2 and oxytocin receptors.  Recent reports on novel vasopressin analogs that exhibit selective vasodepressor agonistic activity suggest the presence of an as yet uncharacterized new vasopressin receptor, as well.  Mol. cloning of this family has confirmed that vasopressin/oxytocin receptor subtypes are members of the G-protein-coupled receptor superfamily.  Several vasopressin agonists have been developed that may be of potential therapeutic interest.  AVP analogs combining high vasopressor potency and specificity with long -acting effects could be of clin. value in hemorrhage and circulatory disorders like hypertension.  AVP and OT antagonists have been widely used as pharmacol. tools in studies on the physiol. and pathophysiol. roles of AVP and OT and in receptor localization and characterization studies.  While potent and selective V1a, V2 and OT antagonists have been developed, there is still a significant need for potent and selective V1b antagonists.  In the future, data will undoubtedly emerge from structure-activity relationships which have been greatly facilitated by the use of human receptors expressed in heterologous systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreUuGtpAOZt7Vg90H21EOLACvtfcHk0liqOLSW0fw4wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVCkt74%253D&md5=ef882e31fa12306888a9c1ea117a9d9a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1358%2Fdnp.1999.12.5.863621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.1999.12.5.863621%26sid%3Dliteratum%253Aachs%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DManning%26aufirst%3DM.%26atitle%3DMolecular%2520pharmacology%2520of%2520AVP%2520an%2520OT%2520receptors%2520and%2520therapeutic%2520potential%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D1999%26volume%3D12%26spage%3D279%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_contrib-group">Kruszynski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title">[1-Beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(<i>O</i>-methyl)tyrosine]arginine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]arginine vasopressin, two high potent antagonists of the vasopressor response to arginine-vasopressin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00178a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=364-368&author=M.+Kruszynskiauthor=B.+Lammekauthor=M.+Manningauthor=J.+Setoauthor=J+Haldarauthor=W.+H.+Sawyer&title=%5B1-Beta-mercapto-beta%2Cbeta-cyclopentamethylenepropionic+acid%29%2C2-%28O-methyl%29tyrosine%5Darginine-vasopressin+and+%5B1-beta-mercapto-beta%2Cbeta-cyclopentamethylenepropionic+acid%29%5Darginine+vasopressin%2C+two+high+potent+antagonists+of+the+vasopressor+response+to+arginine-vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fjm00178a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00178a003%26sid%3Dliteratum%253Aachs%26aulast%3DKruszynski%26aufirst%3DM.%26aulast%3DLammek%26aufirst%3DB.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DSeto%26aufirst%3DJ.%26aulast%3DHaldar%26aufirst%3DJ%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3D%255B1-Beta-mercapto-beta%252Cbeta-cyclopentamethylenepropionic%2520acid%2529%252C2-%2528O-methyl%2529tyrosine%255Darginine-vasopressin%2520and%2520%255B1-beta-mercapto-beta%252Cbeta-cyclopentamethylenepropionic%2520acid%2529%255Darginine%2520vasopressin%252C%2520two%2520high%2520potent%2520antagonists%2520of%2520the%2520vasopressor%2520response%2520to%2520arginine-vasopressin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D364%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2FS0079-6123%2808%2900437-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=18655903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=473-512&author=M.+Manningauthor=S.+Stoevauthor=B.+Chiniauthor=T.+Durrouxauthor=B.+Mouillacauthor=G.+Guillon&title=Peptide+and+non-peptide+agonists+and+antagonists+for+the+vasopressin+and+oxytocin+V1a%2C+V1b%2C+V2+and+OT+receptors%3A+research+tools+and+potential+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span></div><div class="casAuthors">Manning, Maurice; Stoev, Stoytcho; Chini, Bice; Durroux, Thierry; Mouillac, Bernard; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">473-512</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OT) and vasopressin (AVP) mediate their biol. actions by acting on four known receptors: The OT (uterine) and the AVP V1a (vasopressor), V1b (pituitary), V2 (renal) receptors and a fifth putative AVP V1c (vasodilating) receptor.  This presentation will summarize some highlights of the recent progress, in the design and synthesis of selective peptide agonists, antagonists, radioiodinated ligands, fluorescent ligands and bivalent ligands for these receptors.  Here we present published and unpublished pharmacol. data on the most widely used agonists, antagonists and labeled ligands.  The pharmacol. properties of promising new selective OT antagonists and V1b agonists are also presented.  This review should serve as a useful guide for the selection of the most appropriate ligand for a given study.  The current status of non-peptide OT and AVP antagonists and agonists is also summarized.  The relative merits of peptide and non-peptide AVP and OT agonists and antagonists as: (1) research tools and (2) therapeutic agents will be evaluated.  Many of the receptor selective peptide agonists and antagonists from this and other labs. are far more widely used as pharmacol. tools for studies on the peripheral and central effects of OT and AVP than their non-peptide counterparts.  In addn. to OT and to a lesser extent AVP (pitressin), a no. of OT and AVP analogs; such as carbetocin (OT agonist) dDAVP (desmopressin, V2 agonist), terlipressin (V1a agonist), felypressin (V1a agonist) and atosiban (Tractocile OT antagonist) are also in clin. use.  Despite much early promise, no non-peptide V1a or OT antagonists are currently in clin. trials.  While a no. of orally active non-peptide V2 antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clin. trials; to date, only the mixed V2/V1a, antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clin. use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.  Promising new non-peptide V1b and OT antagonists, as well as non-peptide V2 and OT agonists are now in pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3jiQ5LZT5gLVg90H21EOLACvtfcHk0liqOLSW0fw4wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ&md5=c21ad467eaee4a2651232a16c7dc61c5</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900437-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900437-8%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520non-peptide%2520agonists%2520and%2520antagonists%2520for%2520the%2520vasopressin%2520and%2520oxytocin%2520V1a%252C%2520V1b%252C%2520V2%2520and%2520OT%2520receptors%253A%2520research%2520tools%2520and%2520potential%2520therapeutic%2520agents%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D473%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Advenier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naline, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinolle, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouzet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raufaste, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double-Cazanave, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasacal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">SSR126768A: a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1124%2Fjpet.103.061200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=14722330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A280%3ADC%252BD2c7lsVyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=414-424&author=C.+Serradeil-Le+Galauthor=G.+Valetteauthor=L.+Foulonauthor=G.+Germainauthor=C.+Advenierauthor=E.+Nalineauthor=M.+Bardouauthor=J.-P.+Martinolleauthor=B.+Pouzetauthor=D.+Raufasteauthor=C.+Garciaauthor=E.+Double-Cazanaveauthor=M.+Paulyauthor=M.+Pasacalauthor=A.+Barbierauthor=B.+Scattonauthor=J.-P.+Maffrandauthor=G.+Le+Fur&title=SSR126768A%3A+a+new+selective+and+orally+active+oxytocin+receptor+antagonist+for+the+prevention+of+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor</span></div><div class="casAuthors">Serradeil-Le Gal Claudine; Valette Gerard; Foulon Loic; Germain Guy; Advenier Charles; Naline Emmanuel; Bardou Marc; Martinolle Jean-Pierre; Pouzet Brigitte; Raufaste Danielle; Garcia Corinne; Double-Cazanave Eleonore; Pauly Maxime; Pascal Marc; Barbier Alain; Scatton Bernard; Maffrand Jean-Pierre; Le Fur Gerard</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">414-24</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)benzamide, hydrochloride (SSR126768A), a new potent and selective, orally active oxytocin (OT) receptor antagonist was characterized in several biochemical and pharmacological models.  In binding studies, SSR126768A showed nanomolar affinity for rat and human recombinant and native OT receptors (K(i) = 0.44 nM) and exhibited much lower affinity for V(1a), V(1b), and V(2) receptors.  In addition, it did not interact with a large number of other receptors, enzymes, and ion channels (1 microM).  In autoradiographic experiments performed on at-term human pregnant uterus sections, SSR126768A dose dependently displaced [I(125)]d(CH(2))(5)[Tyr(Me)(2), Thr(4), Orn(8) (125)I-Tyr-NH(2)(9)]VT in situ labeling to OT receptors highly expressed in these tissues.  In functional studies, SSR126768A behaved as a full antagonist and potently antagonized OT-induced intracellular Ca(2+) increase (K(i) = 0.50 nM) and prostaglandin release (K(i) = 0.45 nM) in human uterine smooth muscle cells.  In rat isolated myometrium, OT-induced uterine contractions were competitively antagonized by SSR126768A (pA(2) = 8.47).  Similarly, in human pregnant myometrial strips, SSR126768A inhibited the contractile uterine response to OT.  In conscious telemetrated rats, oral administration of SSR126768A (1-10 mg/kg) produced a competitive inhibition of the dose response to OT on uterine contractions up to 24 h at 3 mg/kg p.o.; no tachyphylaxis was observed after 4-day repeated treatment.  Finally, SSR126768A (30 mg/kg p.o.) significantly delayed parturition in pregnant rats in labor similar to ritodrine (10 mg/kg p.o.).  Thus, SSR126768A is a potent, highly selective, orally active OT receptor antagonist with a long duration of action.  This molecule could find therapeutic application as a tocolytic agent for acute and chronic oral management of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6iUVbkwozC5dYoSR9eyvsfW6udTcc2eaNH3pV3757vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7lsVyitQ%253D%253D&md5=136e693c816a368597799687f167dc0a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.061200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.061200%26sid%3Dliteratum%253Aachs%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DValette%26aufirst%3DG.%26aulast%3DFoulon%26aufirst%3DL.%26aulast%3DGermain%26aufirst%3DG.%26aulast%3DAdvenier%26aufirst%3DC.%26aulast%3DNaline%26aufirst%3DE.%26aulast%3DBardou%26aufirst%3DM.%26aulast%3DMartinolle%26aufirst%3DJ.-P.%26aulast%3DPouzet%26aufirst%3DB.%26aulast%3DRaufaste%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DC.%26aulast%3DDouble-Cazanave%26aufirst%3DE.%26aulast%3DPauly%26aufirst%3DM.%26aulast%3DPasacal%26aufirst%3DM.%26aulast%3DBarbier%26aufirst%3DA.%26aulast%3DScatton%26aufirst%3DB.%26aulast%3DMaffrand%26aufirst%3DJ.-P.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DSSR126768A%253A%2520a%2520new%2520selective%2520and%2520orally%2520active%2520oxytocin%2520receptor%2520antagonist%2520for%2520the%2520prevention%2520of%2520preterm%2520labor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D414%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagnon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2FS0079-6123%2802%2939017-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=12436936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFGrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2002&pages=197-210&author=C.+Serradeil-Le+Galauthor=J.+Wagnonauthor=G.+Valetteauthor=G.+Garciaauthor=M.+Pascalauthor=J.+P.+Maffrandauthor=G.+Le+Fur&title=Nonpeptide+vasopressin+receptor+antagonists%3A+development+of+selective+and+orally+active+V1a%2C+V2+and+V1b+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands</span></div><div class="casAuthors">Serradeil-Le Gal, C.; Wagnon, J.; Valette, G.; Garcia, G.; Pascal, M.; Maffrand, J. P.; Le Fur, G.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">Vasopressin and Oxytocin: From Genes to Clinical Applications</span>),
    <span class="NLM_cas:pages">197-210</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The involvement of vasopressin (AVP) in several pathol. states has been reported recently and the selective blockade of the different AVP receptors could offer new clin. perspectives.  During the past few years, various selective, orally active AVP V1a (OPC-21268, SR 49059 (Relcovaptan)), V2 (OPC-31260, OPC-41061 (Tolvaptan), VPA-985 (Lixivaptan), SR121463, VP-343, FR-161282) and mixed V1a/V2 (YM-087 (Conivaptan), JTV-605, CL-385004) receptor antagonists have been intensively studied in various animal models and have reached, Phase IIb clin. trials for some of them.  For many years now, our lab. has focused on the identification of nonpeptide vasopressin antagonists with suitable oral bioavailability.  Using random screening on small mol. libraries, followed by rational SAR and modelization, we identified a chem. series of I-phenylsulfonylindolines which first yielded SR 49059, a V1a receptor antagonist prototype.  This compd. displayed high affinity for animal and human V1a receptors and antagonized various V1a AVP-induced effects in vitro and in vivo (intracellular [Ca2+] increase, platelet aggregation, vascular smooth muscle cell proliferation, hypertension and coronary vasospasm).  We and others have used this compd. to study the role of AVP in various animal models.  Recent findings from clin. trials show a potential interest for SR 49059 in the treatment of dysmenorrhea and in Raynaud's disease.  Structural modifications and simplifications performed in the SR 49059 chem. series yielded highly specific V2 receptor antagonists (N-arylsulfonyl-oxindoles), amongst them SR 121463 which possesses powerful oral aquaretic properties in various animal species and in man.  SR 121463 is well-tolerated and dose-dependently increases urine output and decreases urine osmolality.  It induces free water-excretion without affecting electrolyte balance in contrast to classical diuretics (e.g. furosemide and hydrochlorothiazide).  Notably, in cirrhotic rats with ascites and impaired renal function, a 10-day oral treatment with SR 121463 (0.5 mg/kg) totally cor. hyponatremia and restored normal urine excretion.  This compd. also displayed interesting new properties in a rabbit model of ocular hypertension, decreasing intraocular pressure after single or repeated instillation.  Thus, V2 receptor blockade could be of interest in several water-retaining diseases such as the syndrome of inappropriate antidiuretic hormone secretion (SIADH), liver cirrhosis and congestive heart failure and deserves to be widely explored.  Finally, further chem. developments in the oxindole family have led to the first specific and orally active V1b receptor antagonists (with SSR149415 as a representative), an awaited class of drugs with expected therapeutic interest mainly in ACTH-secreting tumors and various emotional diseases such as stress-related disorders, anxiety and depression.  However, from the recently described tissue localization for this receptor, we could also speculate on other unexpected uses.  In conclusion, the development of AVP receptor antagonists is a field of intensive pharmacol. and clin. investigation.  Selective and orally active compds. are now available to give new insight into the pathophysiol. role of AVP and to provide promising drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJ3b7CqSZr7Vg90H21EOLACvtfcHk0lhW6pJQRfN9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFGrs70%253D&md5=cf18c25e8c99c72f11887db32c864a50</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2802%2939017-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252802%252939017-4%26sid%3Dliteratum%253Aachs%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DWagnon%26aufirst%3DJ.%26aulast%3DValette%26aufirst%3DG.%26aulast%3DGarcia%26aufirst%3DG.%26aulast%3DPascal%26aufirst%3DM.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DNonpeptide%2520vasopressin%2520receptor%2520antagonists%253A%2520development%2520of%2520selective%2520and%2520orally%2520active%2520V1a%252C%2520V2%2520and%2520V1b%2520receptor%2520ligands%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2002%26volume%3D139%26spage%3D197%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Caldwell, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macbeth, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. C.,  II.</span><span> </span><span class="NLM_article-title">Vasopressin: behavioral roles of an original neuropeptide</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2Fj.pneurobio.2007.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=18053631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOrtb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=1-24&author=H.+K.+Caldwellauthor=H.-J.+Leeauthor=A.+H.+Macbethauthor=W.+C.+Young&title=Vasopressin%3A+behavioral+roles+of+an+original+neuropeptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Vasopressin: Behavioral roles of an "original" neuropeptide</span></div><div class="casAuthors">Caldwell, Heather K.; Lee, Heon-Jin; Macbeth, Abbe H.; Young, W. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-24</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Vasopressin (Avp) is mainly synthesized in the magnocellular cells of the hypothalamic supraoptic (SON) and paraventricular nuclei (PVN) whose axons project to the posterior pituitary.  Avp is then released into the blood stream upon appropriate stimulation (e.g., hemorrhage or dehydration) to act at the kidneys and blood vessels.  The brain also contains several populations of smaller, parvocellular neurons whose projections remain within the brain.  These populations are located within the PVN, bed nucleus of the stria terminalis (BNST), medial amygdala (MeA) and suprachiasmatic nucleus (SCN).  Since the 1950s, research examg. the roles of Avp in the brain and periphery has intensified.  The development of specific agonists and antagonists for Avp receptors has allowed for a better elucidation of its contributions to physiol. and behavior.  Anatomical, pharmacol. and transgenic, including "knockout," animal studies have implicated Avp in the regulation of various social behaviors across species.  Avp plays a prominent role in the regulation of aggression, generally of facilitating or promoting it.  Affiliation and certain aspects of pair-bonding are also influenced by Avp.  Memory, one of the first brain functions of Avp that was investigated, has been implicated esp. strongly in social recognition.  The roles of Avp in stress, anxiety, and depressive states are areas of active exploration.  In this review, we conc. on the scientific progress that has been made in understanding the role of Avp in regulating these and other behaviors across species.  We also discuss the implications for human behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zuRs3NFBrrVg90H21EOLACvtfcHk0limj_btt-ZDlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOrtb7O&md5=41b77b1e1988a28b1713aa198732cab7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2007.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2007.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DH.-J.%26aulast%3DMacbeth%26aufirst%3DA.%2BH.%26aulast%3DYoung%26aufirst%3DW.%2BC.%26atitle%3DVasopressin%253A%2520behavioral%2520roles%2520of%2520an%2520original%2520neuropeptide%26jtitle%3DProg.%2520Neurobiol.%26date%3D2008%26volume%3D84%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an “easy guide” to receptor pharmacology</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2FS0079-6123%2808%2900438-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=18655904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=513-517&author=B.+Chiniauthor=M.+Manningauthor=G.+Guillon&title=Affinity+and+efficacy+of+selective+agonists+and+antagonists+for+vasopressin+and+oxytocin+receptors%3A+an+%E2%80%9Ceasy+guide%E2%80%9D+to+receptor+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an easy guide to receptor pharmacology</span></div><div class="casAuthors">Chini, Bice; Manning, Maurice; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">513-517</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of "selective" drugs targeting oxytocin/vasopressin receptors has enormously progressed since the original synthesis of oxytocin more than 50 years ago.  However, several factors still hamper the availability of a rich and complete range of selective agonists and antagonists acting at the different oxytocin/vasopressin receptor subtypes, making the use of these drugs still a daunting task.  In this paper we will briefly review the major problems encountered when dealing with oxytocin/vasopressin selective ligands, proving few rules for their correct pharmacol. use, in order to avoid common pitfalls.  Finally, we will glimpse at new challenges, such us the discovery of coupling selective ligands, which foster the search for new classes of selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN_It28Yr4erVg90H21EOLACvtfcHk0limj_btt-ZDlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfL&md5=9d8d4834a931b53e84d2a898e2854486</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900438-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900438-X%26sid%3Dliteratum%253Aachs%26aulast%3DChini%26aufirst%3DB.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DAffinity%2520and%2520efficacy%2520of%2520selective%2520agonists%2520and%2520antagonists%2520for%2520vasopressin%2520and%2520oxytocin%2520receptors%253A%2520an%2520%25E2%2580%259Ceasy%2520guide%25E2%2580%259D%2520to%2520receptor%2520pharmacology%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D513%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Berezowska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelent, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span> </span><span class="NLM_article-title">Highly potent fluorescent analogues of the opioid peptide [Dmt<sup>1</sup>]DALDA</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=1195-1200&author=I.+Berezowskaauthor=N.+N.+Chungauthor=C.+Lemieuxauthor=B.+Zelentauthor=H.+H.+Szetoauthor=P.+W.+Schiller&title=Highly+potent+fluorescent+analogues+of+the+opioid+peptide+%5BDmt1%5DDALDA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerezowska%26aufirst%3DI.%26aulast%3DChung%26aufirst%3DN.%2BN.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DZelent%26aufirst%3DB.%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26atitle%3DHighly%2520potent%2520fluorescent%2520analogues%2520of%2520the%2520opioid%2520peptide%2520%255BDmt1%255DDALDA%26jtitle%3DPeptides%26date%3D2003%26volume%3D24%26spage%3D1195%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Schiller, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezowska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weltrowska, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, N. N.</span><span> </span><span class="NLM_article-title">Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy</span> <span class="citation_source-journal">J. Pept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1111%2Fj.1399-3011.2005.00252.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=15885115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslOmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=556-563&author=P.+W.+Schillerauthor=I.+Berezowskaauthor=G.+Weltrowskaauthor=H.+Chenauthor=C.+Lemieuxauthor=N.+N.+Chung&title=Type+and+location+of+fluorescent+probes+incorporated+into+the+potent+mu-opioid+peptide+%5Bdmt%5DDALDA+affect+potency%2C+receptor+selectivity+and+intrinsic+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Type and location of fluorescent probes incorporated into the potent μ-opioid peptide [Dmt1]DALDA affect potency, receptor selectivity and intrinsic efficacy</span></div><div class="casAuthors">Schiller, P. W.; Berezowska, I.; Weltrowska, G.; Chen, H.; Lemieux, C.; Chung, N. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">556-563</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The Dermorphin-derived tetrapeptide H-Dmt-D-Arg-Phe-Lys-NH2 (Dmt = 2',6'-dimethyltyrosine) ([Dmt1]DALDA) is a highly potent and selective μ-opioid agonist capable of crossing the blood-brain barrier and producing a potent, centrally mediated analgesic effect when given systemically.  For the purpose of biodistribution studies by fluorescence techniques, [Dmt1]DALDA analogs contg. various fluorescent labels [dansyl, Anthraniloyl (atn), fluorescein, or 6-dimethylamino-2'-naphthoyl] in several different locations of the peptide were synthesized and characterized in vitro in the guinea-pig ileum and mouse vas deferens assays, and in μ-, δ- and κ-opioid receptor-binding assays.  The analogs showed various degrees of μ receptor-binding selectivity, but all of them were less μ-selective than the [Dmt1]DALDA parent peptide.  Most analogs retained potent, full μ-agonist activity, except for one with fluorescein attached at the C-terminus (3a) (partial μ-agonist) and one contg. β-(6'-dimethylamino-2'-naphthoyl)alanine (Aladan) in place of Phe3 (4) (μ- and κ-antagonist).  The obtained data indicate that the receptor-binding affinity, receptor selectivity and intrinsic efficacy of the prepd. analogs vary very significantly, depending on the type of fluorescent label used and on its location in the peptide.  The results suggest that the biol. activity profile of fluorescence-labeled peptide analogs should always be carefully detd. prior to their use in biodistribution studies or other studies.  One of the analogs contg. the atn group (2a) proved highly useful in a study of cellular uptake and intracellular distribution by confocal laser scanning microscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq00XQQ7akIPLVg90H21EOLACvtfcHk0limj_btt-ZDlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslOmt7Y%253D&md5=5dde40b2c1538c0c7df21d970cdc9b4b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.2005.00252.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.2005.00252.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DBerezowska%26aufirst%3DI.%26aulast%3DWeltrowska%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DN.%2BN.%26atitle%3DType%2520and%2520location%2520of%2520fluorescent%2520probes%2520incorporated%2520into%2520the%2520potent%2520mu-opioid%2520peptide%2520%255Bdmt%255DDALDA%2520affect%2520potency%252C%2520receptor%2520selectivity%2520and%2520intrinsic%2520efficacy%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2005%26volume%3D65%26spage%3D556%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Devost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zingg, H. H.</span><span> </span><span class="NLM_article-title">Homo- and hetero-dimeric complex formations of the human oxytocin receptor</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1111%2Fj.0953-8194.2004.01188.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=15089977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvF2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=372-377&author=D.+Devostauthor=H.+H.+Zingg&title=Homo-+and+hetero-dimeric+complex+formations+of+the+human+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Homo- and hetero-dimeric complex formations of the human oxytocin receptor</span></div><div class="casAuthors">Devost, D.; Zingg, H. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Using 2 different coimmunopptn. strategies as well as bioluminescence resonance energy transfer (BRET) techniques, we detd. that the human oxytocin receptor forms dimeric and oligomeric complexes in vivo in intact living cells, and that these complexes exist at the cell surface level.  Using a BRET-based assay, we found that oligomers can form between oxytocin receptors themselves (homo-oligomers) as well as, with a reduced affinity, between the oxytocin receptor and related members of the vasopressin receptor family (V1a and V2 receptors), but not with the more remotely related bradykinin receptor.  The existence of oxytocin receptor oligomers at the level of the cell surface was demonstrated by a coimmunopptn. approach involving direct antibody exposure of intact living cells.  Furthermore, this approach demonstrated that cell surface oxytocin receptor oligomerization is ligand independent.  However, agonist addn. led to an apparent rapid decrease in receptor oligomerization, as assessed by the coimmunopptn. approach, indicating that agonist exposure may modulate the oligomerization status.  It remains to be detd. to what extent oxytocin receptor oligomerization impacts on signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4wgPb6eVDZ7Vg90H21EOLACvtfcHk0lhvhxnFgpqAuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvF2isbw%253D&md5=a4e955922d76174d4790a19b892aa637</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.0953-8194.2004.01188.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0953-8194.2004.01188.x%26sid%3Dliteratum%253Aachs%26aulast%3DDevost%26aufirst%3DD.%26aulast%3DZingg%26aufirst%3DH.%2BH.%26atitle%3DHomo-%2520and%2520hetero-dimeric%2520complex%2520formations%2520of%2520the%2520human%2520oxytocin%2520receptor%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2004%26volume%3D16%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Albizu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kralikova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brabet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourrier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarque, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rives, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinquet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Time-resolved FRET between GPCR ligands reveals oligomers in native tissues</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1038%2Fnchembio.396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=20622858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ahsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=587-594&author=L.+Albizuauthor=M.+Cottetauthor=M.+Kralikovaauthor=S.+Stoevauthor=R.+Seyerauthor=I.+Brabetauthor=T.+Rouxauthor=H.+Bazinauthor=E.+Bourrierauthor=L.+Lamarqueauthor=C.+Bretonauthor=M.-L.+Rivesauthor=A.+Newmanauthor=J.+Javitchauthor=E.+Trinquetauthor=M.+Manningauthor=J.-P.+Pinauthor=B.+Mouillacauthor=T.+Durroux&title=Time-resolved+FRET+between+GPCR+ligands+reveals+oligomers+in+native+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Time-resolved FRET between GPCR ligands reveals oligomers in native tissues</span></div><div class="casAuthors">Albizu, Laura; Cottet, Martin; Kralikova, Michaela; Stoev, Stoytcho; Seyer, Rene; Brabet, Isabelle; Roux, Thomas; Bazin, Herve; Bourrier, Emmanuel; Lamarque, Laurent; Breton, Christophe; Rives, Marie-Laure; Newman, Amy; Javitch, Jonathan; Trinquet, Eric; Manning, Maurice; Pin, Jean-Philippe; Mouillac, Bernard; Durroux, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">587-594</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptor (GPCR) oligomers have been proposed to play crit. roles in cell signaling, but confirmation of their existence in a native context remains elusive, as no direct interactions between receptors have been reported.  To demonstrate their presence in native tissues, we developed a time-resolved FRET strategy that is based on receptor labeling with selective fluorescent ligands.  Specific FRET signals were obsd. with four different receptors expressed in cell lines, consistent with their dimeric or oligomeric nature in these transfected cells.  More notably, the comparison between FRET signals measured with sets of fluorescent agonists and antagonists was consistent with an asym. relationship of the two protomers in an activated GPCR dimer.  Finally, we applied the strategy to native tissues and succeeded in demonstrating the presence of oxytocin receptor dimers and/or oligomers in mammary gland.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRPFTQQ0GNv7Vg90H21EOLACvtfcHk0lhvhxnFgpqAuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ahsbw%253D&md5=7ad4fb48ba7b71d1322e158d7d174b33</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.396%26sid%3Dliteratum%253Aachs%26aulast%3DAlbizu%26aufirst%3DL.%26aulast%3DCottet%26aufirst%3DM.%26aulast%3DKralikova%26aufirst%3DM.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DBrabet%26aufirst%3DI.%26aulast%3DRoux%26aufirst%3DT.%26aulast%3DBazin%26aufirst%3DH.%26aulast%3DBourrier%26aufirst%3DE.%26aulast%3DLamarque%26aufirst%3DL.%26aulast%3DBreton%26aufirst%3DC.%26aulast%3DRives%26aufirst%3DM.-L.%26aulast%3DNewman%26aufirst%3DA.%26aulast%3DJavitch%26aufirst%3DJ.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DTime-resolved%2520FRET%2520between%2520GPCR%2520ligands%2520reveals%2520oligomers%2520in%2520native%2520tissues%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D587%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Terillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayoub, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taulan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jockers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and hetero-dimers during biosynthesis</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1210%2Fme.2002-0222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=12554793" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=677-691&author=S.+Terillonauthor=T.+Durrouxauthor=B.+Mouillacauthor=A.+Breitauthor=M.+A.+Ayoubauthor=M.+Taulanauthor=R.+Jockersauthor=C.+Barberisauthor=M.+Bouvier&title=Oxytocin+and+vasopressin+V1a+and+V2+receptors+form+constitutive+homo-+and+hetero-dimers+during+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1210%2Fme.2002-0222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2002-0222%26sid%3Dliteratum%253Aachs%26aulast%3DTerillon%26aufirst%3DS.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DBreit%26aufirst%3DA.%26aulast%3DAyoub%26aufirst%3DM.%2BA.%26aulast%3DTaulan%26aufirst%3DM.%26aulast%3DJockers%26aufirst%3DR.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DOxytocin%2520and%2520vasopressin%2520V1a%2520and%2520V2%2520receptors%2520form%2520constitutive%2520homo-%2520and%2520hetero-dimers%2520during%2520biosynthesis%26jtitle%3DMol.%2520Endocrinol.%26date%3D2003%26volume%3D17%26spage%3D677%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Terillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1548</span><span class="NLM_x">–</span> <span class="NLM_lpage">1553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=1548-1553&author=S.+Terillonauthor=C.+Barberisauthor=M.+Bouvier&title=Heterodimerization+of+V1a+and+V2+vasopressin+receptors+determines+the+interaction+with+beta-arrestin+and+their+trafficking+patterns"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerillon%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DHeterodimerization%2520of%2520V1a%2520and%2520V2%2520vasopressin%2520receptors%2520determines%2520the%2520interaction%2520with%2520beta-arrestin%2520and%2520their%2520trafficking%2520patterns%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D1548%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Young, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilera, G.</span><span> </span><span class="NLM_article-title">Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1007%2Fs10571-006-9135-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=17318384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlSrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=439-461&author=S.+F.+Youngauthor=C.+Griffanteauthor=G.+Aguilera&title=Dimerization+between+vasopressin+V1b+and+corticotropin+releasing+hormone+type+1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors</span></div><div class="casAuthors">Young, Sharla F.; Griffante, Cristiana; Aguilera, Greti</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-461</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Increasing evidence indicates that guanyl protein coupled receptors (GPCRs), including members of the vasopressin (VP) receptor family can act as homo- and heterodimers.  Regulated expression and interaction of pituitary VP V1b receptor (V1bR) and corticotropin releasing hormone receptor type 1 (CRHR1) are crit. for hypothalamic pituitary adrenal (HPA) axis adaptation, but it is unknown whether this involves phys. interaction between these receptors.  Bioluminescence resonance energy transfer (BRET) expts. using V1bR and CRHR1 fused to either Renilla luciferase (Rluc) or yellow fluorescent protein (YFP) at the N-terminus, but not the carboxyl-terminus, revealed specific interaction (BRET50 = 0.39 ± 0.08, V1bR) that was inhibited by untagged V1b or CRHR1 receptors, suggesting homo- and heterodimerization.  The BRET data were confirmed by coimmunopptn. expts. using fully bioactive receptors tagged at the aminoterminus with c-myc and Flag epitopes, demonstrating specific homodimerization of the V1b receptor and heterodimerization of the V1b receptor with CRHR1 receptors.  Heterodimerization between V1bR and CRHR1 is not ligand dependent since stimulation with CRH and AVP had no effect on coimmunopptn.  In membranes obtained from cells cotransfected with CRHR1 and V1bR, incubation with the heterologous nonpeptide antagonist did not alter the binding affinity or capacity of the receptor.  The data demonstrate that V1bR and CRHR1 can form constitutive homo- and heterodimers and suggests that the heterodimerization does not influence the binding properties of these receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekhYSLo3q3LVg90H21EOLACvtfcHk0liXC5nh_9GZxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlSrtbc%253D&md5=59f772291c5e83bd5ab2bbebadbcdda1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs10571-006-9135-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-006-9135-8%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BF.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DAguilera%26aufirst%3DG.%26atitle%3DDimerization%2520between%2520vasopressin%2520V1b%2520and%2520corticotropin%2520releasing%2520hormone%2520type%25201%2520receptors%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2007%26volume%3D27%26spage%3D439%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Berlier, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filanoski, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telford, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beechem, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugland, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugland, R. P.</span><span> </span><span class="NLM_article-title">Quantitative comparision of long-wavelength Alexa fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1712</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1177%2F002215540305101214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=14623938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFGhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=1699-1712&author=J.+E.+Berlierauthor=A.+Rotheauthor=G.+Bullerauthor=J.+Bradfordauthor=D.+R.+Grayauthor=B.+J.+Filanoskiauthor=W.+G.+Telfordauthor=S.+Yueauthor=J.+Liuauthor=C.-Y.+Cheungauthor=W.+Changauthor=J.+D.+Hirschauthor=J.+M.+Beechemauthor=R.+P.+Hauglandauthor=R.+P.+Haugland&title=Quantitative+comparision+of+long-wavelength+Alexa+fluor+dyes+to+Cy+dyes%3A+fluorescence+of+the+dyes+and+their+bioconjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: Fluorescence of the dyes and their bioconjugates</span></div><div class="casAuthors">Berlier, Judith E.; Rothe, Anca; Buller, Gayle; Bradford, Jolene; Gray, Diane R.; Filanoski, Brian J.; Telford, William G.; Yue, Stephen; Liu, Jixiang; Cheung, Ching-Ying; Chang, Wesley; Hirsch, James D.; Beechem, Joseph M.; Haugland, Rosaria P.; Haugland, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1699-1712</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Amine-reactive N-hydroxysuccinimidyl esters of Alexa Fluor fluorescent dyes with principal absorption maxima at about 555 nm, 633 nm, 647 nm, 660 nm, 680 nm, 700 nm, and 750 nm were conjugated to antibodies and other selected proteins.  These conjugates were compared with spectrally similar protein conjugates of the Cy3, Cy5, Cy5.5, Cy7, DY-630, DY-635, DY-680, and Atto 565 dyes.  As N-hydroxysuccinimidyl ester dyes, the Alexa Fluor 555 dye was similar to the Cy3 dye, and the Alexa Fluor 647 dye was similar to the Cy5 dye with respect to absorption maxima, emission maxima, Stokes shifts, and extinction coeffs.  However, both Alexa Fluor dyes were significantly more resistant to photobleaching than were their Cy dye counterparts.  Absorption spectra of protein conjugates prepd. from these dyes showed prominent blue-shifted shoulder peaks for conjugates of the Cy dyes but only minor shoulder peaks for conjugates of the Alexa Fluor dyes.  The anomalous peaks, previously obsd. for protein conjugates of the Cy5 dye, are presumably due to the formation of dye aggregates.  Absorption of light by the dye aggregates does not result in fluorescence, thereby diminishing the fluorescence of the conjugates.  The Alexa Fluor 555 and the Alexa Fluor 647 dyes in protein conjugates exhibited significantly less of this self-quenching, and therefore the protein conjugates of Alexa Fluor dyes were significantly more fluorescent than those of the Cy dyes, esp. at high degrees of labeling.  The results from our flow cytometry, immunocytochem., and immunohistochem. expts. demonstrate that protein-conjugated, long-wavelength Alexa Fluor dyes have advantages compared to the Cy dyes and other long-wavelength dyes in typical fluorescence-based cell labeling applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9nZHzN2e-7Vg90H21EOLACvtfcHk0liXC5nh_9GZxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFGhurk%253D&md5=7eb5eb61200cf5dbf7b8d5081845a1bb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1177%2F002215540305101214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F002215540305101214%26sid%3Dliteratum%253Aachs%26aulast%3DBerlier%26aufirst%3DJ.%2BE.%26aulast%3DRothe%26aufirst%3DA.%26aulast%3DBuller%26aufirst%3DG.%26aulast%3DBradford%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DD.%2BR.%26aulast%3DFilanoski%26aufirst%3DB.%2BJ.%26aulast%3DTelford%26aufirst%3DW.%2BG.%26aulast%3DYue%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DC.-Y.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DHirsch%26aufirst%3DJ.%2BD.%26aulast%3DBeechem%26aufirst%3DJ.%2BM.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26atitle%3DQuantitative%2520comparision%2520of%2520long-wavelength%2520Alexa%2520fluor%2520dyes%2520to%2520Cy%2520dyes%253A%2520fluorescence%2520of%2520the%2520dyes%2520and%2520their%2520bioconjugates%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2003%26volume%3D51%26spage%3D1699%26epage%3D1712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Gimpl, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">The oxytocin receptor system: structure, function and regulation</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=629-683&author=G+Gimplauthor=F.+Fahrenholz&title=The+oxytocin+receptor+system%3A+structure%2C+function+and+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DThe%2520oxytocin%2520receptor%2520system%253A%2520structure%252C%2520function%2520and%2520regulation%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D629%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Gimpl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trossen, C.</span><span> </span><span class="NLM_article-title">Oxytocin receptors: ligand binding, signalling and cholesterol dependance</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2FS0079-6123%2808%2900417-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=18655883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=193-204&author=G.+Gimplauthor=J.+Reitzauthor=S.+Brauerauthor=C.+Trossen&title=Oxytocin+receptors%3A+ligand+binding%2C+signalling+and+cholesterol+dependance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin receptors: ligand binding, signalling and cholesterol dependence</span></div><div class="casAuthors">Gimpl, Gerald; Reitz, Julian; Brauer, Sabine; Trossen, Conny</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">193-204</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The G protein coupled oxytocin receptor (OTR) reveals some specific mol. and physiol. characteristics.  Ligand-receptor interaction has been analyzed by photoaffinity labeling, site-directed mutagenesis, the construction of receptor chimeras and mol. modeling.  Major results of these studies will be summarized.  The N-terminus of the OTR is mainly involved in agonist binding.  Notably, antagonists that are derived from the ground structure of oxytocin, bind the receptor at distinct sites partly non-overlapping with the agonist binding site.  OTRs are able to couple to different G proteins, with a subsequent stimulation of phospholipase C-β isoforms.  In dependence on G protein coupling, OTRs can transduce growth-inhibitory or proliferatory signals.  Some evidence is provided that OTRs are also present in form of dimeric or oligomeric complexes at the cell surface.  The affinity of the receptor for ligands is strongly dependent on the presence of divalent cations (Mg2+) and cholesterol that both act like pos. allosteric modulators.  While the high-affinity state of the receptor for agonists requires divalent cations and cholesterol, the high-affinity state for antagonists is only dependent on a sufficient amt. of cholesterol.  Cholesterol affects ligand-binding affinity, receptor signalling and stability.  Since the purifn. of the OTR has never been achieved, alternative methods to study the receptor in its native environment are necessary.  Promising strategies for the site-specific labeling of the OTR will be presented.  The employment of diverse reporter mols. introduced at different positions within the OTR might allow us in the near future to measure conformational changes of the receptor in its native lipid environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvpiy6HPCjfrVg90H21EOLACvtfcHk0liXC5nh_9GZxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrvK&md5=f31c61f01930e2c3448d7ef6df854c46</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900417-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900417-2%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG.%26aulast%3DReitz%26aufirst%3DJ.%26aulast%3DBrauer%26aufirst%3DS.%26aulast%3DTrossen%26aufirst%3DC.%26atitle%3DOxytocin%2520receptors%253A%2520ligand%2520binding%252C%2520signalling%2520and%2520cholesterol%2520dependance%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D193%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagnon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2777</span><span class="NLM_x">–</span> <span class="NLM_lpage">2789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1210%2Fme.2004-0124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=15284336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslKksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=2777-2789&author=S.+Derickauthor=A.+Penaauthor=T.+Durrouxauthor=J.+Wagnonauthor=C.+Serradeil-Le+Galauthor=M.+Hibertauthor=D.+Rognanauthor=G.+Guillon&title=Key+amino+acids+located+within+the+transmembrane+domains+5+and+7+account+for+the+pharmacological+specificity+of+the+human+V1b+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor</span></div><div class="casAuthors">Derick, S.; Pena, A.; Durroux, T.; Wagnon, J.; Serradeil-Le Gal, C.; Hibert, M.; Rognan, D.; Guillon, G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2777-2789</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">In mammals, the vasopressin V1b receptor (V1b-R) is known to regulate ACTH secretion and, more recently, stress and anxiety.  The characterization of the mol. determinant responsible for its pharmacol. selectivity was made possible by the recent discovery of the first V1b antagonist, SSR149415.  Based upon the structure of the crystd. bovine rhodopsin, we established a three-dimensional mol. model of interaction between the human V1b-R (hV1b-R) and SSR149415.  Four amino acids located in distinct transmembrane helixes (fourth, fifth, and seventh) were found potentially responsible for the hV1b-R selectivity.  To validate these assumptions, we selectively replaced the leucine 181, methionine 220, alanine 334, and serine 338 residues of hV1a-R by their corresponding amino acids present in the hV1b-R (phenylalanine 164, threonine 203, methionine 324, and asparagine 328, resp.).  Four mutants, which all exhibited nanomolar affinities for vasopressin and good coupling to phospholipase C pathway, were generated.  HV1a receptors mutated at position 220 and 334 exhibited striking increase in affinity for SSR149415 both in binding and phospholipase C assays at variance with the hV1a-R modified at position 181 or 338.  In conclusion, this study provides the first structural features concerning the hV1b-R and highlights the role of few specific residues in its pharmacol. selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4qbDQIm4cFbVg90H21EOLACvtfcHk0ljNM6u4wlA_mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslKksLg%253D&md5=53f8487765ba5adb5a80de4d7d8924b0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1210%2Fme.2004-0124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2004-0124%26sid%3Dliteratum%253Aachs%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DWagnon%26aufirst%3DJ.%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DKey%2520amino%2520acids%2520located%2520within%2520the%2520transmembrane%2520domains%25205%2520and%25207%2520account%2520for%2520the%2520pharmacological%2520specificity%2520of%2520the%2520human%2520V1b%2520vasopressin%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2004%26volume%3D18%26spage%3D2777%26epage%3D2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Arttamangkul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Maubecin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Binding and internalization of fluorescent opioid conjugates in living cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1570</span><span class="NLM_x">–</span> <span class="NLM_lpage">1580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1570-1580&author=S.+Arttamangkulauthor=V.+Alvarez-Maubecinauthor=G.+Thomasauthor=J.+T.+Williamsauthor=D.+K.+Grandy&title=Binding+and+internalization+of+fluorescent+opioid+conjugates+in+living+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArttamangkul%26aufirst%3DS.%26aulast%3DAlvarez-Maubecin%26aufirst%3DV.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DBinding%2520and%2520internalization%2520of%2520fluorescent%2520opioid%2520conjugates%2520in%2520living%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1570%26epage%3D1580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagnon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnerre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulombard, A.</span><span> </span><span class="NLM_article-title">An overview of SSR149415, a selective vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=53-68&author=C.+Serradeil-Le+Galauthor=J.+Wagnonauthor=B.+Tonnerreauthor=R.+Rouxauthor=G.+Garciaauthor=G.+Griebelauthor=A.+Aulombard&title=An+overview+of+SSR149415%2C+a+selective+vasopressin+V%281b%29+receptor+antagonist+for+the+treatment+of+stress-related+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DWagnon%26aufirst%3DJ.%26aulast%3DTonnerre%26aufirst%3DB.%26aulast%3DRoux%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DG.%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DAulombard%26aufirst%3DA.%26atitle%3DAn%2520overview%2520of%2520SSR149415%252C%2520a%2520selective%2520vasopressin%2520V%25281b%2529%2520receptor%2520antagonist%2520for%2520the%2520treatment%2520of%2520stress-related%2520disorders%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2005%26volume%3D11%26spage%3D53%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hope, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walti, M.</span><span> </span><span class="NLM_article-title">Synthesis of α-hydroxy-analogues of <i>S</i>-benzylcysteine and cysteine</span> <span class="citation_source-journal">J. Chem. Soc. C</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_fpage">2475</span><span class="NLM_x">–</span> <span class="NLM_lpage">2478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1039%2Fj39700002475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaE3MXitlWitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&pages=2475-2478&author=D.+B.+Hopeauthor=M.+Walti&title=Synthesis+of+%CE%B1-hydroxy-analogues+of+S-benzylcysteine+and+cysteine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of the α-hydroxy-analogs of S-benzylcysteine and cysteine</span></div><div class="casAuthors">Hope, Derek B.; Walti, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2475-8</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">Β-Chlorolactic acid was condensed with toluene-α-thiol to give 2-hydroxy-3-benzylthiopropanoic acid.  The optical isomers were prepd. by resolution with brucine and quinine.  Removal of benzyl groups yielded (+)- and (-)-2-hydroxy-3-mercaptopropanoic acids.  Desulfurization with Raney Ni gave (+)- and (-)-lactic acid.  Configuration and optical purity of all isomers were detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0QVbzsJrLqrVg90H21EOLACvtfcHk0ljNM6u4wlA_mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXitlWitw%253D%253D&md5=8a17612896990aff15e2ef9a27fed57f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fj39700002475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj39700002475%26sid%3Dliteratum%253Aachs%26aulast%3DHope%26aufirst%3DD.%2BB.%26aulast%3DWalti%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520%25CE%25B1-hydroxy-analogues%2520of%2520S-benzylcysteine%2520and%2520cysteine%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1970%26spage%3D2475%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Merrifield, R. B.</span><span> </span><span class="NLM_article-title">Solid-phase peptide synthesis. III. An improved synthesis of bradykinin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1385</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00897a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1964&pages=1385-1390&author=R.+B.+Merrifield&title=Solid-phase+peptide+synthesis.+III.+An+improved+synthesis+of+bradykinin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbi00897a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00897a032%26sid%3Dliteratum%253Aachs%26aulast%3DMerrifield%26aufirst%3DR.%2BB.%26atitle%3DSolid-phase%2520peptide%2520synthesis.%2520III.%2520An%2520improved%2520synthesis%2520of%2520bradykinin%26jtitle%3DBiochemistry%26date%3D1964%26volume%3D3%26spage%3D1385%26epage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Stewart, J. M.; Young, J. D.</span><span> </span><span class="NLM_article-title">Solid Phase Synthesis</span>; <span class="NLM_publisher-name">Pierce Chemical Co.</span>: <span class="NLM_publisher-loc">Rockford, IL</span>,<span class="NLM_x"> </span><span class="NLM_year">1984</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Stewart%2C+J.+M.%3B+Young%2C+J.+D.+Solid+Phase+Synthesis%3B+Pierce+Chemical+Co.%3A+Rockford%2C+IL%2C+1984."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DJ.%2BM.%26atitle%3DSolid%2520Phase%2520Synthesis%26pub%3DPierce%2520Chemical%2520Co%26date%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszynski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klis, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title">Solid-phase synthesis of 16 potent (selective and non-selective) in vivo antagonists of oxytocin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=383-391&author=M.+Manningauthor=M.+Kruszynskiauthor=K.+Bankowskiauthor=A.+Olmaauthor=B.+Lammekauthor=L.+L.+Chengauthor=W.+A.+Klisauthor=J.+Setoauthor=J.+Haldarauthor=W.+H.+Sawyer&title=Solid-phase+synthesis+of+16+potent+%28selective+and+non-selective%29+in+vivo+antagonists+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DKruszynski%26aufirst%3DM.%26aulast%3DBankowski%26aufirst%3DK.%26aulast%3DOlma%26aufirst%3DA.%26aulast%3DLammek%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DKlis%26aufirst%3DW.%2BA.%26aulast%3DSeto%26aufirst%3DJ.%26aulast%3DHaldar%26aufirst%3DJ.%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3DSolid-phase%2520synthesis%2520of%252016%2520potent%2520%2528selective%2520and%2520non-selective%2529%2520in%2520vivo%2520antagonists%2520of%2520oxytocin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D383%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowbridge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title">Synthesis and Some pharmacological properties of [1-(l-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxyl[4-Thr]-oxytocin), a peptide with strikingly high oxytocic potency, and of [1-(<span class="smallcaps smallerCapital">l</span>-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00225a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1976&pages=376-380&author=M.+Manningauthor=J.+Lowbridgeauthor=J.+Haldarauthor=W.+H.+Sawyer&title=Synthesis+and+Some+pharmacological+properties+of+%5B1-%28l-2-hydroxy-3-mercaptopropanoic+acid%29%2C+4-threonine%5Doxytocin+%28hydroxyl%5B4-Thr%5D-oxytocin%29%2C+a+peptide+with+strikingly+high+oxytocic+potency%2C+and+of+%5B1-%28l-2-hydroxy-3-mercaptopropanoic+acid%29%5Doxytocin+%28hydroxy-oxytocin%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00225a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00225a007%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DLowbridge%26aufirst%3DJ.%26aulast%3DHaldar%26aufirst%3DJ.%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3DSynthesis%2520and%2520Some%2520pharmacological%2520properties%2520of%2520%255B1-%2528l-2-hydroxy-3-mercaptopropanoic%2520acid%2529%252C%25204-threonine%255Doxytocin%2520%2528hydroxyl%255B4-Thr%255D-oxytocin%2529%252C%2520a%2520peptide%2520with%2520strikingly%2520high%2520oxytocic%2520potency%252C%2520and%2520of%2520%255B1-%2528l-2-hydroxy-3-mercaptopropanoic%2520acid%2529%255Doxytocin%2520%2528hydroxy-oxytocin%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1976%26volume%3D19%26spage%3D376%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Koenig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiger, R.</span><span> </span><span class="NLM_article-title">A new method for the synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide by using 1-hydroxy-benzotriazole as additives</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1970&pages=788-798&author=W.+Koenigauthor=R.+Geiger&title=A+new+method+for+the+synthesis+of+peptides%3A+activation+of+the+carboxyl+group+with+dicyclohexylcarbodiimide+by+using+1-hydroxy-benzotriazole+as+additives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoenig%26aufirst%3DW.%26aulast%3DGeiger%26aufirst%3DR.%26atitle%3DA%2520new%2520method%2520for%2520the%2520synthesis%2520of%2520peptides%253A%2520activation%2520of%2520the%2520carboxyl%2520group%2520with%2520dicyclohexylcarbodiimide%2520by%2520using%25201-hydroxy-benzotriazole%2520as%2520additives%26jtitle%3DChem.%2520Ber.%26date%3D1970%26volume%3D103%26spage%3D788%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Bodansky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Vigneaud, V.</span><span> </span><span class="NLM_article-title">A method of synthesis of long peptide chains using a synthesis of oxytocin as an example</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">5688</span><span class="NLM_x">–</span> <span class="NLM_lpage">5691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1959&pages=5688-5691&author=M.+Bodanskyauthor=V.+du+Vigneaud&title=A+method+of+synthesis+of+long+peptide+chains+using+a+synthesis+of+oxytocin+as+an+example"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodansky%26aufirst%3DM.%26aulast%3Ddu%2BVigneaud%26aufirst%3DV.%26atitle%3DA%2520method%2520of%2520synthesis%2520of%2520long%2520peptide%2520chains%2520using%2520a%2520synthesis%2520of%2520oxytocin%2520as%2520an%2520example%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1959%26volume%3D81%26spage%3D5688%26epage%3D5691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Manning, M.</span><span> </span><span class="NLM_article-title">Synthesis by the Merrifield method of a protected nonapeptide amide with the amino acid sequence of oxytocin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1968&pages=1348-1349&author=M.+Manning&title=Synthesis+by+the+Merrifield+method+of+a+protected+nonapeptide+amide+with+the+amino+acid+sequence+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26atitle%3DSynthesis%2520by%2520the%2520Merrifield%2520method%2520of%2520a%2520protected%2520nonapeptide%2520amide%2520with%2520the%2520amino%2520acid%2520sequence%2520of%2520oxytocin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1968%26volume%3D11%26spage%3D1348%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">du Vigneaud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsoyannis, P. G.</span><span> </span><span class="NLM_article-title">A synthetic preparation possessing biological properties associated with arginine-vasopressin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">4751</span><span class="NLM_x">–</span> <span class="NLM_lpage">4752</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01647a089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1954&pages=4751-4752&author=V.+du+Vigneaudauthor=D.+T.+Gishauthor=P.+G.+Katsoyannis&title=A+synthetic+preparation+possessing+biological+properties+associated+with+arginine-vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja01647a089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01647a089%26sid%3Dliteratum%253Aachs%26aulast%3Ddu%2BVigneaud%26aufirst%3DV.%26aulast%3DGish%26aufirst%3DD.%2BT.%26aulast%3DKatsoyannis%26aufirst%3DP.%2BG.%26atitle%3DA%2520synthetic%2520preparation%2520possessing%2520biological%2520properties%2520associated%2520with%2520arginine-vasopressin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1954%26volume%3D76%26spage%3D4751%26epage%3D4752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miteva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pancheva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wo, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. Y.</span><span> </span><span class="NLM_article-title">Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparison with atosiban</span> <span class="citation_source-journal">Int. J. Pept. Protein Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1111%2Fj.1399-3011.1995.tb00596.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=8537178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK2MXovVGjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1995&pages=244-252&author=M.+Manningauthor=K.+Mitevaauthor=S.+Panchevaauthor=S.+Stoevauthor=N.+C.+Woauthor=W.+Y.+Chan&title=Design+and+synthesis+of+highly+selective+in+vitro+and+in+vivo+uterine+receptor+antagonists+of+oxytocin%3A+comparison+with+atosiban"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban</span></div><div class="casAuthors">Manning, M.; Miteva, K.; Pancheva, S.; Stoev, S.; Wo, N. C.; Chan, W. Y.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide & Protein Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">244-53</span>CODEN:
                <span class="NLM_cas:coden">IJPPC3</span>;
        ISSN:<span class="NLM_cas:issn">0367-8377</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">The authors report the solid phase synthesis and some pharmacol. properties of seven position two analogs (peptides 1-7) of one of the lead oxytocin antagonists, des-9-glycinamide[1-(β-mercapto-β,β-pentamethylenepropionic acid),2-O-methyltyrosine,4-threonine]ornithine-vasotocin (desGly-NH2,d(CH2)5-[Tyr(Me)2,Thr4]OVT).  Peptides 1-7 have the following substituents at position two (1) D-Tyr(Me); (2) L-Tyr(Et); (3) D-Tyr(Et); (4) L-Tyr; (5) D-Tyr; (6) D-Phe and (7) D-Trp.  These were evaluated for agonistic and antagonistic activities in in vitro and in vivo OT assays in vivo vasopressor (V1a-receptor) assays and in vivo antidiuretic (V2-receptor) assays.  None of the seven peptides exhibits oxytocic or vasopressor agonism.  Peptides 1, 2, 4, 6 and 7 are extremely weak V2 agonists (V2 activities range from 0.001 to 0.02 U/mg).  Peptides 3 and 5 exhibit weak V2 antagonism (pA2 < 6.0 and <5.5, resp.).  Peptides 1-7 exhibit potent in vitro (no Mg2+) OT antagonism (anti-OT pA2 values range from 7.66 to 8.03).  Peptides 1 and 4-7 exhibit potent in vivo OT antagonism.  Estd. in vivo anti-OT pA2 values range from 7.06 to 7.79 (peptides 2 and 3 were not tested).  With anti-V1a pA2 values of 5.17-6.25 all seven peptides exhibit reduced anti-V1a potencies relative to the parent peptide (anti-V1a pA2 = 6.46).  Four of these peptides (4-7) exhibit striking gains in in vitro and in vivo anti-OT/anti-V1a selectivities compared to the parent peptide which has an in vitro selectivity of 30 and an in vivo selectivity of 18.  The D-Tyr2 (5), D-Trp2 (7), D-Phe2 (6) and L-Tyr2 (4) analogs of the parent peptide exhibit anti-OT (in vitro)/anti-V1a selectivities = 240, 390, 404 and 540, resp.  The L-Tyr2 (4), D-Trp2 (7), D-Phe2 (6) and D-Tyr2 (5) analogs exhibited anti-OT (in vivo)/anti-V1a selectivities of 72, 80, 88 and 95, resp.  Peptides 4-7 appear to be the most selective peptide OT antagonists reported to date.  In this regard it may be noted that they appear to be as or more potent and much more selective than the closely related OT antagonist Atosiban which is currently undergoing clin. trial as a potential therapeutic agent for the prevention of premature labor.  Atosiban (peptide 8) was re-synthesized and pharmacol. evaluated in the labs.  Atosiban exhibits the following antagonistic potencies.  Anti-OT (in vitro, no Mg2+) pA2 = 7.71; anti-OT in vivo pA2 = 7.05; anti=V1a pA2 = 6.14 and anti-V2 pA2 ≈ 5.9.  Its anti-OT (in vivo)/anti-V1a selectivity is 8.  Some of these antagonists may be suitable candidates for evaluation as potential tocolytic agents for use in the treatment of pre-term labor.  They could also serve as useful new pharmacol. tools for studies on the physiol. roles of oxytocin.  Finally, the findings presented here provide useful clues for the design of more potent and more selective OT antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8ff7obT3E7Vg90H21EOLACvtfcHk0lh6UmRt6kQpEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovVGjtbk%253D&md5=a22ffdc7e24d94e536d5a31365e5e443</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.1995.tb00596.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.1995.tb00596.x%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DMiteva%26aufirst%3DK.%26aulast%3DPancheva%26aufirst%3DS.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DWo%26aufirst%3DN.%2BC.%26aulast%3DChan%26aufirst%3DW.%2BY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520highly%2520selective%2520in%2520vitro%2520and%2520in%2520vivo%2520uterine%2520receptor%2520antagonists%2520of%2520oxytocin%253A%2520comparison%2520with%2520atosiban%26jtitle%3DInt.%2520J.%2520Pept.%2520Protein%2520Res.%26date%3D1995%26volume%3D46%26spage%3D244%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Rivier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galyean, R.</span><span> </span><span class="NLM_article-title">Solid-phase synthesis of somatostatin and glucagon-selective analogs in gram quantities</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1938</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1978&pages=1927-1938&author=J.+Rivierauthor=R.+Kaiserauthor=R.+Galyean&title=Solid-phase+synthesis+of+somatostatin+and+glucagon-selective+analogs+in+gram+quantities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRivier%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DR.%26aulast%3DGalyean%26aufirst%3DR.%26atitle%3DSolid-phase%2520synthesis%2520of%2520somatostatin%2520and%2520glucagon-selective%2520analogs%2520in%2520gram%2520quantities%26jtitle%3DBiopolymers%26date%3D1978%26volume%3D17%26spage%3D1927%26epage%3D1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. W. M.</span><span> </span><span class="NLM_article-title">The purification of synthetic oxytocin and analogues by gel filtration on Sephadex G-15</span> <span class="citation_source-journal">J. Chromatogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2F0021-9673%2868%2985065-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=5728336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaF1MXjsVKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1968&pages=396-398&author=M.+Manningauthor=T.+C.+Wuuauthor=J.+W.+M.+Baxter&title=The+purification+of+synthetic+oxytocin+and+analogues+by+gel+filtration+on+Sephadex+G-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of synthetic oxytocin and analogs by gel filtration on Sephadex G-15</span></div><div class="casAuthors">Manning, Maurice; Wuu, Ting-Chi; Baxter, John W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">396-8</span>CODEN:
                <span class="NLM_cas:coden">JOCRAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    </div><div class="casAbstract">Synthetic oxytocin and its analogs can be purified in 64 hrs. by a Sephadex G-15 gel filtration technique which is an adaptation of the Sephadex G-25 procedure described by J. Porath and A. V. Schally (1962), for purifying natural oxytocin.  Dissolve 300 mg. crude lyophilized powder in 2.0 ml. 50% HOAc.  Add the soln. to the gel column, preequilibrated with 500 ml. 50% HOAc, and elute with 50% HOAc at 8-10 ml./hr., collecting 2-ml. aliquots.  The peptide material elutes in 2 partially resolved peaks, clearly sepd. from inorg. salts.  Dil. the 2nd peak, contg. most of the active peptide, with 2 vols. water and lyophilize.  Dissolve 35 mg. lyophilized powder in 2.0 ml. 0.2N HOAc and add to the gel column, which has been reequilibrated for 20 hrs. with 500 ml. 0.2N HOAc.  Elute as before, but at 12-15 ml./hr.  The active peptide emerges as a single, nearly sym. peak, preceded by a small amt. of dimer.  Dil. the main peak with 2 vols. water and lyophilize to give the purified product as a fluffy white powder (30 mg.).  The technique is suitable for purification of synthetic analogs of the neurohypophysial hormones in which the only contaminants are inorg. salts and dimer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3CLWh1D4xBbVg90H21EOLACvtfcHk0lh6UmRt6kQpEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXjsVKrtA%253D%253D&md5=e2e1af9a0d6abd2488cfdafcf201572e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0021-9673%2868%2985065-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9673%252868%252985065-4%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DWuu%26aufirst%3DT.%2BC.%26aulast%3DBaxter%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DThe%2520purification%2520of%2520synthetic%2520oxytocin%2520and%2520analogues%2520by%2520gel%2520filtration%2520on%2520Sephadex%2520G-15%26jtitle%3DJ.%2520Chromatogr.%26date%3D1968%26volume%3D38%26spage%3D396%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Albizu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teppaz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansanay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Toward efficiency drug screening by homogenous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4976</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061404q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4976-4985&author=L.+Albizuauthor=G.+Teppazauthor=R.+Seyerauthor=H.+Bazinauthor=H.+Ansanayauthor=M.+Manningauthor=B.+Mouillacauthor=T.+Durroux&title=Toward+efficiency+drug+screening+by+homogenous+assays+based+on+the+development+of+new+fluorescent+vasopressin+and+oxytocin+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm061404q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061404q%26sid%3Dliteratum%253Aachs%26aulast%3DAlbizu%26aufirst%3DL.%26aulast%3DTeppaz%26aufirst%3DG.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DBazin%26aufirst%3DH.%26aulast%3DAnsanay%26aufirst%3DH.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DToward%2520efficiency%2520drug%2520screening%2520by%2520homogenous%2520assays%2520based%2520on%2520the%2520development%2520of%2520new%2520fluorescent%2520vasopressin%2520and%2520oxytocin%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4976%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Corbani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonindard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J.-C.</span><span> </span><span class="NLM_article-title">Ligand-regulated internalization of the opioid receptor-like 1: a confocal study</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">2876</span><span class="NLM_x">–</span> <span class="NLM_lpage">2885</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2004&pages=2876-2885&author=M.+Corbaniauthor=C.+Gonindardauthor=J.-C.+Meunier&title=Ligand-regulated+internalization+of+the+opioid+receptor-like+1%3A+a+confocal+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorbani%26aufirst%3DM.%26aulast%3DGonindard%26aufirst%3DC.%26aulast%3DMeunier%26aufirst%3DJ.-C.%26atitle%3DLigand-regulated%2520internalization%2520of%2520the%2520opioid%2520receptor-like%25201%253A%2520a%2520confocal%2520study%26jtitle%3DEndocrinology%26date%3D2004%26volume%3D145%26spage%3D2876%26epage%3D2885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorena  Mendive‐Tapia</span>, <span class="hlFld-ContribAuthor ">Jinling  Wang</span>, <span class="hlFld-ContribAuthor ">Marc  Vendrell</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent cyclic peptides for cell imaging. </span><span class="cited-content_cbyCitation_journal-name">Peptide Science</span><span> <strong>2021,</strong> <em>113 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/pep2.24181" title="DOI URL">https://doi.org/10.1002/pep2.24181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pep2.24181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpep2.24181%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptide%2520Science%26atitle%3DFluorescent%252Bcyclic%252Bpeptides%252Bfor%252Bcell%252Bimaging%26aulast%3DMendive%25E2%2580%2590Tapia%26aufirst%3DLorena%26date%3D2021%26date%3D2020%26volume%3D113%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maithé  Corbani</span>, <span class="hlFld-ContribAuthor ">Rafik  Marir</span>, <span class="hlFld-ContribAuthor ">Miguel  Trueba</span>, <span class="hlFld-ContribAuthor ">Magda  Chafai</span>, <span class="hlFld-ContribAuthor ">Anne  Vincent</span>, <span class="hlFld-ContribAuthor ">Amélie M.  Borie</span>, <span class="hlFld-ContribAuthor ">Michel G.  Desarménien</span>, <span class="hlFld-ContribAuthor ">Yoichi  Ueta</span>, <span class="hlFld-ContribAuthor ">Csaba  Tomboly</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Olma</span>, <span class="hlFld-ContribAuthor ">Maurice  Manning</span>, <span class="hlFld-ContribAuthor ">Gilles  Guillon</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroanatomical distribution and function of the vasopressin V1B receptor in the rat brain deciphered using specific fluorescent ligands. </span><span class="cited-content_cbyCitation_journal-name">General and Comparative Endocrinology</span><span> <strong>2018,</strong> <em>258 </em>, 15-32. <a href="https://doi.org/10.1016/j.ygcen.2017.10.011" title="DOI URL">https://doi.org/10.1016/j.ygcen.2017.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ygcen.2017.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ygcen.2017.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DGeneral%2520and%2520Comparative%2520Endocrinology%26atitle%3DNeuroanatomical%252Bdistribution%252Band%252Bfunction%252Bof%252Bthe%252Bvasopressin%252BV1B%252Breceptor%252Bin%252Bthe%252Brat%252Bbrain%252Bdeciphered%252Busing%252Bspecific%252Bfluorescent%252Bligands%26aulast%3DCorbani%26aufirst%3DMaith%25C3%25A9%26date%3D2018%26volume%3D258%26spage%3D15%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sadhana  Sharma</span>, <span class="hlFld-ContribAuthor ">Michael  Floren</span>, <span class="hlFld-ContribAuthor ">Yonghui  Ding</span>, <span class="hlFld-ContribAuthor ">Kurt R.  Stenmark</span>, <span class="hlFld-ContribAuthor ">Wei  Tan</span>, <span class="hlFld-ContribAuthor ">Stephanie J.  Bryant</span>. </span><span class="cited-content_cbyCitation_article-title">A photoclickable peptide microarray platform for facile and rapid screening of 3-D tissue microenvironments. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials</span><span> <strong>2017,</strong> <em>143 </em>, 17-28. <a href="https://doi.org/10.1016/j.biomaterials.2017.07.025" title="DOI URL">https://doi.org/10.1016/j.biomaterials.2017.07.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biomaterials.2017.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biomaterials.2017.07.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%26atitle%3DA%252Bphotoclickable%252Bpeptide%252Bmicroarray%252Bplatform%252Bfor%252Bfacile%252Band%252Brapid%252Bscreening%252Bof%252B3-D%252Btissue%252Bmicroenvironments%26aulast%3DSharma%26aufirst%3DSadhana%26date%3D2017%26volume%3D143%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong Geun  Lee</span>, <span class="hlFld-ContribAuthor ">Guillaume  Lautrette</span>, <span class="hlFld-ContribAuthor ">Bradley L.  Pentelute</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Mediated Arylation of Lysine in Unprotected Peptides. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2017,</strong> <em>129 </em>
                                    (12)
                                     , 3225-3229. <a href="https://doi.org/10.1002/ange.201611202" title="DOI URL">https://doi.org/10.1002/ange.201611202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201611202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201611202%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPalladium-Mediated%252BArylation%252Bof%252BLysine%252Bin%252BUnprotected%252BPeptides%26aulast%3DLee%26aufirst%3DHong%2BGeun%26date%3D2017%26date%3D2017%26volume%3D129%26issue%3D12%26spage%3D3225%26epage%3D3229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong Geun  Lee</span>, <span class="hlFld-ContribAuthor ">Guillaume  Lautrette</span>, <span class="hlFld-ContribAuthor ">Bradley L.  Pentelute</span>, <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Mediated Arylation of Lysine in Unprotected Peptides. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2017,</strong> <em>56 </em>
                                    (12)
                                     , 3177-3181. <a href="https://doi.org/10.1002/anie.201611202" title="DOI URL">https://doi.org/10.1002/anie.201611202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201611202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201611202%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPalladium-Mediated%252BArylation%252Bof%252BLysine%252Bin%252BUnprotected%252BPeptides%26aulast%3DLee%26aufirst%3DHong%2BGeun%26date%3D2017%26date%3D2017%26volume%3D56%26issue%3D12%26spage%3D3177%26epage%3D3181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leigh A.  Stoddart</span>, <span class="hlFld-ContribAuthor ">Laura E.  Kilpatrick</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Briddon</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Hill</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the pharmacology of G protein-coupled receptors with fluorescent ligands. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2015,</strong> <em>98 </em>, 48-57. <a href="https://doi.org/10.1016/j.neuropharm.2015.04.033" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2015.04.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2015.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2015.04.033%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DProbing%252Bthe%252Bpharmacology%252Bof%252BG%252Bprotein-coupled%252Breceptors%252Bwith%252Bfluorescent%252Bligands%26aulast%3DStoddart%26aufirst%3DLeigh%2BA.%26date%3D2015%26volume%3D98%26spage%3D48%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William E.  Armstrong</span>. </span><span class="cited-content_cbyCitation_article-title">Central Nervous System Control of Oxytocin Secretion during Lactation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 527-563. <a href="https://doi.org/10.1016/B978-0-12-397175-3.00013-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-397175-3.00013-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-397175-3.00013-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-397175-3.00013-2%26sid%3Dliteratum%253Aachs%26atitle%3DCentral%252BNervous%252BSystem%252BControl%252Bof%252BOxytocin%252BSecretion%252Bduring%252BLactation%26aulast%3DArmstrong%26aufirst%3DWilliam%2BE.%26date%3D2015%26spage%3D527%26epage%3D563%26pub%3DElsevier%26atitle%3DKnobil%252Band%252BNeill%252527s%252BPhysiology%252Bof%252BReproduction%26date%3D2015%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Niescierowicz</span>, <span class="hlFld-ContribAuthor ">Lydia  Caro</span>, <span class="hlFld-ContribAuthor ">Vadim  Cherezov</span>, <span class="hlFld-ContribAuthor ">Michel  Vivaudou</span>, <span class="hlFld-ContribAuthor ">Christophe J.  Moreau</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Assay for T4 Lysozyme-Engineered G Protein-Coupled Receptors with an Ion Channel Reporter. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2014,</strong> <em>22 </em>
                                    (1)
                                     , 149-155. <a href="https://doi.org/10.1016/j.str.2013.10.002" title="DOI URL">https://doi.org/10.1016/j.str.2013.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2013.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2013.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DFunctional%252BAssay%252Bfor%252BT4%252BLysozyme-Engineered%252BG%252BProtein-Coupled%252BReceptors%252Bwith%252Ban%252BIon%252BChannel%252BReporter%26aulast%3DNiescierowicz%26aufirst%3DKatarzyna%26date%3D2014%26volume%3D22%26issue%3D1%26spage%3D149%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suvendu  Biswas</span>, <span class="hlFld-ContribAuthor ">Ilker  Avan</span>, <span class="hlFld-ContribAuthor ">Akash K.  Basak</span>, <span class="hlFld-ContribAuthor ">Nader E.  Abo-Dya</span>, <span class="hlFld-ContribAuthor ">Abdullah  Asiri</span>, <span class="hlFld-ContribAuthor ">Alan R.  Katritzky</span>. </span><span class="cited-content_cbyCitation_article-title">Photophysics of novel coumarin-labeled depsipeptides in solution: sensing interactions with SDS micelle via TICT model. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2013,</strong> <em>45 </em>
                                    (1)
                                     , 159-170. <a href="https://doi.org/10.1007/s00726-013-1483-3" title="DOI URL">https://doi.org/10.1007/s00726-013-1483-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-013-1483-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-013-1483-3%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DPhotophysics%252Bof%252Bnovel%252Bcoumarin-labeled%252Bdepsipeptides%252Bin%252Bsolution%25253A%252Bsensing%252Binteractions%252Bwith%252BSDS%252Bmicelle%252Bvia%252BTICT%252Bmodel%26aulast%3DBiswas%26aufirst%3DSuvendu%26date%3D2013%26date%3D2013%26volume%3D45%26issue%3D1%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magda  Chafai</span>, <span class="hlFld-ContribAuthor ">Maithé  Corbani</span>, <span class="hlFld-ContribAuthor ">Gilles  Guillon</span>, <span class="hlFld-ContribAuthor ">Michel G.  Desarménien</span>, . </span><span class="cited-content_cbyCitation_article-title">Vasopressin Inhibits LTP in the CA2 Mouse Hippocampal Area. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2012,</strong> <em>7 </em>
                                    (12)
                                     , e49708. <a href="https://doi.org/10.1371/journal.pone.0049708" title="DOI URL">https://doi.org/10.1371/journal.pone.0049708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0049708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0049708%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DVasopressin%252BInhibits%252BLTP%252Bin%252Bthe%252BCA2%252BMouse%252BHippocampal%252BArea%26aulast%3DChafai%26aufirst%3DMagda%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D12%26spage%3De49708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taka-aki  Koshimizu</span>, <span class="hlFld-ContribAuthor ">Kazuaki  Nakamura</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Egashira</span>, <span class="hlFld-ContribAuthor ">Masami  Hiroyama</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Nonoguchi</span>, <span class="hlFld-ContribAuthor ">Akito  Tanoue</span>. </span><span class="cited-content_cbyCitation_article-title">Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems. </span><span class="cited-content_cbyCitation_journal-name">Physiological Reviews</span><span> <strong>2012,</strong> <em>92 </em>
                                    (4)
                                     , 1813-1864. <a href="https://doi.org/10.1152/physrev.00035.2011" title="DOI URL">https://doi.org/10.1152/physrev.00035.2011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/physrev.00035.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fphysrev.00035.2011%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Reviews%26atitle%3DVasopressin%252BV1a%252Band%252BV1b%252BReceptors%25253A%252BFrom%252BMolecules%252Bto%252BPhysiological%252BSystems%26aulast%3DKoshimizu%26aufirst%3DTaka-aki%26date%3D2012%26volume%3D92%26issue%3D4%26spage%3D1813%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Manning</span>, <span class="hlFld-ContribAuthor ">A.  Misicka</span>, <span class="hlFld-ContribAuthor ">A.  Olma</span>, <span class="hlFld-ContribAuthor ">K.  Bankowski</span>, <span class="hlFld-ContribAuthor ">S.  Stoev</span>, <span class="hlFld-ContribAuthor ">B.  Chini</span>, <span class="hlFld-ContribAuthor ">T.  Durroux</span>, <span class="hlFld-ContribAuthor ">B.  Mouillac</span>, <span class="hlFld-ContribAuthor ">M.  Corbani</span>, <span class="hlFld-ContribAuthor ">G.  Guillon</span>. </span><span class="cited-content_cbyCitation_article-title">Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroendocrinology</span><span> <strong>2012,</strong> <em>24 </em>
                                    (4)
                                     , 609-628. <a href="https://doi.org/10.1111/j.1365-2826.2012.02303.x" title="DOI URL">https://doi.org/10.1111/j.1365-2826.2012.02303.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1365-2826.2012.02303.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1365-2826.2012.02303.x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroendocrinology%26atitle%3DOxytocin%252Band%252BVasopressin%252BAgonists%252Band%252BAntagonists%252Bas%252BResearch%252BTools%252Band%252BPotential%252BTherapeutics%26aulast%3DManning%26aufirst%3DM.%26date%3D2012%26date%3D2012%26volume%3D24%26issue%3D4%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Dayanithi</span>, <span class="hlFld-ContribAuthor ">Oksana  Forostyak</span>, <span class="hlFld-ContribAuthor ">Yoichi  Ueta</span>, <span class="hlFld-ContribAuthor ">Alexei  Verkhratsky</span>, <span class="hlFld-ContribAuthor ">Emil C.  Toescu</span>. </span><span class="cited-content_cbyCitation_article-title">Segregation of calcium signalling mechanisms in magnocellular neurones and terminals. </span><span class="cited-content_cbyCitation_journal-name">Cell Calcium</span><span> <strong>2012,</strong> <em>51 </em>
                                    (3-4)
                                     , 293-299. <a href="https://doi.org/10.1016/j.ceca.2012.02.002" title="DOI URL">https://doi.org/10.1016/j.ceca.2012.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ceca.2012.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ceca.2012.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Calcium%26atitle%3DSegregation%252Bof%252Bcalcium%252Bsignalling%252Bmechanisms%252Bin%252Bmagnocellular%252Bneurones%252Band%252Bterminals%26aulast%3DDayanithi%26aufirst%3DGovindan%26date%3D2012%26volume%3D51%26issue%3D3-4%26spage%3D293%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brigitte  Murat</span>, <span class="hlFld-ContribAuthor ">Dominic  Devost</span>, <span class="hlFld-ContribAuthor ">Miriam  Andrés</span>, <span class="hlFld-ContribAuthor ">Julie  Mion</span>, <span class="hlFld-ContribAuthor ">Véra  Boulay</span>, <span class="hlFld-ContribAuthor ">Maithé  Corbani</span>, <span class="hlFld-ContribAuthor ">Hans H.  Zingg</span>, <span class="hlFld-ContribAuthor ">Gilles  Guillon</span>. </span><span class="cited-content_cbyCitation_article-title">V1b and CRHR1 Receptor Heterodimerization Mediates Synergistic Biological Actions of Vasopressin and CRH. </span><span class="cited-content_cbyCitation_journal-name">Molecular Endocrinology</span><span> <strong>2012,</strong> <em>26 </em>
                                    (3)
                                     , 502-520. <a href="https://doi.org/10.1210/me.2011-1202" title="DOI URL">https://doi.org/10.1210/me.2011-1202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/me.2011-1202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fme.2011-1202%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Endocrinology%26atitle%3DV1b%252Band%252BCRHR1%252BReceptor%252BHeterodimerization%252BMediates%252BSynergistic%252BBiological%252BActions%252Bof%252BVasopressin%252Band%252BCRH%26aulast%3DMurat%26aufirst%3DBrigitte%26date%3D2012%26volume%3D26%26issue%3D3%26spage%3D502%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. General structure of fluorescent peptides (<b>1</b>−<b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>−<b>11</b>, <b>13</b>) and parent peptides (<b>A</b>, <b>4</b>, <b>6</b>, <b>8</b>, <b>B</b>, <b>12</b>). X represents the modification on Cys<sup>1</sup> by either H atom or OH group, and Y represents the types of linker and fluorophore attached at position Lys<sup>8</sup> of the parent peptides d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>A</b>) and HO<sup>1</sup>[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (<b>B</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding pharmacological profiles of d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) and d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP analogue <b>9</b> for human vasopressin and oxytocin receptors stably expressed in CHO cells lines. The binding properties of analogues <b>3</b> and <b>9</b> were determined by competition experiments on plasma membranes prepared from CHO cells stably expressing hV1a-R, hV2-R, hV1b-R, or hOT-R. Plasma membranes expressing the different VP/OT receptor isoforms were incubated for 1 h at 30 °C with ∼1 nM <sup>3</sup>[H]AVP in the presence or absence (control, C) of increasing concentrations of unlabeled analogue <b>3</b> or <b>9</b>. Nonspecific and total binding were determined respectively with and without 1 μM of either AVP or OT, depending on the nature of the receptor studied. Specific binding calculated as the difference between total and nonspecific binding is expressed as percent of the corresponding control specific binding and is the mean ± SEM of at least three independent experiments each performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Influence of the size of the linker between Alexa 647 and peptide <b>A</b> on its V1b affinity and selectivity for human vasopressin and oxytocin receptors. (A) The V1b affinity of parent analogues <b>A</b>, <b>4</b>, <b>6</b>, and <b>8</b> and that of their corresponding peptides with Alexa 647 attached to linkers of different lengths (analogues <b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>) are plotted as the numbers of atoms in the spacer bound to Lys<sup>8</sup>. Values are from Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a>. (B) The hV1b-R selectivity index of analogues described above is plotted as the number of atoms of the spacer bound to Lys<sup>8</sup>. Values are from Table <a class="ref showTableEvent internalNav" data-ID="tblII" href="#tblII">2</a> with V1b selectivity index calculated as log[<i>K</i><sub>i</sub>(hVx-R)/<i>K</i><sub>i</sub>(hV1b-R)], where Vx is hV2-R, hV1a-R, or hOT-R.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Functional properties of d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) and d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (analogue <b>9</b>) on phospholipase C activity in CHO cells stably expressing the human V1b and OT receptors. Left: CHO cells stably expressing the hV<sub>1b</sub>-R were incubated with or without (control) increasing amounts of fluorescent or parent peptides. Total inositol phosphate (InsP) that accumulated was measured as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and expressed as % of maximal AVP stimulation (1 μM). Data are the mean ± SEM of three independent experiments, each performed in triplicate. Right: Similar experiments were performed with CHO cells stably expressing the hOT-R. Total inositol phosphate that accumulated was measured as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and expressed as the % of maximal OT stimulation (1 μM). Data are the mean ± SEM of three independent experiments, each performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Fluorescent properties of d[Leu<sup>4</sup>,Lys(Atn)<sup>8</sup>]VP (analogue <b>1</b>), d[Leu<sup>4</sup>,Lys(Alexa 488)<sup>8</sup>]VP (analogue <b>2</b>), and d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) on CHO cells stably expressing the human V1b receptor. (A) Histogram (top): Cells in suspension were incubated for 1 h at 12 °C with 10 nM analogue <b>1</b> in the absence (dark bar) or in the presence (hatched bar) of 1 μM d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (analogue <b>A</b>) and compared to control cells incubated without fluorescent ligand (white bar). Cells were washed three times with cold PBS and measured for fluorescent emission at 412 nm in cuvettes of spectrofluorimetry. Saturation curve (bottom): Aliquots of cells were incubated with increasing concentrations of analogue <b>1</b> for 1 h at 12 °C, washed three times, and counted for fluorescence emission at 412 nm. The endogenous fluorescence at 412 nm of control cells, not exposed to fluorescent ligand, was deduced for each concentration. (B) CHO hV1b-R cells grown on coverslips were incubated in the presence of analogue <b>2</b> (50 nM) or of analogue <b>3</b> (250 nM) for 1 h at 12 °C in the absence or in the presence of 1 μM d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (analogue <b>A</b>). Confocal imaging was performed with Zeiss LSM510 Meta microscope using a 63× (NA 1.4) objective with an argon laser excitation at 488 nm and a BP 505−530 nm emission filter for analogue <b>2</b> (green) and with a helium/neon laser excitation at 633 nm with a LP650 for emission for analogue <b>3</b> (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Displacement of d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) and of d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (analogue <b>9</b>) binding with nonfluorescent ligands on CHO hV1b-R and hOT-R stable cell lines. CHO cells on coverslips were incubated in the presence of analogue <b>3</b> (250 nM) or of analogue <b>9</b> (150 nM) for 1 h at 12 °C in the absence or in the presence of 100 nM selective V1b agonist d[Leu<sup>4</sup>,Lys<sup>8</sup>]VP (analogue <b>A</b>) or of 1 μM non-peptide AVP V2 antagonist <b>15</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or of 500 nM V1a/OT peptide antagonist Manning compound.<a onclick="showRef(event, 'cit27a'); return false;" href="javascript:void(0);" class="ref cit27a">(27a)</a> Confocal imaging was performed with Zeiss LSM510 Meta microscope using a 63× (NA 1.4) with laser excitation at 633 nm and LP650 for emission. The bar represents 10 μm (zoom 4×). Images are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/medium/jm-2010-016208_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Fluorescent binding properties of d[Leu<sup>4</sup>,Lys(Alexa 647)<sup>8</sup>]VP (analogue <b>3</b>) and d[Leu<sup>4</sup>,Lys(Aud-Alexa 647)<sup>8</sup>]VP (analogue <b>9</b>) on CHO cells stably expressing the human V1b and OT receptors. CHO hV1b-R cells on coverslips were incubated in the presence of increasing concentrations of analogue <b>3</b> or of analogue <b>9</b> for 1 h at 12 °C, washed 3 times with PBS, and fixed with 4% PFA. Confocal imaging was performed with a Zeiss LSM510 Meta microscope using a 63× objective with a helium/neon laser excitation at 633 nm with a LP650 for emission. Membrane fluorescence was evaluated on 30−40 cells for each concentration of analogue by LSM Browser and ImageJ using the 1−250 fluorescent unit dynamics. After deduction of the values of control unlabeled lines 5−7 cells, saturation curves were constructed with the mean of three distinct experiments and expressed as % of the maximal labeling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-8/jm1016208/production/images/large/jm-2010-016208_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1016208&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title">Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1986&pages=171-177&author=S.+Jardauthor=R.+C.+Gaillardauthor=G.+Guillonauthor=J.+Marieauthor=P.+Schoenenbergauthor=A.+F.+Mullerauthor=M.+Manningauthor=W.+H.+Sawyer&title=Vasopressin+antagonists+allow+demonstration+of+a+novel+type+of+vasopressin+receptor+in+the+rat+adenohypophysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJard%26aufirst%3DS.%26aulast%3DGaillard%26aufirst%3DR.%2BC.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DMarie%26aufirst%3DJ.%26aulast%3DSchoenenberg%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DA.%2BF.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3DVasopressin%2520antagonists%2520allow%2520demonstration%2520of%2520a%2520novel%2520type%2520of%2520vasopressin%2520receptor%2520in%2520the%2520rat%2520adenohypophysis%26jtitle%3DMol.%2520Pharmacol.%26date%3D1986%26volume%3D30%26spage%3D171%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazzini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chouinard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">Vasopressin, a potent autocrine/paracrine regulator of mammal adrenal functions</span> <span class="citation_source-journal">Endocr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.3109%2F07435809809032672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=9888562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1998&pages=703-710&author=G.+Guillonauthor=E.+Grazziniauthor=M.+Andrezauthor=C.+Bretonauthor=M.+Truebaauthor=C.+Serradeil-Le+Galauthor=C.+Boccaraauthor=S.+Derickauthor=L.+Chouinardauthor=N.+Gallo-Payet&title=Vasopressin%2C+a+potent+autocrine%2Fparacrine+regulator+of+mammal+adrenal+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Vasopressin: a potent autocrine/paracrine regulator of mammal adrenal functions</span></div><div class="casAuthors">Guillon, G.; Grazzini, E.; Andrez, M.; Breton, C.; Trueba, M.; Serradeil-Le Gal, C.; Boccara, G.; Derick, S.; Chouinard, L.; Gallo-Payet, N.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">703-710, 1Plate</span>CODEN:
                <span class="NLM_cas:coden">ENRSE8</span>;
        ISSN:<span class="NLM_cas:issn">0743-5800</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review with 16 refs.  The control of adrenal functions by locally secreted neuropeptides or neurotransmitters is of great physiol. importance.  Vasopressin (VP) is one of these autocrine/paracrine regulators.  The authors demonstrated by RT-PCR and perifusion expts. that rat and human adrenal medulla expressed and released vasopressin under basal conditions and under stimulation by acetylcholine.  Intra-adrenal concns. of VP may be sufficient to activate adrenal VP receptors.  In the cortex, only the V1a receptor subtype has been detected.  It triggered both steroid secretion and cortical growth.  In the medulla, both V1a and V1b receptor subtypes were expressed.  V1b receptors were mainly present on chromaffin cells and stimulated catecholamine secretion.  The role of the V1a receptor remains unclear.  Pathophysiol. studies also revealed that human pheochromocytoma did not overexpress vasopressin receptors but might oversecrete vasopressin causing high plasma VP concns. and elevated blood pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr82uSVpdXfB7Vg90H21EOLACvtfcHk0lhs_FxhO6ivpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVShsA%253D%253D&md5=7ec4840dca1ef993c0577d8c6c99de18</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3109%2F07435809809032672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F07435809809032672%26sid%3Dliteratum%253Aachs%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DGrazzini%26aufirst%3DE.%26aulast%3DAndrez%26aufirst%3DM.%26aulast%3DBreton%26aufirst%3DC.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DBoccara%26aufirst%3DC.%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DChouinard%26aufirst%3DL.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DVasopressin%252C%2520a%2520potent%2520autocrine%252Fparacrine%2520regulator%2520of%2520mammal%2520adrenal%2520functions%26jtitle%3DEndocr.%2520Res.%26date%3D1998%26volume%3D24%26spage%3D703%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wo, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossard, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Pharmacological and physiological characterization of d[Leu<sup>4</sup>,Lys<sup>8</sup>]vasopressin, the first V<sub>1b</sub> selective agonist for rat vasopressin/oxytocin receptors</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">4136</span><span class="NLM_x">–</span> <span class="NLM_lpage">4146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=4136-4146&author=A.+Penaauthor=B.+Muratauthor=M.+Truebaauthor=M.+A.+Venturaauthor=G.+Bertrandauthor=L.+L.+Chengauthor=S.+Stoevauthor=H.+H.+Szetoauthor=N.+C.+Woauthor=G.+Brossardauthor=C.+Serradeil-Le+Galauthor=M.+Manningauthor=G.+Guillon&title=Pharmacological+and+physiological+characterization+of+d%5BLeu4%2CLys8%5Dvasopressin%2C+the+first+V1b+selective+agonist+for+rat+vasopressin%2Foxytocin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPena%26aufirst%3DA.%26aulast%3DMurat%26aufirst%3DB.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DVentura%26aufirst%3DM.%2BA.%26aulast%3DBertrand%26aufirst%3DG.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DWo%26aufirst%3DN.%2BC.%26aulast%3DBrossard%26aufirst%3DG.%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DPharmacological%2520and%2520physiological%2520characterization%2520of%2520d%255BLeu4%252CLys8%255Dvasopressin%252C%2520the%2520first%2520V1b%2520selective%2520agonist%2520for%2520rat%2520vasopressin%252Foxytocin%2520receptors%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D4136%26epage%3D4146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Donaldson, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span> </span><span class="NLM_article-title">Oxytocin, vasopressin and the neurogenetics of sociality</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">904</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=900-904&author=Z.+R.+Donaldsonauthor=L.+J.+Young&title=Oxytocin%2C+vasopressin+and+the+neurogenetics+of+sociality"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonaldson%26aufirst%3DZ.%2BR.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DOxytocin%252C%2520vasopressin%2520and%2520the%2520neurogenetics%2520of%2520sociality%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D900%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreifuss, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title"><sup>125</sup>I-Labelled d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>,Thr<sup>4</sup>,Tyr-NH<sub>2</sub><sup>9</sup>]OVT: a selective oxytocin receptor ligand</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2F0014-2999%2888%2990778-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=2835249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVSnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1988&pages=197-207&author=J.+Elandsauthor=C.+Barberisauthor=S.+Jardauthor=E.+Tribolletauthor=J.-J.+Dreifussauthor=K.+Bankowskiauthor=M.+Manningauthor=W.+H.+Sawyer&title=125I-Labelled+d%28CH2%295%5BTyr%28Me%292%2CThr4%2CTyr-NH29%5DOVT%3A+a+selective+oxytocin+receptor+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Iodine-125-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT:  a selective oxytocin receptor ligand</span></div><div class="casAuthors">Elands, Jack; Barberis, Claude; Jard, Serge; Tribollet, Eliane; Dreifuss, Jean Jacques; Bankowski, Krzysztof; Manning, Maurice; Sawyer, Wilbur H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">An oxytocic antagonist, [1-(β-mercapto-β,β-cyclopentamethylenepropionic acid, 2-O-methyltyrosine, 4-threonine, 8-ornithine, 9-tyrosylamide]vasotocin (d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT) (I), was monoiodinated at the Ph moiety of the tyrosylamide residue at position 9.  125I-labeling was performed with 1,3,4,6-tetrachloro-3α,6α-diphenylglycoluril.  Iodination resulted in an increased affinity for rat uterine oxytocin receptors.  A considerably lower affinity for rat vascular V1- and renal V2-receptors was found, resulting in a highly specific oxytocin receptor ligand.  [125I]I bound selectively to 1 population of binding sites in rat uterus and ventral hippocampal membrane prepns.  Dissocn. consts. ranged 0.03-0.06 nM.  After 3 days of exposure, autoradiog. revealed binding in regions known to contain oxytocin receptors as well as labeling in some new regions, whereas no binding was found in the lateral septum, a structure contg. mainly [8-arginine]vasopressin receptors.  The high specific radioactivity of 125I-labeling allowed important redns. in membrane protein amt., gain in precision of binding anal., and considerably lower exposure times for autoradiog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpGjEbPeGWLVg90H21EOLACvtfcHk0li5kevaCWs85g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVSnsb0%253D&md5=c66ed9424a00ab6f5cd1a74764698d20</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990778-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990778-9%26sid%3Dliteratum%253Aachs%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DJard%26aufirst%3DS.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DDreifuss%26aufirst%3DJ.-J.%26aulast%3DBankowski%26aufirst%3DK.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3D125I-Labelled%2520d%2528CH2%25295%255BTyr%2528Me%25292%252CThr4%252CTyr-NH29%255DOVT%253A%2520a%2520selective%2520oxytocin%2520receptor%2520ligand%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D147%26spage%3D197%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kelly, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzonka, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhonston, C. I.</span><span> </span><span class="NLM_article-title">[<sup>125</sup>I]-d(CH2)5,Sar7]AVP: a selective radioligand for V1 vasopressin receptors</span> <span class="citation_source-journal">J. Recept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=2521670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaL1MXhs1Kgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1989&pages=27-41&author=J.+M.+Kellyauthor=J.+M.+Abrahamsauthor=P.+A.+Philipsauthor=F.+A.+Mendelsohnauthor=Z.+Grzonkaauthor=C.+I.+Jhonston&title=%5B125I%5D-d%28CH2%295%2CSar7%5DAVP%3A+a+selective+radioligand+for+V1+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">[125I]-[d(CH2)5,Sar7]AVP:  a selective radioligand for V1 vasopressin receptors</span></div><div class="casAuthors">Kelly, J. M.; Abrahams, J. M.; Phillips, P. A.; Mendelsohn, F. A. O.; Grzonka, Z.; Johnston, C. I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptor Research</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-41</span>CODEN:
                <span class="NLM_cas:coden">JRERDM</span>;
        ISSN:<span class="NLM_cas:issn">0197-5110</span>.
    </div><div class="casAbstract">The AVP V1 receptor antagonist [1-(β-mercapto-β,β-cyclopentamethylenepropionic acid), 7-sarcosine,8-arginine]vasopressin ([d(CH2)5,Sar7]AVP) was radioiodinated and its receptor-binding properties were detd. in rat liver and kidney plasma membranes.  The binding was of high affinity to single classes of receptors (liver: Kd = 3.0 nM and Bmax = 530 fmol/mg protein, kidney: Kd = 0.5 nM and Bmax = 11 fmol/mg protein).  Competition of [125I]-[d(CH2)5,Sar7]AVP binding by unlabeled AVP analogs gave the following order of potency in both tissues, consistent with that expected for binding to a V1 receptor: [d(CH2)5,Tyr(Me)2]AVP > AVP > [d(CH2)5,D-Ile2,Ile4] AVP > DDAVP.  No degrdn. of [125I]-[d(CH2)5,Sar7]AVP during incubation or storage was detected by HPLC anal.  [125I]-[d(CH2)5,Sar7]AVP and in vitro autoradiog. were used to localize brain AVP receptors.  These studies suggest that [125I]-[d(CH2)5,Sar7]AVP is a suitable selective radioligand for labeling V1 receptors and will provide a valuable tool for the study of the localization and regulation of AVP V1 receptors in tissues and in receptor isolation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhm8CAkFrnB7Vg90H21EOLACvtfcHk0li5kevaCWs85g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhs1Kgtbg%253D&md5=be4bbc5ab2407f4628166692c679f03f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DAbrahams%26aufirst%3DJ.%2BM.%26aulast%3DPhilips%26aufirst%3DP.%2BA.%26aulast%3DMendelsohn%26aufirst%3DF.%2BA.%26aulast%3DGrzonka%26aufirst%3DZ.%26aulast%3DJhonston%26aufirst%3DC.%2BI.%26atitle%3D%255B125I%255D-d%2528CH2%25295%252CSar7%255DAVP%253A%2520a%2520selective%2520radioligand%2520for%2520V1%2520vasopressin%2520receptors%26jtitle%3DJ.%2520Recept.%2520Res.%26date%3D1989%26volume%3D9%26spage%3D27%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goumaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggenbass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreifuss, J. J.</span><span> </span><span class="NLM_article-title">Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain</span> <span class="citation_source-journal">J. Recept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=1653339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK3MXksVahu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=333-346&author=E.+Tribolletauthor=M.+Goumazauthor=M.+Raggenbassauthor=J.+J.+Dreifuss&title=Appearance+and+transient+expression+of+vasopressin+and+oxytocin+receptors+in+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Appearance and transient expression of vasopressin and oxytocin receptors in the rat brain</span></div><div class="casAuthors">Tribollet, E.; Goumaz, M.; Raggenbass, M.; Dreifuss, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptor Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1-4</span>),
    <span class="NLM_cas:pages">333-46</span>CODEN:
                <span class="NLM_cas:coden">JRERDM</span>;
        ISSN:<span class="NLM_cas:issn">0197-5110</span>.
    </div><div class="casAbstract">Binding sites for arginine vasopressin (AVP) and for oxytocin (OT) were studied by in vitro autoradiog. in sections from the brain of rat fetuses, neonates and infants; their distribution was compared to that of the brain of adults.  Specific binding sites were first detected in the vagal complex for OT and in the reticular formation for AVP at embryonic day 14 (E14) and E16 resp.  In the perinatal period, other areas become labeled.  Approx. 1 wk after birth, a stable pattern of distribution is established for AVP-binding sites, and a different stable pattern obtained for OT-binding sites.  For both types of sites and in many areas, the d. of labeling increases during the next 2 wk to reach adult levels, whereas labeling decreases concomitantly in other areas of the brain.  The distribution of AVP-binding sites is of the adult pattern by the time of weaning.  In contrast, the adult pattern of distribution of OT-binding sites is only established after puberty, when new OT receptors appear in some regions of the hypothalamus and basal forebrain.  Transient binding sites for AVP and OT, i.e., sites located in areas which were labeled in neonates but not in weanlings, were shown to have the same ligand affinity as the binding sites present in the adult.  Electrophysiol. studies suggest that at least some of these transient binding sites represent authentic receptors and may be involved in neuronal signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonZkZEhMAm4rVg90H21EOLACvtfcHk0liqtgjlbPtEOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVahu7Y%253D&md5=89c6e2b94be1556d976c7aed1cb7c9fc</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DGoumaz%26aufirst%3DM.%26aulast%3DRaggenbass%26aufirst%3DM.%26aulast%3DDreifuss%26aufirst%3DJ.%2BJ.%26atitle%3DAppearance%2520and%2520transient%2520expression%2520of%2520vasopressin%2520and%2520oxytocin%2520receptors%2520in%2520the%2520rat%2520brain%26jtitle%3DJ.%2520Recept.%2520Res.%26date%3D1991%26volume%3D11%26spage%3D333%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hernando, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoots, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lolait, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbach, J. P. H.</span><span> </span><span class="NLM_article-title">Immunohistochemical localisation of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">1659</span><span class="NLM_x">–</span> <span class="NLM_lpage">1668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2001&pages=1659-1668&author=F.+Hernandoauthor=O.+Schootsauthor=S.+J.+Lolaitauthor=J.+P.+H.+Burbach&title=Immunohistochemical+localisation+of+the+vasopressin+V1b+receptor+in+the+rat+brain+and+pituitary+gland%3A+anatomical+support+for+its+involvement+in+the+central+effects+of+vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHernando%26aufirst%3DF.%26aulast%3DSchoots%26aufirst%3DO.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBurbach%26aufirst%3DJ.%2BP.%2BH.%26atitle%3DImmunohistochemical%2520localisation%2520of%2520the%2520vasopressin%2520V1b%2520receptor%2520in%2520the%2520rat%2520brain%2520and%2520pituitary%2520gland%253A%2520anatomical%2520support%2520for%2520its%2520involvement%2520in%2520the%2520central%2520effects%2520of%2520vasopressin%26jtitle%3DEndocrinology%26date%3D2001%26volume%3D142%26spage%3D1659%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lolait, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Caroll, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahan, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Button, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. R.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browstein, M. J.</span><span> </span><span class="NLM_article-title">Extrapituitary expression of the rat V1b vasopressin receptor gene</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">6783</span><span class="NLM_x">–</span> <span class="NLM_lpage">6787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=6783-6787&author=S.+J.+Lolaitauthor=A.+M.+O%E2%80%99Carollauthor=L.+C.+Mahanauthor=C.+C.+Felderauthor=D.+C.+Buttonauthor=W.+R.+Youngauthor=E.+Mezeyauthor=M.+J.+Browstein&title=Extrapituitary+expression+of+the+rat+V1b+vasopressin+receptor+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Caroll%26aufirst%3DA.%2BM.%26aulast%3DMahan%26aufirst%3DL.%2BC.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DButton%26aufirst%3DD.%2BC.%26aulast%3DYoung%26aufirst%3DW.%2BR.%26aulast%3DMezey%26aufirst%3DE.%26aulast%3DBrowstein%26aufirst%3DM.%2BJ.%26atitle%3DExtrapituitary%2520expression%2520of%2520the%2520rat%2520V1b%2520vasopressin%2520receptor%2520gene%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D6783%26epage%3D6787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, H.</span><span> </span><span class="NLM_article-title">Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues</span> <span class="citation_source-journal">Biochem. Biophy. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1006%2Fbbrc.1995.2033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1995&pages=751-757&author=M.+Saitoauthor=T.+Sugimotoauthor=A.+Taharaauthor=H.+Kawashima&title=Molecular+cloning+and+characterization+of+rat+V1b+vasopressin+receptor%3A+evidence+for+its+expression+in+extra-pituitary+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1995.2033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1995.2033%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DTahara%26aufirst%3DA.%26aulast%3DKawashima%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520rat%2520V1b%2520vasopressin%2520receptor%253A%2520evidence%2520for%2520its%2520expression%2520in%2520extra-pituitary%2520tissues%26jtitle%3DBiochem.%2520Biophy.%2520Res.%2520Commun.%26date%3D1995%26volume%3D26%26spage%3D751%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hurbin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissin-Agasse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orcel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabié, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desarménien, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moos, F. C.</span><span> </span><span class="NLM_article-title">The V1a and V1b, but not V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">4701</span><span class="NLM_x">–</span> <span class="NLM_lpage">4707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=4701-4707&author=A.+Hurbinauthor=L.+Boissin-Agasseauthor=H.+Orcelauthor=A.+Rabi%C3%A9author=N.+Jouxauthor=M.+G.+Desarm%C3%A9nienauthor=P.+Richardauthor=F.+C.+Moos&title=The+V1a+and+V1b%2C+but+not+V2%2C+vasopressin+receptor+genes+are+expressed+in+the+supraoptic+nucleus+of+the+rat+hypothalamus%2C+and+the+transcripts+are+essentially+colocalized+in+the+vasopressinergic+magnocellular+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurbin%26aufirst%3DA.%26aulast%3DBoissin-Agasse%26aufirst%3DL.%26aulast%3DOrcel%26aufirst%3DH.%26aulast%3DRabi%25C3%25A9%26aufirst%3DA.%26aulast%3DJoux%26aufirst%3DN.%26aulast%3DDesarm%25C3%25A9nien%26aufirst%3DM.%2BG.%26aulast%3DRichard%26aufirst%3DP.%26aulast%3DMoos%26aufirst%3DF.%2BC.%26atitle%3DThe%2520V1a%2520and%2520V1b%252C%2520but%2520not%2520V2%252C%2520vasopressin%2520receptor%2520genes%2520are%2520expressed%2520in%2520the%2520supraoptic%2520nucleus%2520of%2520the%2520rat%2520hypothalamus%252C%2520and%2520the%2520transcripts%2520are%2520essentially%2520colocalized%2520in%2520the%2520vasopressinergic%2520magnocellular%2520neurons%26jtitle%3DEndocrinology%26date%3D1998%26volume%3D139%26spage%3D4701%26epage%3D4707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hurbin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favrot, M. C.</span><span> </span><span class="NLM_article-title">The vasopressin receptors colocalize with vasopressin in the magnocellular neurons of the rat supraoptic nucleus and are modulated by water balance</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2002&pages=456-466&author=A.+Hurbinauthor=L.+Dubrezauthor=J.+L.+Collauthor=M.+C.+Favrot&title=The+vasopressin+receptors+colocalize+with+vasopressin+in+the+magnocellular+neurons+of+the+rat+supraoptic+nucleus+and+are+modulated+by+water+balance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurbin%26aufirst%3DA.%26aulast%3DDubrez%26aufirst%3DL.%26aulast%3DColl%26aufirst%3DJ.%2BL.%26aulast%3DFavrot%26aufirst%3DM.%2BC.%26atitle%3DThe%2520vasopressin%2520receptors%2520colocalize%2520with%2520vasopressin%2520in%2520the%2520magnocellular%2520neurons%2520of%2520the%2520rat%2520supraoptic%2520nucleus%2520and%2520are%2520modulated%2520by%2520water%2520balance%26jtitle%3DEndocrinology%26date%3D2002%26volume%3D143%26spage%3D456%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Young, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersinger, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkovits, M.</span><span> </span><span class="NLM_article-title">The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2006&pages=1031-1039&author=W.+S.+Youngauthor=J.+Liauthor=S.+R.+Wersingerauthor=M.+Palkovits&title=The+vasopressin+1b+receptor+is+prominent+in+the+hippocampal+area+CA2+where+it+is+unaffected+by+restraint+stress+or+adrenalectomy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DW.%2BS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWersinger%26aufirst%3DS.%2BR.%26aulast%3DPalkovits%26aufirst%3DM.%26atitle%3DThe%2520vasopressin%25201b%2520receptor%2520is%2520prominent%2520in%2520the%2520hippocampal%2520area%2520CA2%2520where%2520it%2520is%2520unaffected%2520by%2520restraint%2520stress%2520or%2520adrenalectomy%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D143%26spage%3D1031%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neugebauer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestre, M.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escher, E.</span><span> </span><span class="NLM_article-title">Fluorescent peptide hormones: development of high affinity vasopressin analogues</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=7-11&author=G.+Guillonauthor=D.+Barbeauauthor=W.+Neugebauerauthor=S.+Guayauthor=L+Bilodeauauthor=M.-N.+Balestreauthor=N.+Gallo-Payetauthor=E.+Escher&title=Fluorescent+peptide+hormones%3A+development+of+high+affinity+vasopressin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DBarbeau%26aufirst%3DD.%26aulast%3DNeugebauer%26aufirst%3DW.%26aulast%3DGuay%26aufirst%3DS.%26aulast%3DBilodeau%26aufirst%3DL%26aulast%3DBalestre%26aufirst%3DM.-N.%26aulast%3DGallo-Payet%26aufirst%3DN.%26aulast%3DEscher%26aufirst%3DE.%26atitle%3DFluorescent%2520peptide%2520hormones%253A%2520development%2520of%2520high%2520affinity%2520vasopressin%2520analogues%26jtitle%3DPeptides%26date%3D1992%26volume%3D13%26spage%3D7%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelly, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tordjmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufour, M.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forchioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claret, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Distribution of signaling molecules involved in vasopressin-induced Ca<sup>2+</sup> mobilization in rat hepatocytes</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1177%2F002215549904700503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=10219053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlKgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1999&pages=601-616&author=D.+Tranauthor=N.+Stellyauthor=T.+Tordjmannauthor=T.+Durrouxauthor=M.-N.+Dufourauthor=A.+Forchioniauthor=R.+Seyerauthor=M.+Claretauthor=G.+Guillon&title=Distribution+of+signaling+molecules+involved+in+vasopressin-induced+Ca2%2B+mobilization+in+rat+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of signaling molecules involved in vasopressin-induced Ca2+ mobilization in rat hepatocyte multiplets</span></div><div class="casAuthors">Tran, Dien; Stelly, Nicole; Tordjmann, Thierry; Durroux, Thierry; Dufour, Marie Noelle; Forchioni, Arlette; Seyer, Rene; Claret, Michel; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-616</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">In freshly isolated rat hepatocyte multiplets, Ca2+ signals in response to vasopressin are highly organized.  In this study we used specific probes to visualize, by fluorescence and confocal microscopy, the main signaling mols. involved in vasopressin-mediated Ca2+ responses.  V1a receptors were detected with a novel fluorescent antagonist, Rhm8-PVA.  The Gαq/Gα11, PLCβ3, PIP2, and InsP3 receptors were detected with specific antibodies.  V1a vasopressin receptors and PIP2 were assocd. with the basolateral membrane and were not detected in the bile canalicular domain.  Gαq/Gα11, PLCβ3, and InsP3 receptors were assocd. with the basolateral membrane and also with other intracellular structures.  We used double labeling, Western blotting, and drugs (cytochalasin D, colchicine) known to disorganize the cytoskeleton to demonstrate the partial co-localization of Gαq/Gα11 with F-actin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZnn4DSRqwHrVg90H21EOLACvtfcHk0liPAi-Uxpj-vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlKgsrw%253D&md5=d63f61c9b70578d92f37501c00be4e23</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1177%2F002215549904700503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F002215549904700503%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DD.%26aulast%3DStelly%26aufirst%3DN.%26aulast%3DTordjmann%26aufirst%3DT.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DDufour%26aufirst%3DM.-N.%26aulast%3DForchioni%26aufirst%3DA.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DClaret%26aufirst%3DM.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DDistribution%2520of%2520signaling%2520molecules%2520involved%2520in%2520vasopressin-induced%2520Ca2%252B%2520mobilization%2520in%2520rat%2520hepatocytes%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1999%26volume%3D47%26spage%3D601%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Mouillac, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assys and receptors studies</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=996-1005&author=T.+Mouillacauthor=M.+Manningauthor=T.+Durroux&title=Fluorescent+agonists+and+antagonists+for+vasopressin%2Foxytocin+G+protein-coupled+receptors%3A+usefulness+in+ligand+screening+assys+and+receptors+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMouillac%26aufirst%3DT.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DFluorescent%2520agonists%2520and%2520antagonists%2520for%2520vasopressin%252Foxytocin%2520G%2520protein-coupled%2520receptors%253A%2520usefulness%2520in%2520ligand%2520screening%2520assys%2520and%2520receptors%2520studies%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D996%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voirol, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacomini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wo, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben Mimoun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span> </span><span class="NLM_article-title">[1-Deamino-4-cyclohexylalanine]arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">4655</span><span class="NLM_x">–</span> <span class="NLM_lpage">4664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2002&pages=4655-4664&author=S.+Derickauthor=L.+L.+Chengauthor=M.+J.+Voirolauthor=S.+Stoevauthor=M.+Giacominiauthor=N.+C.+Woauthor=H.+H.+Szetoauthor=M.+Ben+Mimounauthor=M.+Andresauthor=R.+C.+Gaillardauthor=G.+Guillonauthor=M.+Manning&title=%5B1-Deamino-4-cyclohexylalanine%5Darginine+vasopressin%3A+a+potent+and+specific+agonist+for+vasopressin+V1b+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DVoirol%26aufirst%3DM.%2BJ.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DGiacomini%26aufirst%3DM.%26aulast%3DWo%26aufirst%3DN.%2BC.%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DBen%2BMimoun%26aufirst%3DM.%26aulast%3DAndres%26aufirst%3DM.%26aulast%3DGaillard%26aufirst%3DR.%2BC.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DManning%26aufirst%3DM.%26atitle%3D%255B1-Deamino-4-cyclohexylalanine%255Darginine%2520vasopressin%253A%2520a%2520potent%2520and%2520specific%2520agonist%2520for%2520vasopressin%2520V1b%2520receptors%26jtitle%3DEndocrinology%26date%3D2002%26volume%3D143%26spage%3D4655%26epage%3D4664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben Mimoun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of deamino-[Cys<sup>1</sup>]arginine vasopressin at position 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2388</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030611c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2375-2388&author=L.+L.+Chengauthor=S.+Stoevauthor=M.+Manningauthor=S.+Derickauthor=A.+Penaauthor=M.+Ben+Mimounauthor=G.+Guillon&title=Design+of+potent+and+selective+agonists+for+the+human+vasopressin+V1b+receptor+based+on+modifications+of+deamino-%5BCys1%5Darginine+vasopressin+at+position+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm030611c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030611c%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DBen%2BMimoun%26aufirst%3DM.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DDesign%2520of%2520potent%2520and%2520selective%2520agonists%2520for%2520the%2520human%2520vasopressin%2520V1b%2520receptor%2520based%2520on%2520modifications%2520of%2520deamino-%255BCys1%255Darginine%2520vasopressin%2520at%2520position%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2375%26epage%3D2388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wo, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of the first selective agonists for the rat vasopressin V<sub>1b</sub> receptor: based on modifications of deamino-[Cys<sup>1</sup>]arginine vasopressin at positions 4 and 8</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060928n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=835-847&author=A.+Penaauthor=B.+Muratauthor=M.+Truebaauthor=M.+A.+Venturaauthor=N.+C.+Woauthor=H.+H.+Szetoauthor=L.+L.+Chengauthor=S.+Stoevauthor=G.+Guillonauthor=M.+Manning&title=Design+and+synthesis+of+the+first+selective+agonists+for+the+rat+vasopressin+V1b+receptor%3A+based+on+modifications+of+deamino-%5BCys1%5Darginine+vasopressin+at+positions+4+and+8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm060928n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060928n%26sid%3Dliteratum%253Aachs%26aulast%3DPena%26aufirst%3DA.%26aulast%3DMurat%26aufirst%3DB.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DVentura%26aufirst%3DM.%2BA.%26aulast%3DWo%26aufirst%3DN.%2BC.%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DManning%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520the%2520first%2520selective%2520agonists%2520for%2520the%2520rat%2520vasopressin%2520V1b%2520receptor%253A%2520based%2520on%2520modifications%2520of%2520deamino-%255BCys1%255Darginine%2520vasopressin%2520at%2520positions%25204%2520and%25208%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D835%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Dyckes, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du Vigneaud, V.</span><span> </span><span class="NLM_article-title">Synthesis and some of the pharmacological properties of [4-leucine]-8-lysine-vasopressin and [1-deamino, 4-leucine]-8-lysine vasopressin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00265a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1973&pages=843-847&author=D.+F.+Dyckesauthor=M.+F.+Fergerauthor=V.+Du+Vigneaud&title=Synthesis+and+some+of+the+pharmacological+properties+of+%5B4-leucine%5D-8-lysine-vasopressin+and+%5B1-deamino%2C+4-leucine%5D-8-lysine+vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm00265a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00265a022%26sid%3Dliteratum%253Aachs%26aulast%3DDyckes%26aufirst%3DD.%2BF.%26aulast%3DFerger%26aufirst%3DM.%2BF.%26aulast%3DDu%2BVigneaud%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520some%2520of%2520the%2520pharmacological%2520properties%2520of%2520%255B4-leucine%255D-8-lysine-vasopressin%2520and%2520%255B1-deamino%252C%25204-leucine%255D-8-lysine%2520vasopressin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1973%26volume%3D16%26spage%3D843%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Rodrigo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trueba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span> </span><span class="NLM_article-title">Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1210%2Fme.2006-0202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=17082326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=512-523&author=J.+Rodrigoauthor=A.+Penaauthor=B.+Muratauthor=M.+Truebaauthor=T.+Durrouxauthor=D.+Rognan&title=Mapping+the+binding+site+of+arginine+vasopressin+to+V1a+and+V1b+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors</span></div><div class="casAuthors">Rodrigo, Jordi; Pena, Ana; Murat, Brigitte; Trueba, Miguel; Durroux, Thierry; Guillon, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">512-523</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Starting from the 2.8-Å resoln. x-ray structure of bovine rhodopsin, three-dimensional mol. models of the complexes between arginine vasopressin and two receptor subtypes (V1a, V1b) have been built.  Amino acid sequence alignment and docking studies suggest that four key residues (1.35, 2.65, 4.61, and 5.35) fine tune the binding of vasopressin and related peptide agonists to both receptor subtypes.  To validate these predictions, a series of single or double mutants were engineered at V1a and V1b receptor subtypes and tested for their binding and functional properties.  Two neg. charged amino acids at positions 1.35 and 2.65 are key anchoring residues to the Arg8 residue of arginine vasopressin.  Moreover, two amino acids (V4.61 and P5.35) delineating a hydrophobic subsite at the human V1b receptor are responsible for the recognition of V1b selective peptide agonists.  Last, one of the latter positions (5.35) is hypothesized to explain the pharmacol. species differences between rat and human vasopressin receptors for a V1b peptide agonist.  Altogether these refined three-dimensional models of V1a and V1b human receptors should enable the identification of further new selective V1a and V1b agonists as pharmacol. but also therapeutic tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiSR2zAZAfYrVg90H21EOLACvtfcHk0ljjc92eIhA3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWisbg%253D&md5=3da9d009a1b55b8e9420dfba0b0b77f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1210%2Fme.2006-0202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2006-0202%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DMurat%26aufirst%3DB.%26aulast%3DTrueba%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DMapping%2520the%2520binding%2520site%2520of%2520arginine%2520vasopressin%2520to%2520V1a%2520and%2520V1b%2520vasopressin%2520receptors%26jtitle%3DMol.%2520Endocrinol.%26date%3D2007%26volume%3D21%26spage%3D512%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Terillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V1a receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2588</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2579-2588&author=S.+Terillonauthor=L.+L.+Chengauthor=S.+Stoevauthor=B.+Mouillacauthor=C.+Barberisauthor=M.+Manningauthor=T.+Durroux&title=Synthesis+and+characterization+of+fluorescent+antagonists+and+agonists+for+human+oxytocin+and+vasopressin+V1a+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerillon%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520fluorescent%2520antagonists%2520and%2520agonists%2520for%2520human%2520oxytocin%2520and%2520vasopressin%2520V1a%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2579%26epage%3D2588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Taki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohsaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisido, M.</span><span> </span><span class="NLM_article-title">A non-natural amino acid for efficient incorporation into proteins as a sensitive fluorescent probe</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">507</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2001&pages=35-38&author=M.+Takiauthor=T.+Hohsakaauthor=H.+Murakamiauthor=K.+Tairaauthor=M.+Sisido&title=A+non-natural+amino+acid+for+efficient+incorporation+into+proteins+as+a+sensitive+fluorescent+probe"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaki%26aufirst%3DM.%26aulast%3DHohsaka%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DTaira%26aufirst%3DK.%26aulast%3DSisido%26aufirst%3DM.%26atitle%3DA%2520non-natural%2520amino%2520acid%2520for%2520efficient%2520incorporation%2520into%2520proteins%2520as%2520a%2520sensitive%2520fluorescent%2520probe%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D507%26spage%3D35%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Panchuk-Voloshina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugland, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop-Stewart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalgat, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millard, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huagland, R.</span><span> </span><span class="NLM_article-title">Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1177%2F002215549904700910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=10449539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK1MXmtValsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1999&pages=1179-1188&author=N.+Panchuk-Voloshinaauthor=R.+P.+Hauglandauthor=J.+Bishop-Stewartauthor=M.+K.+Bhalgatauthor=P.+J.+Millardauthor=F.+Maoauthor=W.-Y.+Leungauthor=R.+Huagland&title=Alexa+dyes%2C+a+series+of+new+fluorescent+dyes+that+yield+exceptionally+bright%2C+photostable+conjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates</span></div><div class="casAuthors">Panchuk-Voloshina, Nataliya; Haugland, Rosaria P.; Bishop-Stewart, Janell; Bhalgat, Mahesh K.; Millard, Paul J.; Mao, Fei; Leung, Wai-Yee; Haugland, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1179-1188</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Alexa 350, Alexa 430, Alexa 488, Alexa 532, Alexa 546, Alexa 568, and Alexa 594 dyes are a new series of fluorescent dyes with emission/excitation spectra similar to those of AMCA, Lucifer Yellow, fluorescein, rhodamine 6G, tetramethylrhodamine or Cy3, lissamine rhodamine B, and Texas Red, resp. (the nos. in the Alexa names indicate the approx. excitation wavelength max. in nm).  All Alexa dyes and their conjugates are more fluorescent and more photostable than their commonly used spectral analogs listed above.  In addn., Alexa dyes are insensitive to pH in the 4-10 range.  We evaluated Alexa dyes compared with conventional dyes in applications using various conjugates, including those of goat anti-mouse IgG (GAM), streptavidin, wheat germ agglutinin (WGA), and Con A (ConA).  Conjugates of Alexa 546 are at least twofold more fluorescent than Cy3 conjugates.  Proteins labeled with the Alexa 568 or Alexa 594 dyes are several-fold brighter than the same proteins labeled with lissamine rhodamine B or Texas Red dyes, resp.  Alexa dye derivs. of phalloidin stain F-actin with high specificity.  Hydrazide forms of the Alexa dyes are very bright, formaldehyde-fixable polar tracers.  Conjugates of the Alexa 430 (ex 430 nm/em 520 nm) and Alexa 532 (ex 530 nm/em 548 nm) fluorochromes are spectrally unique fluorescent probes, with relatively high quantum yields in their excitation and emission wavelength ranges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXJnPjLPC6lbVg90H21EOLACvtfcHk0ljjc92eIhA3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtValsLw%253D&md5=9dd2e5d27eed61cc38242ed476435ef4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1177%2F002215549904700910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F002215549904700910%26sid%3Dliteratum%253Aachs%26aulast%3DPanchuk-Voloshina%26aufirst%3DN.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26aulast%3DBishop-Stewart%26aufirst%3DJ.%26aulast%3DBhalgat%26aufirst%3DM.%2BK.%26aulast%3DMillard%26aufirst%3DP.%2BJ.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DLeung%26aufirst%3DW.-Y.%26aulast%3DHuagland%26aufirst%3DR.%26atitle%3DAlexa%2520dyes%252C%2520a%2520series%2520of%2520new%2520fluorescent%2520dyes%2520that%2520yield%2520exceptionally%2520bright%252C%2520photostable%2520conjugates%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1999%26volume%3D47%26spage%3D1179%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ballard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeva, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deSilva, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, N. R.</span><span> </span><span class="NLM_article-title">Comparison of Alexa Fluor and Cy dye for practical DNA microarray use</span> <span class="citation_source-journal">Mol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1007%2Fs12033-007-0006-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=17873405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1WktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=175-183&author=J.+L.+Ballardauthor=V.+K.+Peevaauthor=C.+J.+deSilvaauthor=J.+L.+Lynchauthor=N.+R.+Swanson&title=Comparison+of+Alexa+Fluor+and+Cy+dye+for+practical+DNA+microarray+use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Alexa Fluor and CyDye for practical DNA microarray use</span></div><div class="casAuthors">Ballard, Joanne L.; Peeva, Violet K.; de Silva, Christopher J. S.; Lynch, Jessica L.; Swanson, Nigel R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-183</span>CODEN:
                <span class="NLM_cas:coden">MLBOEO</span>;
        ISSN:<span class="NLM_cas:issn">1073-6085</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Microarrays are a powerful tool for comparison and understanding of gene expression levels in healthy and diseased states.  The method relies upon the assumption that signals from microarray features are a reflection of relative gene expression levels of the cell types under investigation.  It has previously been reported that the classical fluorescent dyes used for microarray technol., Cy3 and Cy5, are not ideal due to the decreased stability and fluorescence intensity of the Cy5 dye relative to the Cy3, such that dye bias is an accepted phenomena necessitating dye swap exptl. protocols and anal. of differential dye affects.  The incentive to find new fluorophores is based on alleviating the problem of dye bias through synonymous performance between counterpart dyes.  Alexa Fluor 555 and Alexa Fluor 647 are increasingly promoted as replacements for CyDye in microarray expts.  Performance relates to the mol. and steric similarities, which will vary for each new pair of dyes as well as the spectral integrity for the specific application required.  Comparative anal. of the performance of these two competitive dye pairs in practical microarray applications is warranted towards this end.  The findings of the study showed that both dye pairs were comparable but that conventional CyDye resulted in significantly higher signal intensities and signal minus background levels with no significant difference in background values.  This translated to greater levels of differential gene expression with CyDye than with the Alexa Fluor counterparts.  However, CyDye fluorophores and in particular Cy5, were less photostable over time and following repeated scans in microarray expts.  These results suggest that precautions against potential dye affects will continue to be necessary and that no one dye pair negates this need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQAm8fW1hXXbVg90H21EOLACvtfcHk0lha7KiMZhr3Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1WktL0%253D&md5=93213e5b08d3b03cbd34b395b2229ba8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs12033-007-0006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12033-007-0006-4%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DJ.%2BL.%26aulast%3DPeeva%26aufirst%3DV.%2BK.%26aulast%3DdeSilva%26aufirst%3DC.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BL.%26aulast%3DSwanson%26aufirst%3DN.%2BR.%26atitle%3DComparison%2520of%2520Alexa%2520Fluor%2520and%2520Cy%2520dye%2520for%2520practical%2520DNA%2520microarray%2520use%26jtitle%3DMol.%2520Biotechnol.%26date%3D2007%26volume%3D36%26spage%3D175%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span> </span><span class="NLM_article-title">Molecular pharmacology of AVP an OT receptors and therapeutic potential</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1358%2Fdnp.1999.12.5.863621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK1MXltVCkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=279-298&author=C.+Barberisauthor=D.+Morinauthor=T.+Durrouxauthor=B.+Mouillacauthor=G.+Guillonauthor=R.+Seyerauthor=M.+Hibertauthor=E.+Tribolletauthor=M.+Manning&title=Molecular+pharmacology+of+AVP+an+OT+receptors+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacology of AVP and OT receptors and therapeutic potential</span></div><div class="casAuthors">Barberis, C.; Morin, D.; Durroux, T.; Mouillac, B.; Guillon, G.; Seyer, R.; Hibert, M.; Tribollet, E.; Manning, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">279-292</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review with 142 refs.  Classically, vasopressin (AVP) and oxytocin (OT) receptors were defined on the basis of the second messenger system coupled to the receptors and the affinity of a series of AVP and OT analogs with enhanced selectivity for a certain receptor type.  These classification criteria have led to the distinction of vasopressin V1a, V1b and V2 and oxytocin receptors.  Recent reports on novel vasopressin analogs that exhibit selective vasodepressor agonistic activity suggest the presence of an as yet uncharacterized new vasopressin receptor, as well.  Mol. cloning of this family has confirmed that vasopressin/oxytocin receptor subtypes are members of the G-protein-coupled receptor superfamily.  Several vasopressin agonists have been developed that may be of potential therapeutic interest.  AVP analogs combining high vasopressor potency and specificity with long -acting effects could be of clin. value in hemorrhage and circulatory disorders like hypertension.  AVP and OT antagonists have been widely used as pharmacol. tools in studies on the physiol. and pathophysiol. roles of AVP and OT and in receptor localization and characterization studies.  While potent and selective V1a, V2 and OT antagonists have been developed, there is still a significant need for potent and selective V1b antagonists.  In the future, data will undoubtedly emerge from structure-activity relationships which have been greatly facilitated by the use of human receptors expressed in heterologous systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreUuGtpAOZt7Vg90H21EOLACvtfcHk0lha7KiMZhr3Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVCkt74%253D&md5=ef882e31fa12306888a9c1ea117a9d9a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1358%2Fdnp.1999.12.5.863621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.1999.12.5.863621%26sid%3Dliteratum%253Aachs%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DManning%26aufirst%3DM.%26atitle%3DMolecular%2520pharmacology%2520of%2520AVP%2520an%2520OT%2520receptors%2520and%2520therapeutic%2520potential%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D1999%26volume%3D12%26spage%3D279%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_contrib-group">Kruszynski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title">[1-Beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(<i>O</i>-methyl)tyrosine]arginine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]arginine vasopressin, two high potent antagonists of the vasopressor response to arginine-vasopressin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00178a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=364-368&author=M.+Kruszynskiauthor=B.+Lammekauthor=M.+Manningauthor=J.+Setoauthor=J+Haldarauthor=W.+H.+Sawyer&title=%5B1-Beta-mercapto-beta%2Cbeta-cyclopentamethylenepropionic+acid%29%2C2-%28O-methyl%29tyrosine%5Darginine-vasopressin+and+%5B1-beta-mercapto-beta%2Cbeta-cyclopentamethylenepropionic+acid%29%5Darginine+vasopressin%2C+two+high+potent+antagonists+of+the+vasopressor+response+to+arginine-vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fjm00178a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00178a003%26sid%3Dliteratum%253Aachs%26aulast%3DKruszynski%26aufirst%3DM.%26aulast%3DLammek%26aufirst%3DB.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DSeto%26aufirst%3DJ.%26aulast%3DHaldar%26aufirst%3DJ%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3D%255B1-Beta-mercapto-beta%252Cbeta-cyclopentamethylenepropionic%2520acid%2529%252C2-%2528O-methyl%2529tyrosine%255Darginine-vasopressin%2520and%2520%255B1-beta-mercapto-beta%252Cbeta-cyclopentamethylenepropionic%2520acid%2529%255Darginine%2520vasopressin%252C%2520two%2520high%2520potent%2520antagonists%2520of%2520the%2520vasopressor%2520response%2520to%2520arginine-vasopressin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D364%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2FS0079-6123%2808%2900437-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=18655903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=473-512&author=M.+Manningauthor=S.+Stoevauthor=B.+Chiniauthor=T.+Durrouxauthor=B.+Mouillacauthor=G.+Guillon&title=Peptide+and+non-peptide+agonists+and+antagonists+for+the+vasopressin+and+oxytocin+V1a%2C+V1b%2C+V2+and+OT+receptors%3A+research+tools+and+potential+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span></div><div class="casAuthors">Manning, Maurice; Stoev, Stoytcho; Chini, Bice; Durroux, Thierry; Mouillac, Bernard; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">473-512</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OT) and vasopressin (AVP) mediate their biol. actions by acting on four known receptors: The OT (uterine) and the AVP V1a (vasopressor), V1b (pituitary), V2 (renal) receptors and a fifth putative AVP V1c (vasodilating) receptor.  This presentation will summarize some highlights of the recent progress, in the design and synthesis of selective peptide agonists, antagonists, radioiodinated ligands, fluorescent ligands and bivalent ligands for these receptors.  Here we present published and unpublished pharmacol. data on the most widely used agonists, antagonists and labeled ligands.  The pharmacol. properties of promising new selective OT antagonists and V1b agonists are also presented.  This review should serve as a useful guide for the selection of the most appropriate ligand for a given study.  The current status of non-peptide OT and AVP antagonists and agonists is also summarized.  The relative merits of peptide and non-peptide AVP and OT agonists and antagonists as: (1) research tools and (2) therapeutic agents will be evaluated.  Many of the receptor selective peptide agonists and antagonists from this and other labs. are far more widely used as pharmacol. tools for studies on the peripheral and central effects of OT and AVP than their non-peptide counterparts.  In addn. to OT and to a lesser extent AVP (pitressin), a no. of OT and AVP analogs; such as carbetocin (OT agonist) dDAVP (desmopressin, V2 agonist), terlipressin (V1a agonist), felypressin (V1a agonist) and atosiban (Tractocile OT antagonist) are also in clin. use.  Despite much early promise, no non-peptide V1a or OT antagonists are currently in clin. trials.  While a no. of orally active non-peptide V2 antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clin. trials; to date, only the mixed V2/V1a, antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clin. use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.  Promising new non-peptide V1b and OT antagonists, as well as non-peptide V2 and OT agonists are now in pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3jiQ5LZT5gLVg90H21EOLACvtfcHk0lgLJp7LDR_dyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ&md5=c21ad467eaee4a2651232a16c7dc61c5</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900437-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900437-8%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520non-peptide%2520agonists%2520and%2520antagonists%2520for%2520the%2520vasopressin%2520and%2520oxytocin%2520V1a%252C%2520V1b%252C%2520V2%2520and%2520OT%2520receptors%253A%2520research%2520tools%2520and%2520potential%2520therapeutic%2520agents%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D473%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Advenier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naline, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinolle, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouzet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raufaste, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double-Cazanave, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasacal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">SSR126768A: a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1124%2Fjpet.103.061200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=14722330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A280%3ADC%252BD2c7lsVyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=414-424&author=C.+Serradeil-Le+Galauthor=G.+Valetteauthor=L.+Foulonauthor=G.+Germainauthor=C.+Advenierauthor=E.+Nalineauthor=M.+Bardouauthor=J.-P.+Martinolleauthor=B.+Pouzetauthor=D.+Raufasteauthor=C.+Garciaauthor=E.+Double-Cazanaveauthor=M.+Paulyauthor=M.+Pasacalauthor=A.+Barbierauthor=B.+Scattonauthor=J.-P.+Maffrandauthor=G.+Le+Fur&title=SSR126768A%3A+a+new+selective+and+orally+active+oxytocin+receptor+antagonist+for+the+prevention+of+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor</span></div><div class="casAuthors">Serradeil-Le Gal Claudine; Valette Gerard; Foulon Loic; Germain Guy; Advenier Charles; Naline Emmanuel; Bardou Marc; Martinolle Jean-Pierre; Pouzet Brigitte; Raufaste Danielle; Garcia Corinne; Double-Cazanave Eleonore; Pauly Maxime; Pascal Marc; Barbier Alain; Scatton Bernard; Maffrand Jean-Pierre; Le Fur Gerard</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">414-24</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)benzamide, hydrochloride (SSR126768A), a new potent and selective, orally active oxytocin (OT) receptor antagonist was characterized in several biochemical and pharmacological models.  In binding studies, SSR126768A showed nanomolar affinity for rat and human recombinant and native OT receptors (K(i) = 0.44 nM) and exhibited much lower affinity for V(1a), V(1b), and V(2) receptors.  In addition, it did not interact with a large number of other receptors, enzymes, and ion channels (1 microM).  In autoradiographic experiments performed on at-term human pregnant uterus sections, SSR126768A dose dependently displaced [I(125)]d(CH(2))(5)[Tyr(Me)(2), Thr(4), Orn(8) (125)I-Tyr-NH(2)(9)]VT in situ labeling to OT receptors highly expressed in these tissues.  In functional studies, SSR126768A behaved as a full antagonist and potently antagonized OT-induced intracellular Ca(2+) increase (K(i) = 0.50 nM) and prostaglandin release (K(i) = 0.45 nM) in human uterine smooth muscle cells.  In rat isolated myometrium, OT-induced uterine contractions were competitively antagonized by SSR126768A (pA(2) = 8.47).  Similarly, in human pregnant myometrial strips, SSR126768A inhibited the contractile uterine response to OT.  In conscious telemetrated rats, oral administration of SSR126768A (1-10 mg/kg) produced a competitive inhibition of the dose response to OT on uterine contractions up to 24 h at 3 mg/kg p.o.; no tachyphylaxis was observed after 4-day repeated treatment.  Finally, SSR126768A (30 mg/kg p.o.) significantly delayed parturition in pregnant rats in labor similar to ritodrine (10 mg/kg p.o.).  Thus, SSR126768A is a potent, highly selective, orally active OT receptor antagonist with a long duration of action.  This molecule could find therapeutic application as a tocolytic agent for acute and chronic oral management of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6iUVbkwozC5dYoSR9eyvsfW6udTcc2ebZ3QzetuiJIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7lsVyitQ%253D%253D&md5=136e693c816a368597799687f167dc0a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.061200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.061200%26sid%3Dliteratum%253Aachs%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DValette%26aufirst%3DG.%26aulast%3DFoulon%26aufirst%3DL.%26aulast%3DGermain%26aufirst%3DG.%26aulast%3DAdvenier%26aufirst%3DC.%26aulast%3DNaline%26aufirst%3DE.%26aulast%3DBardou%26aufirst%3DM.%26aulast%3DMartinolle%26aufirst%3DJ.-P.%26aulast%3DPouzet%26aufirst%3DB.%26aulast%3DRaufaste%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DC.%26aulast%3DDouble-Cazanave%26aufirst%3DE.%26aulast%3DPauly%26aufirst%3DM.%26aulast%3DPasacal%26aufirst%3DM.%26aulast%3DBarbier%26aufirst%3DA.%26aulast%3DScatton%26aufirst%3DB.%26aulast%3DMaffrand%26aufirst%3DJ.-P.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DSSR126768A%253A%2520a%2520new%2520selective%2520and%2520orally%2520active%2520oxytocin%2520receptor%2520antagonist%2520for%2520the%2520prevention%2520of%2520preterm%2520labor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D414%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagnon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2FS0079-6123%2802%2939017-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=12436936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFGrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2002&pages=197-210&author=C.+Serradeil-Le+Galauthor=J.+Wagnonauthor=G.+Valetteauthor=G.+Garciaauthor=M.+Pascalauthor=J.+P.+Maffrandauthor=G.+Le+Fur&title=Nonpeptide+vasopressin+receptor+antagonists%3A+development+of+selective+and+orally+active+V1a%2C+V2+and+V1b+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands</span></div><div class="casAuthors">Serradeil-Le Gal, C.; Wagnon, J.; Valette, G.; Garcia, G.; Pascal, M.; Maffrand, J. P.; Le Fur, G.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">Vasopressin and Oxytocin: From Genes to Clinical Applications</span>),
    <span class="NLM_cas:pages">197-210</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The involvement of vasopressin (AVP) in several pathol. states has been reported recently and the selective blockade of the different AVP receptors could offer new clin. perspectives.  During the past few years, various selective, orally active AVP V1a (OPC-21268, SR 49059 (Relcovaptan)), V2 (OPC-31260, OPC-41061 (Tolvaptan), VPA-985 (Lixivaptan), SR121463, VP-343, FR-161282) and mixed V1a/V2 (YM-087 (Conivaptan), JTV-605, CL-385004) receptor antagonists have been intensively studied in various animal models and have reached, Phase IIb clin. trials for some of them.  For many years now, our lab. has focused on the identification of nonpeptide vasopressin antagonists with suitable oral bioavailability.  Using random screening on small mol. libraries, followed by rational SAR and modelization, we identified a chem. series of I-phenylsulfonylindolines which first yielded SR 49059, a V1a receptor antagonist prototype.  This compd. displayed high affinity for animal and human V1a receptors and antagonized various V1a AVP-induced effects in vitro and in vivo (intracellular [Ca2+] increase, platelet aggregation, vascular smooth muscle cell proliferation, hypertension and coronary vasospasm).  We and others have used this compd. to study the role of AVP in various animal models.  Recent findings from clin. trials show a potential interest for SR 49059 in the treatment of dysmenorrhea and in Raynaud's disease.  Structural modifications and simplifications performed in the SR 49059 chem. series yielded highly specific V2 receptor antagonists (N-arylsulfonyl-oxindoles), amongst them SR 121463 which possesses powerful oral aquaretic properties in various animal species and in man.  SR 121463 is well-tolerated and dose-dependently increases urine output and decreases urine osmolality.  It induces free water-excretion without affecting electrolyte balance in contrast to classical diuretics (e.g. furosemide and hydrochlorothiazide).  Notably, in cirrhotic rats with ascites and impaired renal function, a 10-day oral treatment with SR 121463 (0.5 mg/kg) totally cor. hyponatremia and restored normal urine excretion.  This compd. also displayed interesting new properties in a rabbit model of ocular hypertension, decreasing intraocular pressure after single or repeated instillation.  Thus, V2 receptor blockade could be of interest in several water-retaining diseases such as the syndrome of inappropriate antidiuretic hormone secretion (SIADH), liver cirrhosis and congestive heart failure and deserves to be widely explored.  Finally, further chem. developments in the oxindole family have led to the first specific and orally active V1b receptor antagonists (with SSR149415 as a representative), an awaited class of drugs with expected therapeutic interest mainly in ACTH-secreting tumors and various emotional diseases such as stress-related disorders, anxiety and depression.  However, from the recently described tissue localization for this receptor, we could also speculate on other unexpected uses.  In conclusion, the development of AVP receptor antagonists is a field of intensive pharmacol. and clin. investigation.  Selective and orally active compds. are now available to give new insight into the pathophysiol. role of AVP and to provide promising drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJ3b7CqSZr7Vg90H21EOLACvtfcHk0liSifXcxGdLYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFGrs70%253D&md5=cf18c25e8c99c72f11887db32c864a50</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2802%2939017-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252802%252939017-4%26sid%3Dliteratum%253Aachs%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DWagnon%26aufirst%3DJ.%26aulast%3DValette%26aufirst%3DG.%26aulast%3DGarcia%26aufirst%3DG.%26aulast%3DPascal%26aufirst%3DM.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DNonpeptide%2520vasopressin%2520receptor%2520antagonists%253A%2520development%2520of%2520selective%2520and%2520orally%2520active%2520V1a%252C%2520V2%2520and%2520V1b%2520receptor%2520ligands%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2002%26volume%3D139%26spage%3D197%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Caldwell, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macbeth, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. C.,  II.</span><span> </span><span class="NLM_article-title">Vasopressin: behavioral roles of an original neuropeptide</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2Fj.pneurobio.2007.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=18053631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOrtb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2008&pages=1-24&author=H.+K.+Caldwellauthor=H.-J.+Leeauthor=A.+H.+Macbethauthor=W.+C.+Young&title=Vasopressin%3A+behavioral+roles+of+an+original+neuropeptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Vasopressin: Behavioral roles of an "original" neuropeptide</span></div><div class="casAuthors">Caldwell, Heather K.; Lee, Heon-Jin; Macbeth, Abbe H.; Young, W. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-24</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Vasopressin (Avp) is mainly synthesized in the magnocellular cells of the hypothalamic supraoptic (SON) and paraventricular nuclei (PVN) whose axons project to the posterior pituitary.  Avp is then released into the blood stream upon appropriate stimulation (e.g., hemorrhage or dehydration) to act at the kidneys and blood vessels.  The brain also contains several populations of smaller, parvocellular neurons whose projections remain within the brain.  These populations are located within the PVN, bed nucleus of the stria terminalis (BNST), medial amygdala (MeA) and suprachiasmatic nucleus (SCN).  Since the 1950s, research examg. the roles of Avp in the brain and periphery has intensified.  The development of specific agonists and antagonists for Avp receptors has allowed for a better elucidation of its contributions to physiol. and behavior.  Anatomical, pharmacol. and transgenic, including "knockout," animal studies have implicated Avp in the regulation of various social behaviors across species.  Avp plays a prominent role in the regulation of aggression, generally of facilitating or promoting it.  Affiliation and certain aspects of pair-bonding are also influenced by Avp.  Memory, one of the first brain functions of Avp that was investigated, has been implicated esp. strongly in social recognition.  The roles of Avp in stress, anxiety, and depressive states are areas of active exploration.  In this review, we conc. on the scientific progress that has been made in understanding the role of Avp in regulating these and other behaviors across species.  We also discuss the implications for human behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zuRs3NFBrrVg90H21EOLACvtfcHk0ljn0599VOKS0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOrtb7O&md5=41b77b1e1988a28b1713aa198732cab7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2007.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2007.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DH.-J.%26aulast%3DMacbeth%26aufirst%3DA.%2BH.%26aulast%3DYoung%26aufirst%3DW.%2BC.%26atitle%3DVasopressin%253A%2520behavioral%2520roles%2520of%2520an%2520original%2520neuropeptide%26jtitle%3DProg.%2520Neurobiol.%26date%3D2008%26volume%3D84%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an “easy guide” to receptor pharmacology</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2FS0079-6123%2808%2900438-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=18655904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=513-517&author=B.+Chiniauthor=M.+Manningauthor=G.+Guillon&title=Affinity+and+efficacy+of+selective+agonists+and+antagonists+for+vasopressin+and+oxytocin+receptors%3A+an+%E2%80%9Ceasy+guide%E2%80%9D+to+receptor+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an easy guide to receptor pharmacology</span></div><div class="casAuthors">Chini, Bice; Manning, Maurice; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">513-517</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of "selective" drugs targeting oxytocin/vasopressin receptors has enormously progressed since the original synthesis of oxytocin more than 50 years ago.  However, several factors still hamper the availability of a rich and complete range of selective agonists and antagonists acting at the different oxytocin/vasopressin receptor subtypes, making the use of these drugs still a daunting task.  In this paper we will briefly review the major problems encountered when dealing with oxytocin/vasopressin selective ligands, proving few rules for their correct pharmacol. use, in order to avoid common pitfalls.  Finally, we will glimpse at new challenges, such us the discovery of coupling selective ligands, which foster the search for new classes of selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN_It28Yr4erVg90H21EOLACvtfcHk0ljn0599VOKS0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfL&md5=9d8d4834a931b53e84d2a898e2854486</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900438-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900438-X%26sid%3Dliteratum%253Aachs%26aulast%3DChini%26aufirst%3DB.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DAffinity%2520and%2520efficacy%2520of%2520selective%2520agonists%2520and%2520antagonists%2520for%2520vasopressin%2520and%2520oxytocin%2520receptors%253A%2520an%2520%25E2%2580%259Ceasy%2520guide%25E2%2580%259D%2520to%2520receptor%2520pharmacology%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D513%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Berezowska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelent, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szeto, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, P. W.</span><span> </span><span class="NLM_article-title">Highly potent fluorescent analogues of the opioid peptide [Dmt<sup>1</sup>]DALDA</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=1195-1200&author=I.+Berezowskaauthor=N.+N.+Chungauthor=C.+Lemieuxauthor=B.+Zelentauthor=H.+H.+Szetoauthor=P.+W.+Schiller&title=Highly+potent+fluorescent+analogues+of+the+opioid+peptide+%5BDmt1%5DDALDA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerezowska%26aufirst%3DI.%26aulast%3DChung%26aufirst%3DN.%2BN.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DZelent%26aufirst%3DB.%26aulast%3DSzeto%26aufirst%3DH.%2BH.%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26atitle%3DHighly%2520potent%2520fluorescent%2520analogues%2520of%2520the%2520opioid%2520peptide%2520%255BDmt1%255DDALDA%26jtitle%3DPeptides%26date%3D2003%26volume%3D24%26spage%3D1195%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Schiller, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezowska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weltrowska, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, N. N.</span><span> </span><span class="NLM_article-title">Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy</span> <span class="citation_source-journal">J. Pept. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1111%2Fj.1399-3011.2005.00252.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=15885115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslOmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=556-563&author=P.+W.+Schillerauthor=I.+Berezowskaauthor=G.+Weltrowskaauthor=H.+Chenauthor=C.+Lemieuxauthor=N.+N.+Chung&title=Type+and+location+of+fluorescent+probes+incorporated+into+the+potent+mu-opioid+peptide+%5Bdmt%5DDALDA+affect+potency%2C+receptor+selectivity+and+intrinsic+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Type and location of fluorescent probes incorporated into the potent μ-opioid peptide [Dmt1]DALDA affect potency, receptor selectivity and intrinsic efficacy</span></div><div class="casAuthors">Schiller, P. W.; Berezowska, I.; Weltrowska, G.; Chen, H.; Lemieux, C.; Chung, N. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">556-563</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The Dermorphin-derived tetrapeptide H-Dmt-D-Arg-Phe-Lys-NH2 (Dmt = 2',6'-dimethyltyrosine) ([Dmt1]DALDA) is a highly potent and selective μ-opioid agonist capable of crossing the blood-brain barrier and producing a potent, centrally mediated analgesic effect when given systemically.  For the purpose of biodistribution studies by fluorescence techniques, [Dmt1]DALDA analogs contg. various fluorescent labels [dansyl, Anthraniloyl (atn), fluorescein, or 6-dimethylamino-2'-naphthoyl] in several different locations of the peptide were synthesized and characterized in vitro in the guinea-pig ileum and mouse vas deferens assays, and in μ-, δ- and κ-opioid receptor-binding assays.  The analogs showed various degrees of μ receptor-binding selectivity, but all of them were less μ-selective than the [Dmt1]DALDA parent peptide.  Most analogs retained potent, full μ-agonist activity, except for one with fluorescein attached at the C-terminus (3a) (partial μ-agonist) and one contg. β-(6'-dimethylamino-2'-naphthoyl)alanine (Aladan) in place of Phe3 (4) (μ- and κ-antagonist).  The obtained data indicate that the receptor-binding affinity, receptor selectivity and intrinsic efficacy of the prepd. analogs vary very significantly, depending on the type of fluorescent label used and on its location in the peptide.  The results suggest that the biol. activity profile of fluorescence-labeled peptide analogs should always be carefully detd. prior to their use in biodistribution studies or other studies.  One of the analogs contg. the atn group (2a) proved highly useful in a study of cellular uptake and intracellular distribution by confocal laser scanning microscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq00XQQ7akIPLVg90H21EOLACvtfcHk0lhpkZVkxUWAhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslOmt7Y%253D&md5=5dde40b2c1538c0c7df21d970cdc9b4b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.2005.00252.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.2005.00252.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchiller%26aufirst%3DP.%2BW.%26aulast%3DBerezowska%26aufirst%3DI.%26aulast%3DWeltrowska%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DN.%2BN.%26atitle%3DType%2520and%2520location%2520of%2520fluorescent%2520probes%2520incorporated%2520into%2520the%2520potent%2520mu-opioid%2520peptide%2520%255Bdmt%255DDALDA%2520affect%2520potency%252C%2520receptor%2520selectivity%2520and%2520intrinsic%2520efficacy%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2005%26volume%3D65%26spage%3D556%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Devost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zingg, H. H.</span><span> </span><span class="NLM_article-title">Homo- and hetero-dimeric complex formations of the human oxytocin receptor</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1111%2Fj.0953-8194.2004.01188.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=15089977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvF2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=372-377&author=D.+Devostauthor=H.+H.+Zingg&title=Homo-+and+hetero-dimeric+complex+formations+of+the+human+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Homo- and hetero-dimeric complex formations of the human oxytocin receptor</span></div><div class="casAuthors">Devost, D.; Zingg, H. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372-377</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Using 2 different coimmunopptn. strategies as well as bioluminescence resonance energy transfer (BRET) techniques, we detd. that the human oxytocin receptor forms dimeric and oligomeric complexes in vivo in intact living cells, and that these complexes exist at the cell surface level.  Using a BRET-based assay, we found that oligomers can form between oxytocin receptors themselves (homo-oligomers) as well as, with a reduced affinity, between the oxytocin receptor and related members of the vasopressin receptor family (V1a and V2 receptors), but not with the more remotely related bradykinin receptor.  The existence of oxytocin receptor oligomers at the level of the cell surface was demonstrated by a coimmunopptn. approach involving direct antibody exposure of intact living cells.  Furthermore, this approach demonstrated that cell surface oxytocin receptor oligomerization is ligand independent.  However, agonist addn. led to an apparent rapid decrease in receptor oligomerization, as assessed by the coimmunopptn. approach, indicating that agonist exposure may modulate the oligomerization status.  It remains to be detd. to what extent oxytocin receptor oligomerization impacts on signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4wgPb6eVDZ7Vg90H21EOLACvtfcHk0lhpkZVkxUWAhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvF2isbw%253D&md5=a4e955922d76174d4790a19b892aa637</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.0953-8194.2004.01188.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0953-8194.2004.01188.x%26sid%3Dliteratum%253Aachs%26aulast%3DDevost%26aufirst%3DD.%26aulast%3DZingg%26aufirst%3DH.%2BH.%26atitle%3DHomo-%2520and%2520hetero-dimeric%2520complex%2520formations%2520of%2520the%2520human%2520oxytocin%2520receptor%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2004%26volume%3D16%26spage%3D372%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Albizu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kralikova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brabet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourrier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarque, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rives, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinquet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Time-resolved FRET between GPCR ligands reveals oligomers in native tissues</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1038%2Fnchembio.396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=20622858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ahsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=587-594&author=L.+Albizuauthor=M.+Cottetauthor=M.+Kralikovaauthor=S.+Stoevauthor=R.+Seyerauthor=I.+Brabetauthor=T.+Rouxauthor=H.+Bazinauthor=E.+Bourrierauthor=L.+Lamarqueauthor=C.+Bretonauthor=M.-L.+Rivesauthor=A.+Newmanauthor=J.+Javitchauthor=E.+Trinquetauthor=M.+Manningauthor=J.-P.+Pinauthor=B.+Mouillacauthor=T.+Durroux&title=Time-resolved+FRET+between+GPCR+ligands+reveals+oligomers+in+native+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Time-resolved FRET between GPCR ligands reveals oligomers in native tissues</span></div><div class="casAuthors">Albizu, Laura; Cottet, Martin; Kralikova, Michaela; Stoev, Stoytcho; Seyer, Rene; Brabet, Isabelle; Roux, Thomas; Bazin, Herve; Bourrier, Emmanuel; Lamarque, Laurent; Breton, Christophe; Rives, Marie-Laure; Newman, Amy; Javitch, Jonathan; Trinquet, Eric; Manning, Maurice; Pin, Jean-Philippe; Mouillac, Bernard; Durroux, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">587-594</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptor (GPCR) oligomers have been proposed to play crit. roles in cell signaling, but confirmation of their existence in a native context remains elusive, as no direct interactions between receptors have been reported.  To demonstrate their presence in native tissues, we developed a time-resolved FRET strategy that is based on receptor labeling with selective fluorescent ligands.  Specific FRET signals were obsd. with four different receptors expressed in cell lines, consistent with their dimeric or oligomeric nature in these transfected cells.  More notably, the comparison between FRET signals measured with sets of fluorescent agonists and antagonists was consistent with an asym. relationship of the two protomers in an activated GPCR dimer.  Finally, we applied the strategy to native tissues and succeeded in demonstrating the presence of oxytocin receptor dimers and/or oligomers in mammary gland.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRPFTQQ0GNv7Vg90H21EOLACvtfcHk0lhSEGasSiEV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ahsbw%253D&md5=7ad4fb48ba7b71d1322e158d7d174b33</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.396%26sid%3Dliteratum%253Aachs%26aulast%3DAlbizu%26aufirst%3DL.%26aulast%3DCottet%26aufirst%3DM.%26aulast%3DKralikova%26aufirst%3DM.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DBrabet%26aufirst%3DI.%26aulast%3DRoux%26aufirst%3DT.%26aulast%3DBazin%26aufirst%3DH.%26aulast%3DBourrier%26aufirst%3DE.%26aulast%3DLamarque%26aufirst%3DL.%26aulast%3DBreton%26aufirst%3DC.%26aulast%3DRives%26aufirst%3DM.-L.%26aulast%3DNewman%26aufirst%3DA.%26aulast%3DJavitch%26aufirst%3DJ.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DTime-resolved%2520FRET%2520between%2520GPCR%2520ligands%2520reveals%2520oligomers%2520in%2520native%2520tissues%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D587%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Terillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayoub, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taulan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jockers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and hetero-dimers during biosynthesis</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1210%2Fme.2002-0222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=12554793" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=677-691&author=S.+Terillonauthor=T.+Durrouxauthor=B.+Mouillacauthor=A.+Breitauthor=M.+A.+Ayoubauthor=M.+Taulanauthor=R.+Jockersauthor=C.+Barberisauthor=M.+Bouvier&title=Oxytocin+and+vasopressin+V1a+and+V2+receptors+form+constitutive+homo-+and+hetero-dimers+during+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1210%2Fme.2002-0222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2002-0222%26sid%3Dliteratum%253Aachs%26aulast%3DTerillon%26aufirst%3DS.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DBreit%26aufirst%3DA.%26aulast%3DAyoub%26aufirst%3DM.%2BA.%26aulast%3DTaulan%26aufirst%3DM.%26aulast%3DJockers%26aufirst%3DR.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DOxytocin%2520and%2520vasopressin%2520V1a%2520and%2520V2%2520receptors%2520form%2520constitutive%2520homo-%2520and%2520hetero-dimers%2520during%2520biosynthesis%26jtitle%3DMol.%2520Endocrinol.%26date%3D2003%26volume%3D17%26spage%3D677%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Terillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1548</span><span class="NLM_x">–</span> <span class="NLM_lpage">1553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=1548-1553&author=S.+Terillonauthor=C.+Barberisauthor=M.+Bouvier&title=Heterodimerization+of+V1a+and+V2+vasopressin+receptors+determines+the+interaction+with+beta-arrestin+and+their+trafficking+patterns"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerillon%26aufirst%3DS.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DHeterodimerization%2520of%2520V1a%2520and%2520V2%2520vasopressin%2520receptors%2520determines%2520the%2520interaction%2520with%2520beta-arrestin%2520and%2520their%2520trafficking%2520patterns%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D1548%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Young, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilera, G.</span><span> </span><span class="NLM_article-title">Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1007%2Fs10571-006-9135-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=17318384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlSrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=439-461&author=S.+F.+Youngauthor=C.+Griffanteauthor=G.+Aguilera&title=Dimerization+between+vasopressin+V1b+and+corticotropin+releasing+hormone+type+1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors</span></div><div class="casAuthors">Young, Sharla F.; Griffante, Cristiana; Aguilera, Greti</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-461</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Increasing evidence indicates that guanyl protein coupled receptors (GPCRs), including members of the vasopressin (VP) receptor family can act as homo- and heterodimers.  Regulated expression and interaction of pituitary VP V1b receptor (V1bR) and corticotropin releasing hormone receptor type 1 (CRHR1) are crit. for hypothalamic pituitary adrenal (HPA) axis adaptation, but it is unknown whether this involves phys. interaction between these receptors.  Bioluminescence resonance energy transfer (BRET) expts. using V1bR and CRHR1 fused to either Renilla luciferase (Rluc) or yellow fluorescent protein (YFP) at the N-terminus, but not the carboxyl-terminus, revealed specific interaction (BRET50 = 0.39 ± 0.08, V1bR) that was inhibited by untagged V1b or CRHR1 receptors, suggesting homo- and heterodimerization.  The BRET data were confirmed by coimmunopptn. expts. using fully bioactive receptors tagged at the aminoterminus with c-myc and Flag epitopes, demonstrating specific homodimerization of the V1b receptor and heterodimerization of the V1b receptor with CRHR1 receptors.  Heterodimerization between V1bR and CRHR1 is not ligand dependent since stimulation with CRH and AVP had no effect on coimmunopptn.  In membranes obtained from cells cotransfected with CRHR1 and V1bR, incubation with the heterologous nonpeptide antagonist did not alter the binding affinity or capacity of the receptor.  The data demonstrate that V1bR and CRHR1 can form constitutive homo- and heterodimers and suggests that the heterodimerization does not influence the binding properties of these receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekhYSLo3q3LVg90H21EOLACvtfcHk0lhSEGasSiEV9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlSrtbc%253D&md5=59f772291c5e83bd5ab2bbebadbcdda1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs10571-006-9135-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-006-9135-8%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DS.%2BF.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DAguilera%26aufirst%3DG.%26atitle%3DDimerization%2520between%2520vasopressin%2520V1b%2520and%2520corticotropin%2520releasing%2520hormone%2520type%25201%2520receptors%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2007%26volume%3D27%26spage%3D439%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Berlier, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filanoski, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telford, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beechem, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugland, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugland, R. P.</span><span> </span><span class="NLM_article-title">Quantitative comparision of long-wavelength Alexa fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1712</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1177%2F002215540305101214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=14623938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFGhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=1699-1712&author=J.+E.+Berlierauthor=A.+Rotheauthor=G.+Bullerauthor=J.+Bradfordauthor=D.+R.+Grayauthor=B.+J.+Filanoskiauthor=W.+G.+Telfordauthor=S.+Yueauthor=J.+Liuauthor=C.-Y.+Cheungauthor=W.+Changauthor=J.+D.+Hirschauthor=J.+M.+Beechemauthor=R.+P.+Hauglandauthor=R.+P.+Haugland&title=Quantitative+comparision+of+long-wavelength+Alexa+fluor+dyes+to+Cy+dyes%3A+fluorescence+of+the+dyes+and+their+bioconjugates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: Fluorescence of the dyes and their bioconjugates</span></div><div class="casAuthors">Berlier, Judith E.; Rothe, Anca; Buller, Gayle; Bradford, Jolene; Gray, Diane R.; Filanoski, Brian J.; Telford, William G.; Yue, Stephen; Liu, Jixiang; Cheung, Ching-Ying; Chang, Wesley; Hirsch, James D.; Beechem, Joseph M.; Haugland, Rosaria P.; Haugland, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1699-1712</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Amine-reactive N-hydroxysuccinimidyl esters of Alexa Fluor fluorescent dyes with principal absorption maxima at about 555 nm, 633 nm, 647 nm, 660 nm, 680 nm, 700 nm, and 750 nm were conjugated to antibodies and other selected proteins.  These conjugates were compared with spectrally similar protein conjugates of the Cy3, Cy5, Cy5.5, Cy7, DY-630, DY-635, DY-680, and Atto 565 dyes.  As N-hydroxysuccinimidyl ester dyes, the Alexa Fluor 555 dye was similar to the Cy3 dye, and the Alexa Fluor 647 dye was similar to the Cy5 dye with respect to absorption maxima, emission maxima, Stokes shifts, and extinction coeffs.  However, both Alexa Fluor dyes were significantly more resistant to photobleaching than were their Cy dye counterparts.  Absorption spectra of protein conjugates prepd. from these dyes showed prominent blue-shifted shoulder peaks for conjugates of the Cy dyes but only minor shoulder peaks for conjugates of the Alexa Fluor dyes.  The anomalous peaks, previously obsd. for protein conjugates of the Cy5 dye, are presumably due to the formation of dye aggregates.  Absorption of light by the dye aggregates does not result in fluorescence, thereby diminishing the fluorescence of the conjugates.  The Alexa Fluor 555 and the Alexa Fluor 647 dyes in protein conjugates exhibited significantly less of this self-quenching, and therefore the protein conjugates of Alexa Fluor dyes were significantly more fluorescent than those of the Cy dyes, esp. at high degrees of labeling.  The results from our flow cytometry, immunocytochem., and immunohistochem. expts. demonstrate that protein-conjugated, long-wavelength Alexa Fluor dyes have advantages compared to the Cy dyes and other long-wavelength dyes in typical fluorescence-based cell labeling applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9nZHzN2e-7Vg90H21EOLACvtfcHk0lgo6c8byKkvHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFGhurk%253D&md5=7eb5eb61200cf5dbf7b8d5081845a1bb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1177%2F002215540305101214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F002215540305101214%26sid%3Dliteratum%253Aachs%26aulast%3DBerlier%26aufirst%3DJ.%2BE.%26aulast%3DRothe%26aufirst%3DA.%26aulast%3DBuller%26aufirst%3DG.%26aulast%3DBradford%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DD.%2BR.%26aulast%3DFilanoski%26aufirst%3DB.%2BJ.%26aulast%3DTelford%26aufirst%3DW.%2BG.%26aulast%3DYue%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DC.-Y.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DHirsch%26aufirst%3DJ.%2BD.%26aulast%3DBeechem%26aufirst%3DJ.%2BM.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26atitle%3DQuantitative%2520comparision%2520of%2520long-wavelength%2520Alexa%2520fluor%2520dyes%2520to%2520Cy%2520dyes%253A%2520fluorescence%2520of%2520the%2520dyes%2520and%2520their%2520bioconjugates%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2003%26volume%3D51%26spage%3D1699%26epage%3D1712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Gimpl, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">The oxytocin receptor system: structure, function and regulation</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=629-683&author=G+Gimplauthor=F.+Fahrenholz&title=The+oxytocin+receptor+system%3A+structure%2C+function+and+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DThe%2520oxytocin%2520receptor%2520system%253A%2520structure%252C%2520function%2520and%2520regulation%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D629%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Gimpl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trossen, C.</span><span> </span><span class="NLM_article-title">Oxytocin receptors: ligand binding, signalling and cholesterol dependance</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2FS0079-6123%2808%2900417-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=18655883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=193-204&author=G.+Gimplauthor=J.+Reitzauthor=S.+Brauerauthor=C.+Trossen&title=Oxytocin+receptors%3A+ligand+binding%2C+signalling+and+cholesterol+dependance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin receptors: ligand binding, signalling and cholesterol dependence</span></div><div class="casAuthors">Gimpl, Gerald; Reitz, Julian; Brauer, Sabine; Trossen, Conny</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">193-204</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The G protein coupled oxytocin receptor (OTR) reveals some specific mol. and physiol. characteristics.  Ligand-receptor interaction has been analyzed by photoaffinity labeling, site-directed mutagenesis, the construction of receptor chimeras and mol. modeling.  Major results of these studies will be summarized.  The N-terminus of the OTR is mainly involved in agonist binding.  Notably, antagonists that are derived from the ground structure of oxytocin, bind the receptor at distinct sites partly non-overlapping with the agonist binding site.  OTRs are able to couple to different G proteins, with a subsequent stimulation of phospholipase C-β isoforms.  In dependence on G protein coupling, OTRs can transduce growth-inhibitory or proliferatory signals.  Some evidence is provided that OTRs are also present in form of dimeric or oligomeric complexes at the cell surface.  The affinity of the receptor for ligands is strongly dependent on the presence of divalent cations (Mg2+) and cholesterol that both act like pos. allosteric modulators.  While the high-affinity state of the receptor for agonists requires divalent cations and cholesterol, the high-affinity state for antagonists is only dependent on a sufficient amt. of cholesterol.  Cholesterol affects ligand-binding affinity, receptor signalling and stability.  Since the purifn. of the OTR has never been achieved, alternative methods to study the receptor in its native environment are necessary.  Promising strategies for the site-specific labeling of the OTR will be presented.  The employment of diverse reporter mols. introduced at different positions within the OTR might allow us in the near future to measure conformational changes of the receptor in its native lipid environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvpiy6HPCjfrVg90H21EOLACvtfcHk0lgo6c8byKkvHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrvK&md5=f31c61f01930e2c3448d7ef6df854c46</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900417-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900417-2%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG.%26aulast%3DReitz%26aufirst%3DJ.%26aulast%3DBrauer%26aufirst%3DS.%26aulast%3DTrossen%26aufirst%3DC.%26atitle%3DOxytocin%2520receptors%253A%2520ligand%2520binding%252C%2520signalling%2520and%2520cholesterol%2520dependance%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D193%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Derick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagnon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2777</span><span class="NLM_x">–</span> <span class="NLM_lpage">2789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1210%2Fme.2004-0124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=15284336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslKksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=2777-2789&author=S.+Derickauthor=A.+Penaauthor=T.+Durrouxauthor=J.+Wagnonauthor=C.+Serradeil-Le+Galauthor=M.+Hibertauthor=D.+Rognanauthor=G.+Guillon&title=Key+amino+acids+located+within+the+transmembrane+domains+5+and+7+account+for+the+pharmacological+specificity+of+the+human+V1b+vasopressin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor</span></div><div class="casAuthors">Derick, S.; Pena, A.; Durroux, T.; Wagnon, J.; Serradeil-Le Gal, C.; Hibert, M.; Rognan, D.; Guillon, G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2777-2789</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">In mammals, the vasopressin V1b receptor (V1b-R) is known to regulate ACTH secretion and, more recently, stress and anxiety.  The characterization of the mol. determinant responsible for its pharmacol. selectivity was made possible by the recent discovery of the first V1b antagonist, SSR149415.  Based upon the structure of the crystd. bovine rhodopsin, we established a three-dimensional mol. model of interaction between the human V1b-R (hV1b-R) and SSR149415.  Four amino acids located in distinct transmembrane helixes (fourth, fifth, and seventh) were found potentially responsible for the hV1b-R selectivity.  To validate these assumptions, we selectively replaced the leucine 181, methionine 220, alanine 334, and serine 338 residues of hV1a-R by their corresponding amino acids present in the hV1b-R (phenylalanine 164, threonine 203, methionine 324, and asparagine 328, resp.).  Four mutants, which all exhibited nanomolar affinities for vasopressin and good coupling to phospholipase C pathway, were generated.  HV1a receptors mutated at position 220 and 334 exhibited striking increase in affinity for SSR149415 both in binding and phospholipase C assays at variance with the hV1a-R modified at position 181 or 338.  In conclusion, this study provides the first structural features concerning the hV1b-R and highlights the role of few specific residues in its pharmacol. selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4qbDQIm4cFbVg90H21EOLACvtfcHk0lhiBAdTA64rxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslKksLg%253D&md5=53f8487765ba5adb5a80de4d7d8924b0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1210%2Fme.2004-0124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2004-0124%26sid%3Dliteratum%253Aachs%26aulast%3DDerick%26aufirst%3DS.%26aulast%3DPena%26aufirst%3DA.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DWagnon%26aufirst%3DJ.%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DKey%2520amino%2520acids%2520located%2520within%2520the%2520transmembrane%2520domains%25205%2520and%25207%2520account%2520for%2520the%2520pharmacological%2520specificity%2520of%2520the%2520human%2520V1b%2520vasopressin%2520receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2004%26volume%3D18%26spage%3D2777%26epage%3D2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Arttamangkul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Maubecin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Binding and internalization of fluorescent opioid conjugates in living cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1570</span><span class="NLM_x">–</span> <span class="NLM_lpage">1580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1570-1580&author=S.+Arttamangkulauthor=V.+Alvarez-Maubecinauthor=G.+Thomasauthor=J.+T.+Williamsauthor=D.+K.+Grandy&title=Binding+and+internalization+of+fluorescent+opioid+conjugates+in+living+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArttamangkul%26aufirst%3DS.%26aulast%3DAlvarez-Maubecin%26aufirst%3DV.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DBinding%2520and%2520internalization%2520of%2520fluorescent%2520opioid%2520conjugates%2520in%2520living%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1570%26epage%3D1580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagnon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonnerre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulombard, A.</span><span> </span><span class="NLM_article-title">An overview of SSR149415, a selective vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=53-68&author=C.+Serradeil-Le+Galauthor=J.+Wagnonauthor=B.+Tonnerreauthor=R.+Rouxauthor=G.+Garciaauthor=G.+Griebelauthor=A.+Aulombard&title=An+overview+of+SSR149415%2C+a+selective+vasopressin+V%281b%29+receptor+antagonist+for+the+treatment+of+stress-related+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DWagnon%26aufirst%3DJ.%26aulast%3DTonnerre%26aufirst%3DB.%26aulast%3DRoux%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DG.%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DAulombard%26aufirst%3DA.%26atitle%3DAn%2520overview%2520of%2520SSR149415%252C%2520a%2520selective%2520vasopressin%2520V%25281b%2529%2520receptor%2520antagonist%2520for%2520the%2520treatment%2520of%2520stress-related%2520disorders%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2005%26volume%3D11%26spage%3D53%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hope, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walti, M.</span><span> </span><span class="NLM_article-title">Synthesis of α-hydroxy-analogues of <i>S</i>-benzylcysteine and cysteine</span> <span class="citation_source-journal">J. Chem. Soc. C</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_fpage">2475</span><span class="NLM_x">–</span> <span class="NLM_lpage">2478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1039%2Fj39700002475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaE3MXitlWitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1970&pages=2475-2478&author=D.+B.+Hopeauthor=M.+Walti&title=Synthesis+of+%CE%B1-hydroxy-analogues+of+S-benzylcysteine+and+cysteine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of the α-hydroxy-analogs of S-benzylcysteine and cysteine</span></div><div class="casAuthors">Hope, Derek B.; Walti, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2475-8</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">Β-Chlorolactic acid was condensed with toluene-α-thiol to give 2-hydroxy-3-benzylthiopropanoic acid.  The optical isomers were prepd. by resolution with brucine and quinine.  Removal of benzyl groups yielded (+)- and (-)-2-hydroxy-3-mercaptopropanoic acids.  Desulfurization with Raney Ni gave (+)- and (-)-lactic acid.  Configuration and optical purity of all isomers were detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0QVbzsJrLqrVg90H21EOLACvtfcHk0lhiBAdTA64rxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXitlWitw%253D%253D&md5=8a17612896990aff15e2ef9a27fed57f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fj39700002475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj39700002475%26sid%3Dliteratum%253Aachs%26aulast%3DHope%26aufirst%3DD.%2BB.%26aulast%3DWalti%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520%25CE%25B1-hydroxy-analogues%2520of%2520S-benzylcysteine%2520and%2520cysteine%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1970%26spage%3D2475%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Merrifield, R. B.</span><span> </span><span class="NLM_article-title">Solid-phase peptide synthesis. III. An improved synthesis of bradykinin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1385</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00897a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1964&pages=1385-1390&author=R.+B.+Merrifield&title=Solid-phase+peptide+synthesis.+III.+An+improved+synthesis+of+bradykinin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fbi00897a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00897a032%26sid%3Dliteratum%253Aachs%26aulast%3DMerrifield%26aufirst%3DR.%2BB.%26atitle%3DSolid-phase%2520peptide%2520synthesis.%2520III.%2520An%2520improved%2520synthesis%2520of%2520bradykinin%26jtitle%3DBiochemistry%26date%3D1964%26volume%3D3%26spage%3D1385%26epage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Stewart, J. M.; Young, J. D.</span><span> </span><span class="NLM_article-title">Solid Phase Synthesis</span>; <span class="NLM_publisher-name">Pierce Chemical Co.</span>: <span class="NLM_publisher-loc">Rockford, IL</span>,<span class="NLM_x"> </span><span class="NLM_year">1984</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Stewart%2C+J.+M.%3B+Young%2C+J.+D.+Solid+Phase+Synthesis%3B+Pierce+Chemical+Co.%3A+Rockford%2C+IL%2C+1984."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DJ.%2BM.%26atitle%3DSolid%2520Phase%2520Synthesis%26pub%3DPierce%2520Chemical%2520Co%26date%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszynski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bankowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klis, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title">Solid-phase synthesis of 16 potent (selective and non-selective) in vivo antagonists of oxytocin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=383-391&author=M.+Manningauthor=M.+Kruszynskiauthor=K.+Bankowskiauthor=A.+Olmaauthor=B.+Lammekauthor=L.+L.+Chengauthor=W.+A.+Klisauthor=J.+Setoauthor=J.+Haldarauthor=W.+H.+Sawyer&title=Solid-phase+synthesis+of+16+potent+%28selective+and+non-selective%29+in+vivo+antagonists+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DKruszynski%26aufirst%3DM.%26aulast%3DBankowski%26aufirst%3DK.%26aulast%3DOlma%26aufirst%3DA.%26aulast%3DLammek%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DL.%2BL.%26aulast%3DKlis%26aufirst%3DW.%2BA.%26aulast%3DSeto%26aufirst%3DJ.%26aulast%3DHaldar%26aufirst%3DJ.%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3DSolid-phase%2520synthesis%2520of%252016%2520potent%2520%2528selective%2520and%2520non-selective%2529%2520in%2520vivo%2520antagonists%2520of%2520oxytocin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D383%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowbridge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, W. H.</span><span> </span><span class="NLM_article-title">Synthesis and Some pharmacological properties of [1-(l-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxyl[4-Thr]-oxytocin), a peptide with strikingly high oxytocic potency, and of [1-(<span class="smallcaps smallerCapital">l</span>-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00225a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1976&pages=376-380&author=M.+Manningauthor=J.+Lowbridgeauthor=J.+Haldarauthor=W.+H.+Sawyer&title=Synthesis+and+Some+pharmacological+properties+of+%5B1-%28l-2-hydroxy-3-mercaptopropanoic+acid%29%2C+4-threonine%5Doxytocin+%28hydroxyl%5B4-Thr%5D-oxytocin%29%2C+a+peptide+with+strikingly+high+oxytocic+potency%2C+and+of+%5B1-%28l-2-hydroxy-3-mercaptopropanoic+acid%29%5Doxytocin+%28hydroxy-oxytocin%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00225a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00225a007%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DLowbridge%26aufirst%3DJ.%26aulast%3DHaldar%26aufirst%3DJ.%26aulast%3DSawyer%26aufirst%3DW.%2BH.%26atitle%3DSynthesis%2520and%2520Some%2520pharmacological%2520properties%2520of%2520%255B1-%2528l-2-hydroxy-3-mercaptopropanoic%2520acid%2529%252C%25204-threonine%255Doxytocin%2520%2528hydroxyl%255B4-Thr%255D-oxytocin%2529%252C%2520a%2520peptide%2520with%2520strikingly%2520high%2520oxytocic%2520potency%252C%2520and%2520of%2520%255B1-%2528l-2-hydroxy-3-mercaptopropanoic%2520acid%2529%255Doxytocin%2520%2528hydroxy-oxytocin%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1976%26volume%3D19%26spage%3D376%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Koenig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geiger, R.</span><span> </span><span class="NLM_article-title">A new method for the synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide by using 1-hydroxy-benzotriazole as additives</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1970&pages=788-798&author=W.+Koenigauthor=R.+Geiger&title=A+new+method+for+the+synthesis+of+peptides%3A+activation+of+the+carboxyl+group+with+dicyclohexylcarbodiimide+by+using+1-hydroxy-benzotriazole+as+additives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoenig%26aufirst%3DW.%26aulast%3DGeiger%26aufirst%3DR.%26atitle%3DA%2520new%2520method%2520for%2520the%2520synthesis%2520of%2520peptides%253A%2520activation%2520of%2520the%2520carboxyl%2520group%2520with%2520dicyclohexylcarbodiimide%2520by%2520using%25201-hydroxy-benzotriazole%2520as%2520additives%26jtitle%3DChem.%2520Ber.%26date%3D1970%26volume%3D103%26spage%3D788%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Bodansky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Vigneaud, V.</span><span> </span><span class="NLM_article-title">A method of synthesis of long peptide chains using a synthesis of oxytocin as an example</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">5688</span><span class="NLM_x">–</span> <span class="NLM_lpage">5691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1959&pages=5688-5691&author=M.+Bodanskyauthor=V.+du+Vigneaud&title=A+method+of+synthesis+of+long+peptide+chains+using+a+synthesis+of+oxytocin+as+an+example"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodansky%26aufirst%3DM.%26aulast%3Ddu%2BVigneaud%26aufirst%3DV.%26atitle%3DA%2520method%2520of%2520synthesis%2520of%2520long%2520peptide%2520chains%2520using%2520a%2520synthesis%2520of%2520oxytocin%2520as%2520an%2520example%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1959%26volume%3D81%26spage%3D5688%26epage%3D5691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Manning, M.</span><span> </span><span class="NLM_article-title">Synthesis by the Merrifield method of a protected nonapeptide amide with the amino acid sequence of oxytocin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1968&pages=1348-1349&author=M.+Manning&title=Synthesis+by+the+Merrifield+method+of+a+protected+nonapeptide+amide+with+the+amino+acid+sequence+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26atitle%3DSynthesis%2520by%2520the%2520Merrifield%2520method%2520of%2520a%2520protected%2520nonapeptide%2520amide%2520with%2520the%2520amino%2520acid%2520sequence%2520of%2520oxytocin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1968%26volume%3D11%26spage%3D1348%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">du Vigneaud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsoyannis, P. G.</span><span> </span><span class="NLM_article-title">A synthetic preparation possessing biological properties associated with arginine-vasopressin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">4751</span><span class="NLM_x">–</span> <span class="NLM_lpage">4752</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01647a089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1954&pages=4751-4752&author=V.+du+Vigneaudauthor=D.+T.+Gishauthor=P.+G.+Katsoyannis&title=A+synthetic+preparation+possessing+biological+properties+associated+with+arginine-vasopressin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja01647a089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01647a089%26sid%3Dliteratum%253Aachs%26aulast%3Ddu%2BVigneaud%26aufirst%3DV.%26aulast%3DGish%26aufirst%3DD.%2BT.%26aulast%3DKatsoyannis%26aufirst%3DP.%2BG.%26atitle%3DA%2520synthetic%2520preparation%2520possessing%2520biological%2520properties%2520associated%2520with%2520arginine-vasopressin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1954%26volume%3D76%26spage%3D4751%26epage%3D4752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miteva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pancheva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wo, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. Y.</span><span> </span><span class="NLM_article-title">Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparison with atosiban</span> <span class="citation_source-journal">Int. J. Pept. Protein Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1111%2Fj.1399-3011.1995.tb00596.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=8537178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaK2MXovVGjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1995&pages=244-252&author=M.+Manningauthor=K.+Mitevaauthor=S.+Panchevaauthor=S.+Stoevauthor=N.+C.+Woauthor=W.+Y.+Chan&title=Design+and+synthesis+of+highly+selective+in+vitro+and+in+vivo+uterine+receptor+antagonists+of+oxytocin%3A+comparison+with+atosiban"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban</span></div><div class="casAuthors">Manning, M.; Miteva, K.; Pancheva, S.; Stoev, S.; Wo, N. C.; Chan, W. Y.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide & Protein Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">244-53</span>CODEN:
                <span class="NLM_cas:coden">IJPPC3</span>;
        ISSN:<span class="NLM_cas:issn">0367-8377</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">The authors report the solid phase synthesis and some pharmacol. properties of seven position two analogs (peptides 1-7) of one of the lead oxytocin antagonists, des-9-glycinamide[1-(β-mercapto-β,β-pentamethylenepropionic acid),2-O-methyltyrosine,4-threonine]ornithine-vasotocin (desGly-NH2,d(CH2)5-[Tyr(Me)2,Thr4]OVT).  Peptides 1-7 have the following substituents at position two (1) D-Tyr(Me); (2) L-Tyr(Et); (3) D-Tyr(Et); (4) L-Tyr; (5) D-Tyr; (6) D-Phe and (7) D-Trp.  These were evaluated for agonistic and antagonistic activities in in vitro and in vivo OT assays in vivo vasopressor (V1a-receptor) assays and in vivo antidiuretic (V2-receptor) assays.  None of the seven peptides exhibits oxytocic or vasopressor agonism.  Peptides 1, 2, 4, 6 and 7 are extremely weak V2 agonists (V2 activities range from 0.001 to 0.02 U/mg).  Peptides 3 and 5 exhibit weak V2 antagonism (pA2 < 6.0 and <5.5, resp.).  Peptides 1-7 exhibit potent in vitro (no Mg2+) OT antagonism (anti-OT pA2 values range from 7.66 to 8.03).  Peptides 1 and 4-7 exhibit potent in vivo OT antagonism.  Estd. in vivo anti-OT pA2 values range from 7.06 to 7.79 (peptides 2 and 3 were not tested).  With anti-V1a pA2 values of 5.17-6.25 all seven peptides exhibit reduced anti-V1a potencies relative to the parent peptide (anti-V1a pA2 = 6.46).  Four of these peptides (4-7) exhibit striking gains in in vitro and in vivo anti-OT/anti-V1a selectivities compared to the parent peptide which has an in vitro selectivity of 30 and an in vivo selectivity of 18.  The D-Tyr2 (5), D-Trp2 (7), D-Phe2 (6) and L-Tyr2 (4) analogs of the parent peptide exhibit anti-OT (in vitro)/anti-V1a selectivities = 240, 390, 404 and 540, resp.  The L-Tyr2 (4), D-Trp2 (7), D-Phe2 (6) and D-Tyr2 (5) analogs exhibited anti-OT (in vivo)/anti-V1a selectivities of 72, 80, 88 and 95, resp.  Peptides 4-7 appear to be the most selective peptide OT antagonists reported to date.  In this regard it may be noted that they appear to be as or more potent and much more selective than the closely related OT antagonist Atosiban which is currently undergoing clin. trial as a potential therapeutic agent for the prevention of premature labor.  Atosiban (peptide 8) was re-synthesized and pharmacol. evaluated in the labs.  Atosiban exhibits the following antagonistic potencies.  Anti-OT (in vitro, no Mg2+) pA2 = 7.71; anti-OT in vivo pA2 = 7.05; anti=V1a pA2 = 6.14 and anti-V2 pA2 ≈ 5.9.  Its anti-OT (in vivo)/anti-V1a selectivity is 8.  Some of these antagonists may be suitable candidates for evaluation as potential tocolytic agents for use in the treatment of pre-term labor.  They could also serve as useful new pharmacol. tools for studies on the physiol. roles of oxytocin.  Finally, the findings presented here provide useful clues for the design of more potent and more selective OT antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8ff7obT3E7Vg90H21EOLACvtfcHk0lg3Gv7vjEsi7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovVGjtbk%253D&md5=a22ffdc7e24d94e536d5a31365e5e443</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.1995.tb00596.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.1995.tb00596.x%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DMiteva%26aufirst%3DK.%26aulast%3DPancheva%26aufirst%3DS.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DWo%26aufirst%3DN.%2BC.%26aulast%3DChan%26aufirst%3DW.%2BY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520highly%2520selective%2520in%2520vitro%2520and%2520in%2520vivo%2520uterine%2520receptor%2520antagonists%2520of%2520oxytocin%253A%2520comparison%2520with%2520atosiban%26jtitle%3DInt.%2520J.%2520Pept.%2520Protein%2520Res.%26date%3D1995%26volume%3D46%26spage%3D244%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Rivier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galyean, R.</span><span> </span><span class="NLM_article-title">Solid-phase synthesis of somatostatin and glucagon-selective analogs in gram quantities</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1938</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1978&pages=1927-1938&author=J.+Rivierauthor=R.+Kaiserauthor=R.+Galyean&title=Solid-phase+synthesis+of+somatostatin+and+glucagon-selective+analogs+in+gram+quantities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRivier%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DR.%26aulast%3DGalyean%26aufirst%3DR.%26atitle%3DSolid-phase%2520synthesis%2520of%2520somatostatin%2520and%2520glucagon-selective%2520analogs%2520in%2520gram%2520quantities%26jtitle%3DBiopolymers%26date%3D1978%26volume%3D17%26spage%3D1927%26epage%3D1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. W. M.</span><span> </span><span class="NLM_article-title">The purification of synthetic oxytocin and analogues by gel filtration on Sephadex G-15</span> <span class="citation_source-journal">J. Chromatogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm1016208&amp;key=10.1016%2F0021-9673%2868%2985065-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm1016208&amp;key=5728336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm1016208&amp;key=1%3ACAS%3A528%3ADyaF1MXjsVKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1968&pages=396-398&author=M.+Manningauthor=T.+C.+Wuuauthor=J.+W.+M.+Baxter&title=The+purification+of+synthetic+oxytocin+and+analogues+by+gel+filtration+on+Sephadex+G-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of synthetic oxytocin and analogs by gel filtration on Sephadex G-15</span></div><div class="casAuthors">Manning, Maurice; Wuu, Ting-Chi; Baxter, John W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">396-8</span>CODEN:
                <span class="NLM_cas:coden">JOCRAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    </div><div class="casAbstract">Synthetic oxytocin and its analogs can be purified in 64 hrs. by a Sephadex G-15 gel filtration technique which is an adaptation of the Sephadex G-25 procedure described by J. Porath and A. V. Schally (1962), for purifying natural oxytocin.  Dissolve 300 mg. crude lyophilized powder in 2.0 ml. 50% HOAc.  Add the soln. to the gel column, preequilibrated with 500 ml. 50% HOAc, and elute with 50% HOAc at 8-10 ml./hr., collecting 2-ml. aliquots.  The peptide material elutes in 2 partially resolved peaks, clearly sepd. from inorg. salts.  Dil. the 2nd peak, contg. most of the active peptide, with 2 vols. water and lyophilize.  Dissolve 35 mg. lyophilized powder in 2.0 ml. 0.2N HOAc and add to the gel column, which has been reequilibrated for 20 hrs. with 500 ml. 0.2N HOAc.  Elute as before, but at 12-15 ml./hr.  The active peptide emerges as a single, nearly sym. peak, preceded by a small amt. of dimer.  Dil. the main peak with 2 vols. water and lyophilize to give the purified product as a fluffy white powder (30 mg.).  The technique is suitable for purification of synthetic analogs of the neurohypophysial hormones in which the only contaminants are inorg. salts and dimer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3CLWh1D4xBbVg90H21EOLACvtfcHk0lg3Gv7vjEsi7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXjsVKrtA%253D%253D&md5=e2e1af9a0d6abd2488cfdafcf201572e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2F0021-9673%2868%2985065-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9673%252868%252985065-4%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DWuu%26aufirst%3DT.%2BC.%26aulast%3DBaxter%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DThe%2520purification%2520of%2520synthetic%2520oxytocin%2520and%2520analogues%2520by%2520gel%2520filtration%2520on%2520Sephadex%2520G-15%26jtitle%3DJ.%2520Chromatogr.%26date%3D1968%26volume%3D38%26spage%3D396%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Albizu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teppaz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansanay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span> </span><span class="NLM_article-title">Toward efficiency drug screening by homogenous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4976</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061404q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4976-4985&author=L.+Albizuauthor=G.+Teppazauthor=R.+Seyerauthor=H.+Bazinauthor=H.+Ansanayauthor=M.+Manningauthor=B.+Mouillacauthor=T.+Durroux&title=Toward+efficiency+drug+screening+by+homogenous+assays+based+on+the+development+of+new+fluorescent+vasopressin+and+oxytocin+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm061404q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061404q%26sid%3Dliteratum%253Aachs%26aulast%3DAlbizu%26aufirst%3DL.%26aulast%3DTeppaz%26aufirst%3DG.%26aulast%3DSeyer%26aufirst%3DR.%26aulast%3DBazin%26aufirst%3DH.%26aulast%3DAnsanay%26aufirst%3DH.%26aulast%3DManning%26aufirst%3DM.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26atitle%3DToward%2520efficiency%2520drug%2520screening%2520by%2520homogenous%2520assays%2520based%2520on%2520the%2520development%2520of%2520new%2520fluorescent%2520vasopressin%2520and%2520oxytocin%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4976%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Corbani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonindard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J.-C.</span><span> </span><span class="NLM_article-title">Ligand-regulated internalization of the opioid receptor-like 1: a confocal study</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">2876</span><span class="NLM_x">–</span> <span class="NLM_lpage">2885</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2004&pages=2876-2885&author=M.+Corbaniauthor=C.+Gonindardauthor=J.-C.+Meunier&title=Ligand-regulated+internalization+of+the+opioid+receptor-like+1%3A+a+confocal+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorbani%26aufirst%3DM.%26aulast%3DGonindard%26aufirst%3DC.%26aulast%3DMeunier%26aufirst%3DJ.-C.%26atitle%3DLigand-regulated%2520internalization%2520of%2520the%2520opioid%2520receptor-like%25201%253A%2520a%2520confocal%2520study%26jtitle%3DEndocrinology%26date%3D2004%26volume%3D145%26spage%3D2876%26epage%3D2885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm1016208&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm1016208%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-8%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm1016208" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799e40b6b28d94a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
